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A B S T R A C T
Background
In settings where both Plasmodium vivax and Plasmodium falciparum infection cause malaria, rapid diagnostic tests (RDTs) need to
distinguish which species is causing the patients’ symptoms, as different treatments are required. Older RDTs incorporated two test
lines to distinguish malaria due to P. falciparum, from malaria due to any other Plasmodium species (non-falciparum). These RDTs
can be classified according to which antibodies they use: Type 2 RDTs use HRP-2 (for P. falciparum) and aldolase (all species); Type 3
RDTs use HRP-2 (for P. falciparum) and pLDH (all species); Type 4 use pLDH (fromP. falciparum) and pLDH (all species).
More recently, RDTs have been developed to distinguish P. vivax parasitaemia by utilizing a pLDH antibody specific to P. vivax.
Objectives
To assess the diagnostic accuracy of RDTs for detecting non-falciparum or P. vivax parasitaemia in people living in malaria-endemic
areas who present to ambulatory healthcare facilities with symptoms suggestive of malaria, and to identify which types and brands of
commercial test best detect non-falciparum and P. vivax malaria.
Search methods
We undertook a comprehensive search of the following databases up to 31 December 2013: Cochrane Infectious Diseases Group
Specialized Register; MEDLINE; EMBASE;MEDION; Science Citation Index; Web of Knowledge; African Index Medicus; LILACS;
and IndMED.
Selection criteria
Studies comparing RDTs with a reference standard (microscopy or polymerase chain reaction) in blood samples from a random or
consecutive series of patients attending ambulatory health facilities with symptoms suggestive of malaria in non-falciparum endemic
areas.
1Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries (Review)
Copyright © 2015 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Data collection and analysis
For each study, two review authors independently extracted a standard set of data using a tailored data extraction form. We grouped
comparisons by type of RDT (defined by the combinations of antibodies used), and combined in meta-analysis where appropriate.
Average sensitivities and specificities are presented alongside 95% confidence intervals (95% CI).
Main results
We included 47 studies enrolling 22,862 participants. Patient characteristics, sampling methods and reference standard methods were
poorly reported in most studies.
RDTs detecting ’non-falciparum’ parasitaemia
Eleven studies evaluated Type 2 tests compared with microscopy, 25 evaluated Type 3 tests, and 11 evaluated Type 4 tests. In meta-
analyses, average sensitivities and specificities were 78% (95% CI 73% to 82%) and 99% (95% CI 97% to 99%) for Type 2 tests, 78%
(95% CI 69% to 84%) and 99% (95% CI 98% to 99%) for Type 3 tests, and 89% (95% CI 79% to 95%) and 98% (95% CI 97%
to 99%) for Type 4 tests, respectively. Type 4 tests were more sensitive than both Type 2 (P = 0.01) and Type 3 tests (P = 0.03).
Five studies compared Type 3 tests with PCR; in meta-analysis, the average sensitivity and specificity were 81% (95% CI 72% to 88%)
and 99% (95% CI 97% to 99%) respectively.
RDTs detecting P.vivax parasitaemia
Eight studies compared pLDH tests to microscopy; the average sensitivity and specificity were 95% (95% CI 86% to 99%) and 99%
(95% CI 99% to 100%), respectively.
Authors’ conclusions
RDTs designed to detect P. vivax specifically, whether alone or as part of a mixed infection, appear to be more accurate than older tests
designed to distinguish P. falciparum malaria from non-falciparum malaria. Compared to microscopy, these tests fail to detect around
5% ofP. vivax cases. This Cochrane Review, in combination with other published information about in vitro test performance and
stability in the field, can assist policy-makers to choose between the available RDTs.
P L A I N L A N G U A G E S U M M A R Y
Rapid tests for diagnosing malaria caused by Plasmodium vivax or other less common parasites
This review summarises trials evaluating the accuracy of rapid diagnostic tests (RDTs) for diagnosing malaria due to Plasmodium vivax
or other non-falciparum species. After searching for relevant studies up to December 2013, we included 47 studies, enrolling 22,862
adults and children.
What are rapid tests and why do they need to be able to distinguish Plasmodium vivax malaria
RDTs are simple to use, point of care tests, suitable for use in rural settings by primary healthcare workers. RDTs work by using
antibodies to detect malaria antigens in the patient’s blood. A drop of blood is placed on the test strip where the antibodies and antigen
combine to create a distinct line indicating a positive test.
Malaria can be caused any one of five species of Plasmodium parasite, but P. falciparum and P. vivax are the most common. In some
areas, RDTs need to be able to distinguish which species is causing the malaria symptoms as different species may require different
treatments. Unlike P. falciparum, P. vivax has a liver stage which can cause repeated illness every few months unless it is treated with
primaquine. The most common types of RDTs for P. vivax use two test lines in combination; one line specific to P. falciparum, and one
line which can detect any species of Plasmodium. If the P. falciparum line is negative and the ’any species’ line is positive, the illness is
presumed to be due to P. vivax (but could also be caused by P. malariae, or P. ovale). More recently, RDTs have been developed which
specifically test for P. vivax.
What does the research say
RDTs testing for non-falciparum malaria were very specific (range 98% to 100%) meaning that only 1% to 2% of patients who test
positive would actually not have the disease. However, they were less sensitive (range 78% to 89%), meaning between 11% and 22%
of people with non-falciparum malaria would actually get a negative test result.
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RDTs which specifically tested for P. vivax were more accurate with a specificity of 99% and a sensitivity of 95%, meaning that only
5% of people with P. vivax malaria would have a negative test result.
B A C K G R O U N D
Target condition being diagnosed
Malaria is a life-threatening illness caused by protozoan Plasmod-
ium parasites, which are transmitted by many species of Anophe-
les mosquitoes. In 2008, there were between 190 and 311 mil-
lion cases of malaria worldwide (WHO 2009b). The two most
common species of parasites that cause malaria are Plasmodium
falciparum andPlasmodium vivax. Falciparum malaria is the most
common cause of severe malaria and malaria deaths and can also
cause other complications, such as anaemia and, in pregnancy, low
birthweight babies. Vivax malaria is a relapsing form, which is
rarely fatal but can cause serious anaemia in children. Other, less
common, Plasmodium species that cause malaria in people include
P. malariae and P. ovale.Malaria is a curable disease, and therefore
malaria-related morbidity and mortality can be reduced. Early,
prompt and accurate diagnosis followed by appropriate treatment
is the key to effective disease management (WHO 2003) and is
a basic tenet of current malaria control policy (WHO 2005; Bell
2006).
People who are exposed repeatedly to Plasmodium infection de-
velop a partial and incomplete immunity. This means that in
highly endemic areas those most at risk are children under the age
of five, who have not yet had the chance to develop immunity. In
less endemic areas, or areas of seasonal or epidemic transmission,
older children and adults are also at risk due to less developed im-
munity. Travellers from non-endemic to endemic countries are at
highest risk because they have no immunity at all.
Index test(s)
Rapid diagnostic tests (RDTs) (WHO 2003) detect parasite-spe-
cific antigens in a drop of fresh blood through lateral flow im-
munochromatography (WHO 2006). The World Health Orga-
nization (WHO) currently lists 96 commercially available test
kits meeting ISO131485 manufacturing standards (WHO 2009).
RDTs do not require a laboratory or any special equipment (WHO
2006), are simple to use and can give results as a simple positive or
negative result, at thresholds pre-set by the manufacturers, within
15 minutes (Talman 2007). Therefore, RDTs are, in general, suit-
able for remote areas with limited facilities and relatively untrained
staff. However, they have a limited shelf life and need to be kept
dry and away from temperature extremes. They may also fail to
detect malaria where there are low levels of Plasmodium parasites
in the blood, for example in young children with low immunity,
and false positives are possible due to cross reactions or gametocy-
taemia (Kakkilaya 2003).
Different types of RDT use different types of antibody or com-
bination of antibodies to detect Plasmodium antigens. Some an-
tibodies aim to detect a particular species while others are pan-
malarial, aiming to detect all types of Plasmodium.Table 1 lists the
main types of RDT that were available in 2010. Since this classi-
fication was developed, the following test types have also become
available:
• Pan pLDH only, with possible results of: no malaria; P.
falciparum (Pf ), P. vivax (Pv), P. ovale (Po), or P. malariae (Pm);
invalid
• P. vivax specific pLDH only, with possible results of: no
malaria; Pv; invalid;
• P. falciparum specific HRP-2 and P. vivax specific pLDH,
with possible results of: no malaria; Pf, Pv, Pf + Pv; invalid.
HRP-2 can stay in the blood for 28 days after initiating the anti-
malarial therapy (Kakkilaya 2003). Because of this ’persistent anti-
genaemia’, it is not possible to use these tests in assessing parasite
clearance following treatment, and false positive results may be
found in patients who have recently been treated for malaria. In
contrast, pLDH is rapidly cleared from the blood following para-
site death; in fact it may clear more rapidly than the dead parasites
(WHO 2009).
Alternative test(s)
Microscopic examination of Giemsa-stained thick and thin blood
films remains the conventional laboratory method and is still re-
garded as the ’gold standard’. Microscopic examination provides
a good sensitivity and specificity, and it allows species and stage
differentiations and quantification of parasites, all of which are
important in assessing the disease severity and prescribing appro-
priate therapy. Intensive examination is more likely to reveal par-
asitaemia so the test is carried out with a fixed number of fields
examined. Infections may be missed if slides are not examined
carefully (Wongsrichanalai 2007). Very low parasitaemia may be
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missed even by good quality microscopy; the limit of detection of
thick smear microscopy has been estimated at approximately four
to 20 asexual parasites per µL, although under field conditions a
threshold of 50 to 100 asexual parasites per µL is more realistic
(Wongsrichanalai 2007). False positive results are also possible; if
blood slides are not prepared carefully, artefacts may be formed
which can be mistaken for Plasmodium parasites (Wongsrichanalai
2007).
The polymerase chain reaction (PCR), which is a molecular
method based onDNA amplification, is themost accuratemethod
of detecting parasites in the blood. Compared tomicroscopy, PCR
is less prone to observer error and more sensitive at low levels of
parasitaemia (Snounou 1993). For PCR, the limit of detection
may be as low as 0.004 asexual parasites per µL (Hänscheid 2002).
However, whether this increased ability to detect low level para-
sitaemia makes it a better diagnostic test is uncertain, as sub-mi-
croscopic parasitaemia are of unknown clinical significance and
the prevalence of asymptomatic sub-microscopic infection is high
in some areas (May 1999). PCR is currently not widely available
due to logistical constraints and the need for specially trained tech-
nicians and a well-equipped laboratory. It is usually used only for
research purposes.
Rationale
A diagnostic test which is simple to perform, rapid and accurate is
important in many situations to ensure prompt specific treatment,
reduce misdiagnosis of non-malarial illness as malaria, limit the
development of drug resistance (Talman 2007) and reduce drug
wastage. The WHO lists some of the situations where RDTs can
be particularly useful in remote areas without access to expert
microscopy, complex emergencies and severe malaria, where rapid
diagnosis is essential to save lives (WHO 2000).
The WHO 2010 guidelines recommend chloroquine for P. vivax
malaria in areas in which parasites remain sensitive to this drug, al-
though they are currently considering recommending artemisinin-
based combination therapies (ACTs) for all P. vivax infections as
they are effective (Gogtay 2013). Primaquine may be added to
immediate treatment of P. vivax (and P. ovale) to effect a radical
cure and prevent relapse (WHO 2010). Therefore, in areas where
both P. falciparum and P. vivax are endemic, it is often useful to
be able to distinguish between the two species.
The relative costs of microscopy and RDTs vary according to con-
text. Where there is a relatively high prevalence of malaria and an
established microscopy service, microscopy would usually be less
expensive than RDTs because most of the costs associated with
microscopy are fixed costs, and microscopy can also be used to
diagnose other diseases. In areas where malaria is less prevalent, or
very rural areas where access to good quality microscopy services
is limited, RDTs may be less expensive than microscopy (WHO
2008). The cost of RDTs also depends on the type of test used,
which will depend on the types of malaria parasite endemic in the
area; the WHO describes three zones (WHO 2005a) as shown in
Table 2.
RDTs may be used to confirm diagnosis before commencing treat-
ment in people with symptoms of malaria where confirmation by
microscopy is currently unavailable or unused, thereby increasing
the specificity of diagnosis, which would otherwise be made on
symptoms only. Alternatively, RDTs may replace microscopy for
confirmatory diagnosis, where logistical factors and relative costs
indicate that this may be beneficial. The usefulness of RDTs in
these roles will depend to a large extent on their accuracy. The
sensitivity and specificity thresholds that decide whether a test is
useful in practice will depend upon the situation; as malaria en-
demicity varies enormously by geographic area, and positive and
negative predictive values will vary considerably with endemicity,
relating to the proportion of patients with fever who have malaria.
In addition, microscopy is not a perfect reference standard in itself,
and the relative accuracy of RDTs and microscopy will depend to
a large extent on the performance of the laboratory facilities and
personnel available for microscopy.
Previously published systematic reviews have focused on the accu-
racy of RDTs for diagnosing malaria in travellers returning to non-
endemic countries from endemic countries (Marx 2005). As far as
we know this is the first systematic review to assess the accuracy of
the full range of RDTs for diagnosing non-falciparum orP. vivax
malaria in people with symptoms in malaria-endemic areas.
This review is the second of two Cochrane Reviews assessing the
accuracy of RDTs for diagnosing symptomatic uncomplicated
malaria in endemic countries. It covers two slightly different target
conditions; non-falciparummalaria in the absence of P. falciparum
infection and P. vivax malaria, corresponding to the results ob-
tainable with different RDT test types. The first review reported
separately on RDTs for diagnosing P. falciparum malaria (Abba
2011). The summaries in this review are to assist decision mak-
ing, in conjunction with other relevant information about these
tests, including in vitro assessment and tests of stability and costs
(WHO 2012).
O B J E C T I V E S
To assess the diagnostic accuracy of RDTs for detecting non-falci-
parum or P. vivaxmalaria parasitaemia in people living in malaria-
endemic areas who present to ambulatory healthcare facilities with
symptoms suggestive of malaria and to identify which types and
brands of commercial test best detect non-falciparum and P. vivax
malaria.
Investigation of sources of heterogeneity
We planned to investigate heterogeneity in relation to age group,
continent where the study took place, and adequacy of reference
standard.
4Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries (Review)
Copyright © 2015 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Studies sampling a consecutive series of patients, or a randomly
selected series of patients were eligible. Where the report did not
explicitly state that sampling was consecutive, but we judged that
consecutive sampling was most probable, we included the report.
We excluded studies if they did not present sufficient data to allow
us to extract absolute numbers of true positives, false positives, false
negatives and true negatives. Due to resource constraints, we also
excluded studies if the report did not present enough information
to allow full assessment of eligibility or if the study was reported
only in a non-English language.
Participants
Studies recruiting people living in P. vivax,P. ovale or P. malar-
iae endemic areas attending ambulatory healthcare settings with
symptoms of uncomplicated malaria were eligible.
We excluded studies if participants:
1. were non-immune people returning from endemic
countries or were mainly recent migrant or displaced populations
from non-endemic or very low endemicity areas;
2. had been treated for malaria and the test was performed to
assess treatment outcome;
3. had symptoms of severe malaria;
4. did not have symptoms of malaria;
5. were recruited through active case finding (for example,
door to door surveys).
In studies where only a subgroup of participants was eligible for
inclusion in the review, we included the study provided that we
could extract relevant data specific to that subgroup. If studies in-
cluded some patients with severe malaria, and we could not extract
data specific to a subgroup of participants with uncomplicated
malaria, we included the study if 90% or more of the participants
had uncomplicated malaria.
Index tests
Studies evaluating any immunochromatography-based RDTs
specifically designed to detect non-falciparum or P. vivaxmalaria.
We included commercial tests that are no longer available because
they may use the same antibodies and very similar technology to
tests that are currently available or may become available in the
future. Older and more recently available versions of the same test,
for example, OptiMAL and OptiMAL-IT were included sepa-
rately.We also included prototype tests which are not longer avail-
able but which correspond to one of the commercial tests.
Comparator tests
We included studies regardless of whether they made comparisons
with other RDT tests or not.
Target conditions
Studies aimed to detect non-falciparum or P. vivaxmalaria. Where
no distinction was made by species, but over 98% of malaria infec-
tions were identified by the reference standard as non-falciparum
or P. vivax, the study was eligible for inclusion.
Reference standards
Studies were required to diagnose non-falciparum or P. vivax
malaria using at least one of the following two reference standards:
1. Conventional microscopy of thick blood smears, thin blood
smears or both. Presence of asexual parasites of any density was
regarded as a positive smear;
2. PCR.
The reference standard was required to be performed using blood
samples drawn at the same time as those for the index tests. Where
studies used more than one reference standard, we presented data
relating to comparisons with each reference standard.
Search methods for identification of studies
We used a single search strategy for both Cochrane Reviews in this
series (see Abba 2011).
Electronic searches
To identify all relevant studies, we used the search terms and strat-
egy outlined in Appendix 1 to search the following databases:
Cochrane Infectious Diseases Group Specialized Register; MED-
LINE; EMBASE; MEDION; Science Citation Index; Web of
Knowledge; African Index Medicus; LILACS; and IndMED. We
based the search on the following MeSH, full text and keyword
terms: Malaria, Plasmodium, reagent kits, diagnosis, diagnostics,
RDT, dipstick, MRDD, OptiMal, Binax Now, Parasight, Immu-
mochromatography, antigen detection, antigen test, Combo card.
We did not limit the search by language or publication status (al-
though we later excluded non-English language studies due to re-
source constraints). We restricted the searches to human studies.
We updated the search on 31 December 2013.
Searching other resources
We searched the reference lists of included studies for relevant
publications. Due to resource constraints, we did not search any
other resources.
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Data collection and analysis
Selection of studies
We initially used a single selection procedure to identify studies
for inclusion in either of the two Cochrane Reviews in this se-
ries. The inclusion criteria differed between the reviews only in
the target condition and parasite species. Therefore, of the study
characteristics examined, we assessed parasite species last , for ex-
ample a study listed as excluded due to not presenting sufficient
data may also have not been a study of non-falciparum or P. vivax
malaria. One author (KA) initially assessed the titles identified by
the search, excluding those obviously irrelevant to the diagnosis of
malaria using RDTs. We retained titles where we had any doubt
regarding inclusion.
Based on abstract examination, we excluded irrelevant letters, re-
view articles and articles and then excluded other irrelevant notes.
Using a pro forma, two review authors (KA and NM) indepen-
dently assessed the eligibility of the remaining potentially relevant
articles based on full text publications. We have listed the excluded
studies in theCharacteristics of excluded studies table.We resolved
any discrepancies by discussion. Where we could not reach agree-
ment, we consulted a third author (PG or PO).Where it remained
unclear whether a study was eligible for inclusion because of a lack
of detail or poor reporting, we excluded it. Similiarly, we excluded
non-English language reports for logistical reasons.
We named studies according to the surname of the first study
author and the year of publication. The study naming used in
this review uniquely identifies multiple study cohorts within each
study report (for example as ’Bell 2001a’ and ’Bell 2001b’), each of
which use different reference standards or present data separately
for more than one population with different characteristics. More
than one RDT may be evaluated in each study cohort, thus the
number of test evaluations exceeds the number of study cohorts,
which exceeds the number of study reports.
Data extraction and management
Two review authors (KA and NM) independently extracted data
and resolved any discrepancies by discussion. In cases of studies
where only a subgroup of participants met the review inclusion
criteria, we extracted and presented data only for that particular
subgroup.Where two versions of one reference standardwere used,
for example local clinic and expert standard microscopy, or field
versus laboratory RDT testing, we only included the one most
likely to yield the highest quality results.
For each study, we systematically extracted data on the charac-
teristics of the study, as shown in Appendix 2. We also extracted
data relating to the sensitivity of the RDT at different levels of
parasitaemia (asexual parasites per µL of blood) as presented by
the study authors. For each comparison of index test with ref-
erence test, we extracted data on the number of true positives,
true negatives, false positives and false negatives in the form of
a two by two table. RDT results are dichotomous; microscopy
results were deemed positive at any level of asexual parasitaemia;
and PCR results used the cut-off points presented by the study
authors. Gametocyte-only parasitaemia was considered negative;
where a study was unclear on how they had classed gametocyte-
only parasitaemia, they were assumed to have used the same clas-
sification as ourselves and we included the data in the study.
We extracted data for each study (Smidt 2008), using currentman-
ufacturers’ instructions in interpreting the RDT results. P. falci-
parum malaria only was considered as negative for parasitaemia.
The target condition was defined slightly differently depending
on the type of the test, as follows:
• Types 2, 3 and 4 - Non-falciparum malaria in the absence
of falciparum malaria
RDT Types 2, 3 and 4 are designed to detect non-falciparum
species (mainly P. vivax in most situations) when they occur with-
out concurrent P. falciparum infection. They have two test lines,
one specific for P. falciparum and one pan-malarial line to detect all
malaria species. Non-falciparum malaria is identified by a positive
pan-malarial line and negative P. falciparum line; mixed infections
will produce positive results for both the P. falciparum and pan-
malaria lines and are indistinguishable from P. falciparum alone.
Mixed infections detected by microscopy were considered true
negative if RDT indicated P. falciparum; true positive if RDT
indicated non-falciparum in the absence of P. falciparum; and false
negative if RDT indicated no malaria. This method corresponded
to themethodmost often described by the authors of the included
studies, first described by Tjitra 1999.
• Tests using Pf HRP2 and Pv pLDH - P. vivax (whether
alone or part of mixed infection)
These types of tests are designed to identify P. vivax parasitaemia
specifically, as they have a test line specific to P. vivax. Some also
include other test lines, specific to other types of malaria parasite.
Test results were considered positive for P. vivax whether or not
they also indicated the presence of P. falciparum.
Where study authors interpreted test results or presented data dif-
ferently, we used all the information presented in the paper to ex-
tract data consistent with our own methods; if we were unable to
do this, we did not include the data in the analyses.
Assessment of methodological quality
Three researchers (KA, NM and SJ) assessed the quality of each
individual study using the checklist adapted from the QUADAS
tool (Whiting 2003). We answered each question on the check-
list with a yes or no response, or noted unclear if study authors
reported insufficient information to enable a judgement, and we
documented the reasons for the judgement made. We have sum-
marized the criteria we used in Appendix 3.
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Statistical analysis and data synthesis
The comparisons made in this review can be considered in a hi-
erarchy. We classified the data on each test type in the primary
studies according to commercial brands. In order to provide a co-
herent description of the studies contributing to each analysis, we
structured the results first by grouping studies according to their
commercial brand, then grouping brands to form test types. The
analytical strategy thus compared the test accuracy of commercial
brands within each test type before making comparisons between
test types. Comparative analyses first included all studies with rel-
evant data, and were then restricted to studies that made direct
comparisons between tests with the same participants, where such
studies existed.
For each test type, we plotted estimates of the observed sensitivities
and specificities in forest plots and in receiver-operating character-
istic (ROC) space. These plots illustrate variation in accuracy be-
tween studies. Where adequate data were available, we performed
meta-analyses using the bivariate model (Reitsma 2005) to pro-
duce summary sensitivities and specificities. Using a random-ef-
fects approach, the model jointly synthesises sensitivity and speci-
ficity by allowing for correlation between them across studies. We
made comparisons between tests by adding a covariate for brand
or test type to the bivariate model to investigate association with
sensitivity or specificity, or both. Also, we investigated the effect
of test type on the variances of the random effects of logit sensi-
tivity and logit specificity and we included separate variance terms
where required. We assessed the significance of the difference in
test performance by a likelihood ratio test comparing models with
and without covariate terms for sensitivity and specificity. Where
inadequate studies were available to estimate all parameters, we
simplified the bivariate model to two univariate random-effects
logistic regressionmodels by assuming no correlation between sen-
sitivity and specificity. We fitted the models using the xtmelogit
command in StataCorp 2011.
Where more than one commercial brand of the same test type was
evaluated on the same patients against the same reference standard,
we selected one brand at random from the analysis by test type
in order to avoid bias due to inclusion of the same participants
more than once in the analysis. We included both brands in any
analyses comparing commercial brands.
Investigations of heterogeneity
We inspected forest plots and summary ROC plots to visually as-
sess heterogeneity between study specific estimates of sensitivity
and specificity. We planned to investigate the effect of age group,
continent where the study took place, and adequacy of the refer-
ence standard on summary estimates of sensitivity and specificity
by adding each factor as a covariate to the bivariate model.
We did not attempt to assess reporting bias because little is known
about how this should be done for diagnostic test accuracy (DTA)
reviews.
R E S U L T S
Results of the search
In the initial searchwe identified 4837 titles, of which we excluded
4325 based on their title or abstract alone. We were unable to
obtain one article in full text form. We retrieved full text articles
for 511 titles; of which we excluded 474 articles; 316 because
they were initially assessed as ineligible; 22 because the reports did
not present enough information for us to assess their eligibility;
21 because they were available only in non-English languages;
21 because we were unable to extract absolute numbers of true
positives, false positives, false negatives and true negatives; and 94
because they did not present data on non-falciparum or P. vivax
malaria, although they were eligible for other reviews in this series.
See Figure 1 for a flow diagram of search and eligibility results.
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Figure 1. Study flow diagram.
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We therefore included a total of 37 study publications. One of the
included publications described two related studies, and another
publication reported data separately for 10 different sites, making
a total of 47 study cohorts. Seven of the 47 cohorts evaluatedmore
than one test; one compared four tests, three compared three tests
and three compared two tests. There were a total of 67 test evalu-
ations reporting on a total of 32,466 tests in 22,862 participants.
We have given a summary of the number of studies by test type
and reference standard (microscopy or PCR) in Table 3.
Methodological quality of included studies
We summarised the overall methodological quality of the included
studies in Figure 2. Twenty-seven study cohorts (57%) clearly in-
cluded a representative spectrum of patients attending ambula-
tory healthcare setting with symptoms of malaria; the remaining
20 were unclear, most often because they had not adequately de-
scribed their sampling methods. Twenty study cohorts (43%) re-
ported an adequate reference standard, 19 (40%) did not provide
enough information on the reference standard, and eight (17%)
had an inadequate reference standard, in all cases because a sec-
ond microscopist did not verify the results. Thirty-five study co-
horts (75%) reported blinding of the reference standard results,
11 (23%) did not describe whether the reference standard was
blinded and one (2%) did not blind the reference standard. Thirty-
seven (79%) study cohorts blinded the RDT results to the results
of the reference tests, nine (19%) were unclear and one (2%) did
not blind the RDTs. All 47 cohorts reported avoidance of partial
verification, differential verification and incorporation.
Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
Eleven study cohorts (23%) reported on uninterpretable test re-
sults; of these, three excluded uninterpretable results from the anal-
ysis, four reported that there were no uninterpretable results, three
repeated any uninterpretable tests and one presented the results for
uninterpretable tests. The proportion of uninterpretable tests was
low in every study that reported this information (maximum 6%).
Thirty study cohorts (64%) did not report on uninterpretable re-
sults, but appeared to have no uninterpretable results, because they
had an exact correlation between the number of participants en-
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rolled and the number presented in the analysis. Six study cohorts
(13%) did not report on uninterpretable results and also either
did not clearly state the number of participants initially enrolled
or showed a discrepancy between the number of participants en-
rolled and the number presented in the analysis.
Thirty-seven study cohorts (79%) reported either no withdrawals
from the study or recorded the reasons for any withdrawals; eight
(17%) were unclear as to whether there were any withdrawals;
one (2%) had one participant missing from the analysis, with no
explanation, and another (2%) reported that samples with mixed
infection or where microscopists disagreed were excluded, while
the number of samples excluded, and the original number of par-
ticipants enrolled, was not presented.
Findings
Target condition: non-falciparum malaria only
In this section we present the results for RDTs which identify
’non-falciparum malaria’ by the presence of a positive pan-malaria
antibody line in the absence of a positive P. falciparum specific
antibody line.
Verified by microscopy
Type 2 tests
There were 11 evaluations of Type 2 RDTs verified with mi-
croscopy (Figure 3); eight were undertaken in Asia, two in Africa
and one in South America. The median sample size was 372
(range 113 to 2383), the median prevalence of non-falciparum
only malaria was 14% (range 7% to 32%) and the median per-
centage of malaria that was non-falciparum was 46% (range 13%
to 80%). None of the evaluations were undertaken only in chil-
dren under the age of five years. Five different test brands were
evaluated: ICT Malaria Pf/Pv (seven); ICT Malaria combo cas-
sette (one), Malascan (one), NOWMalaria ICT (one) and VIKIA
Malaria Ag Pf/Pan (one). Sensitivities of the tests ranged from
67% to 90%; specificities ranged from 89% to 100%. In meta-
analysis (11 evaluations, 6879 participants) the pooled sensitiv-
ity was 78% (95% confidence interval (CI) 73% to 82%) and
the specificity was 99% (95% CI 97% to 99%) (Figure 4). Of
the false negative RDT results (where microscopy identified non-
falciparum malaria only, but RDT gave a different result) 65%
(95% CI 43% to 81%) of RDT results indicated ’no malaria’; the
remaining false negative RDT results indicated P. falciparum or
mixed infection (Table 4).
Figure 3. Forest plot of commercial brands of Type 2 tests for detection of non-falciparum species (verified
with microscopy). We ordered studies by continent, age group and study identifier.
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Figure 4. Summary ROC plot of Type 2 tests for detection of non-falciparum species (verified with
microscopy). The black solid circle corresponds to the summary estimate of sensitivity and specificity, and is
shown with a 95% confidence region.
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Type 3 tests
There were 25 evaluations of Type 3 RDTs verified with mi-
croscopy (Figure 5); eightwere undertaken inAsia, 15 inAfrica and
two in South America. The median sample size was 200 (range 30
to 2585), the median prevalence of non-falciparum only malaria
was 10% (range 7% to 36%) and themedian percentage ofmalaria
that was non-falciparum was 36% (range 17% to 85%). None of
the evaluations were undertaken only in children under the age
of five years. Five different test brands were evaluated: Parascreen
(14), SD Malaria Antigen Bioline (four), Carestart Pf/Pan (four),
First Response Malaria Combo (two) and One Step Malaria Pf/
Pan (one). Sensitivities of the tests ranged from 25% to 100%;
specificities ranged from 94% to 100%. Two studies evaluated
two brands and so one brand was selected at random for inclusion
in the meta-analysis. Therefore, based on 23 evaluations (11,234
participants), the pooled sensitivity was 78% (95% CI 69% to
84%) and the specificity was 99% (95% CI 98% to 99%) (Figure
6). Of the false negative RDT results (where microscopy identified
non-falciparum malaria only, but RDT gave a different result),
74% (52% to 88%) of RDT results indicated ’no malaria’; the
remaining false negative RDT results indicated P. falciparum or
mixed infection (Table 4).
Figure 5. Forest plot of commercial brands of Type 3 tests for detection of non-falciparum species (verified
with microscopy). We ordered studies by continent, age group and study identifier.
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Figure 6. Summary ROC plot of Type 3 tests for detection of non-falciparum species (verified with
microscopy). The black solid circle corresponds to the summary estimate of sensitivity and specificity, and is
shown with a 95% confidence region.
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Type 4 tests
There were 11 evaluations of Type 4 RDTs compared microscopy
(Figure 7); six were undertaken in Asia, two in Africa and three
in South America. The median sample size was 289 (range 80 to
896), the median prevalence of non-falciparum only malaria was
27% (range 8% to 33%) and the median percentage of malaria
that was non-falciparum was 51% (range 21% to 100%). None of
the evaluations were undertaken only in children under the age of
five years. Three different test brands were evaluated: OptiMAL
(six), OptiMAL-IT (four) and Carestart Malaria Pf/Pan (one).
Sensitivities of the tests ranged from 63% to 100%; specificities
ranged from 94% to 100%. One study evaluated two brands and
so one brand was selected at random for inclusion in the meta-
analysis. Based on 10 evaluations (3831 participants), the pooled
sensitivity was 89% (95%CI 79% to 95%) and the specificity was
98% (95%CI 97% to 99%) (Figure 8). Of the false negative RDT
results (where microscopy identified non-falciparum malaria only,
but RDT gave a different result), 87% (79% to 92%) of RDT
results indicated ’no malaria’; the remaining false negative RDT
results indicated P. falciparum or mixed infection (Table 4).
Figure 7. Forest plot of commercial brands of Type 4 tests for detection of non-falciparum species (verified
with microscopy). We ordered studies by continent, age group and study identifier.
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Figure 8. Summary ROC plot of Type 4 tests for detection of non-falciparum species (verified with
microscopy). The black circle corresponds to the summary estimate of sensitivity and specificity, and is shown
with a 95% confidence region.
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Other test types
There was one evaluation ofMalariagenMalaria, a type of test that
does not fit into the classification presented in Table 1.Malariagen
Malaria uses antibodies to the HRP-2 antigen of P. falciparum and
unspecified monoclonal antibodies for detection of pan-malarial
antigens. The study (Selimuzzaman 2010) was undertaken on a
sample of 262 adults in Asia and the study prevalence of non-
falciparum malaria was 5%. The sensitivity of this test verified
against microscopy was 92% (95% CI 62% to 100%) and the
specificity was 95% (95% CI 92% to 97%).
Comparisons between RDT types
We summarised the comparison of different RDT types in Figure
9, Figure 10, Table 5 and Table 6. There was a statistically signif-
icant (P = 0.008) difference in accuracy between test types (Table
5) with Type 4 tests being significantly more sensitive than Type 2
(P = 0.01) and Type 3 (P = 0.03) (Table 6) based on indirect com-
parisons using all available data. Specificities were similarly high
across the three test types. Few studies directly compared tests and
so meta-analyses restricted to direct comparisons were not possi-
ble. The results from the only study (van den Broek 2006) that
directly compared a Type 2 test and a Type 4 test were consistent
with the meta-analytic finding and also demonstrated a statisti-
cally significant difference (P < 0.001) in sensitivity (Appendix 4).
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Figure 9. Forest plot of Type 2, Type 3 and Type 4 tests for detection of non-falciparum species (verified
with microscopy). We ordered studies by continent, age group and study identifier.
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Figure 10. Summary ROC plot comparing Type 2, Type 3 and Type 4 tests for detection of non-falciparum
species (verified with microscopy). The solid circles correspond to the summary estimates of sensitivity and
specificity for each test type, and are shown with 95% confidence regions (dotted lines) and 95% prediction
regions (dashed lines). The summary points for Type 2 and Type 3 and their 95% confidence regions are
identical but the 95% prediction regions differ. The 95% prediction regions illustrate the extent of between
study heterogeneity.
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Comparison of brands
We compared the test performance of three Type 3 test brands-
Parascreen (14 studies, 547 participants), Carestart Pf/Pan (four
studies, 3544 participants) and SDMalaria Antigen Bioline (four
studies, 3769 participants). We excluded the other two brands-
First ResponseMalaria Combo (two studies, 663 participants) and
One Step Malaria Pf/Pan (one study, 606 participants)-from the
analysis due to limited data. There was no evidence (P = 0.88) to
suggest that the sensitivity or specificity, or both, of type 3 tests
was associated with brand. The summary sensitivity (95% CI)
was 79% (67% to 88%) for Parascreen, 74% (45% to 91%) for
Carestart Pf/Pan, and 80% (73% to 85%) for SDMalaria Antigen
Bioline. The summary specificity (95% CI) was 98% (98% to
99%) for Parascreen, 99% (96% to 100%) for Carestart Pf/Pan,
and 99% (98% to 100%) for SD Malaria Antigen Bioline.
For Type 4 tests, we compared the diagnostic accuracy of the Op-
tiMAL (six studies, 1843 participants) and OptiMAL-IT (four
studies, 1987 participants) brands. We excluded a third brand,
Carestart Pf/Pan (one study, 195 participants), because of limited
data. There was no evidence (P = 0.79) to suggest a difference in
the sensitivity or specificity, or both, of the two brands. The sum-
mary sensitivity of OptiMAL was 90% (85% to 93%) and that of
OptiMAL-IT was 91% (49% to 99%). The summary specificities
were 98% (97% to 99%) and 98% (96% to 99%) for OptiMAL
and OptiMAL-IT respectively.
Investigations of heterogeneity
Due to the limited number of studies available for each test type,
we were only able to investigate the effect of continent and ade-
quacy of the reference standard on the sensitivity and specificity of
Type 3 tests for detecting non-falciparum species with microscopy
as reference standard. There were three continents-Africa (14 stud-
ies, 5551 participants), Asia (eight studies, 4997 participants) and
South America (two studies, 704 participants)-but we excluded
South America from the analysis due to the limited data available.
There was no evidence (P = 0.55) to suggest a difference in sensi-
tivity or specificity, or both, between studies conducted in Africa
and those in Asia. The summary sensitivity (95% CI) was 74%
(57% to 86%) for Africa and 80% (73% to 85%) for Asia. The
summary specificity (95% CI) was 99% (98% to 99%) for Africa
and 99% (97% to 99%) for Asia. For adequacy of the reference
standard, six studies were scored ’Yes’, 12 studies were scored ’No’
and five studies were scored ’Unclear’; there was no evidence (P =
0.54) to suggest a difference in sensitivity or specificity, or both.
The summary sensitivity and specificity were 77% (67% to 85%)
and 99% (98% to 99%) for studies with an acceptable reference
standard; 78% (65% to 88%) and 99% (98% to 99%) for stud-
ies without an acceptable reference standard; and 86% (78% to
91%) and 98% (97% to 99%) for studies where the assessment
was judged to be unclear.
Verified by PCR
Type 2 tests
No study verified a Type 2 test with PCR.
Type 3 tests
There were five evaluations of a Type 3 test verified with PCR
(Figure 11); three were undertaken in Asia and two were under-
taken in South America. The median sample size was 327 (range
178 to 606), and themedian prevalence of non-falciparummalaria
was 15% (range 7% to 33%). None of the evaluations were un-
dertaken only in children under the age of five years. Four dif-
ferent test brands were evaluated; Parascreen (two studies); SD
Malaria Antigen Bioline (one study), CareStart Pf/Pan (one study)
and One StepMalaria Pf/Pan (one study). Sensitivities of the tests
ranged from 64% to 91% and specificities ranged from 97% to
100%. In meta-analysis, the pooled sensitivity was 81% (95% CI
72% to 88%) and the pooled specificity was 99% (95% CI 97%
to 99%).
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Figure 11. Summary ROC plot of Type 3 tests for detection of non-falciparum species (verified with PCR).
The solid circles correspond to the summary estimate of sensitivity and specificity, and is shown with a 95%
confidence region.
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Type 4 tests
One study (Rakotonirina 2008) verified a Type 4 test, OptiMAL,
against PCR and gave results consistent with the summary results
of the six studies that used microscopy as the reference standard
(Appendix 5).
Comparison of results verified by microscopy or PCR
Four studies used both microscopy and PCR as reference stan-
dards to verify parasitaemia. Elahi 2013 estimated a sensitivity
of 91% and specificity of 99% for both PCR and microscopy;
Bendezu 2010 estimated a sensitivity of 76% and specificity of
98% with PCR, and sensitivity of 77% and specificity of 99%
with microscopy. The accuracy of CareStart Pf/Pan reported by
Xiaodong 2013 was similar for both reference standards with sen-
sitivity of 91% and specificity of 100%. Yan 2013 evaluated One
Step Malaria Pf/Pan with an estimated sensitivity of 72% when
verified against PCR and 70% against microscopy, and a speci-
ficity of 97% with PCR and 99% with microscopy. Ratsimbasoa
2008 verified the Malaria Antigen Bioline test against PCR and
gave results within the 95% CI of the pooled results of the two
studies that used microscopy as the reference standard (Appendix
5).
Target condition: P. vivax
In this section we present the results for RDTs which identify P.
vivax by the presence of a positive P. vivax specific antibody line.
The majority of the tests had two test lines, an HRP-2 line to
detect P. falciparum and an pLDH line to detect P. vivax. One
study, which verified results using PCR, evaluated a Type 6 tests,
with additional test with an additional pan line to detect all species
of malaria. In each case, only the Pv PLDH line is considered in
the analysis.
Verified by microscopy
Eight studies evaluated the performance of Pf HRP-2 and Pv
pLDH antibody tests verified with microscopy-four were under-
taken in Africa and four in Asia (Figure 12). The median sam-
ple size was 361 (range 240 to 1092), with a median preva-
lence of P. vivax malaria of 19% (range 2% to 45%). Evaluations
were conducted in mixed age groups or adults only. Five differ-
ent test brands were assessed: CareStart Pf/Pv (three), Falcivax
(two), Biotech Malaria Pf/Pv (one), OnSite Pf/Pv (one), and Pf/
Pv Malaria Device (one). The sensitivities of the tests ranged from
66% to 100%, and specificities ranged from 98% to 100%. In
meta-analysis (eight evaluations, 3682 participants) the summary
sensitivity and specificity (95% CI) were 95% (86% to 99%) and
99% (99% to 100%) respectively (Figure 13).
Figure 12. Forest plot of Pf HRP-2 and Pv pLDH for detection of P. vivax (verified with microscopy). Studies
are ordered by continent, age group and study identifier.
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Figure 13. Summary ROC plot Pf HRP-2 and Pv pLDH for detection of P. vivax (verified with microscopy).
The black circle corresponds to the summary estimate of sensitivity and specificity, and is shown with a 95%
confidence region.
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Verified by PCR
Two studies evaluated the performance of three different brands of
Pf HRP-2 and Pv pLDH antibody tests against PCR. One study
was undertaken in Bangladesh and the other in China. Sensitivi-
ties ranged from 59% (47% to 70%) to 77% (56% to 91%) and
specificities ranged from 97% (95% to 99%) to 100% (99% to
100%). One study evaluated a Type 6 RDT and reported a sen-
sitivity of 90% (70% to 99%) and specificity of 100% (99% to
100%).
Additional analyses
Sensitivities of tests at different levels of P. vivax
parasitaemia
Type 2 tests
Four studies presented additional data relating to the sensitivity
of Type 2 RDTs against microscopy at different levels of par-
asitaemia (Fernando 2004; Tjitra 1999; van den Broek 2006;
Wongsrichanalai 2003). The findings varied; all found very low
sensitivities below 100 parasites per µL, rising with level of para-
sitaemia, but the level at which a high sensitivity (over 90%) was
achieved varied between 500 parasites per µL and 5,000 parasites
per µL.
Type 3 tests
Four studies presented additional data relating to the sensitivity of a
Type 3 RDT against microscopy at different levels of parasitaemia.
In Ratsimbasoa 2008 sensitivity was 93% at levels of 501 to 5000
asexual parasites per µL; and 100% at levels above 5000 asexual
parasites per µL. In Mohon 2012, sensitivity ranged from 80% at
1 to 100 asexual parasites per µL, to 90% at 101 to 500 asexual
parasites per µL to 100% at 501 or more asexual parasites per µL.
In Yan 2013, sensitivity was 73.3% at under 500 asexual parasites
per µL to 100%, and 69% at over 500 asexual parasites per µL to
100%. In Kosack 2013 sensitivity was 14% at one to nine asexual
parasites per 100 fields, 70% at one to 10 asexual parasites in 10
fields, 96% at one to 10 asexual parasites per field, and 98% at
more than 10 asexual parasites per field.
Type 4 tests
Three studies presented additional data relating to the sensitivity of
Type 4RDTs againstmicroscopy at different levels of parasitaemia,
although two had only small numbers. One study presented useful
data (Valecha 2003), reporting a sensitivity of 30% at under 500
asexual parasites per µL; 48% at 500 to 999 asexual parasites per
µL; 91% at 1000 to 5000 asexual parasites per µL; and 100% at
over 5000 asexual parasites per µL.
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Summary of findings
Patients/populations People presenting with symptoms suggestive of uncomplicated malaria
Prior testing None
Settings Ambulatory healthcare settings in P. vivax,P. malariae or P. ovale malaria endemic areas in Asia, Africa and South America
Index tests Immunochromatography-based rapid diagnostic tests (RDTs) for non-falciparum malaria in the absence of P. falciparum co-infection, or P. vivax malaria with or
without other malaria species
Reference standard Conventional microscopy, polymerase chain reaction (PCR)
Importance Accurate and fast diagnosis allows appropriate and quick treatment for malaria to be provided
Studies 37 unique publications reporting 47 studies (22,862 participants)
Quality concerns Poor reporting of patient characteristics, sampling method and reference standard methods were common concerns
Test type Quantity of evidence
Number of evaluations
(malaria cases/partici-
pants)
Average sensitivity
(95% CI)
Average specificity
(95% CI)
Prevalence (%) Consequences in a cohort of 1000
Missed cases False positives
Target condition (reference standard): non-falciparum malaria (microscopy)
Type 2
HRP-2 (P. falciparum
specific) and aldolase
(pan-specific)
11 (958/6879) 78% (73% to 82%) 99% (97% to 99%) 5 11 10
15 33 9
30 66 7
Type 3
HRP-2 (P. falciparum
specific) and pLDH (pan-
specific)
23 (1537/11,234) 78% (69% to 84%) 99% (98% to 99%) 5 11 10
15 33 9
30 66 7
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Type 4
pLDH (P. falciparum spe-
cific) and pLDH (pan-spe-
cific)
10 (986/3831) 89% (79% to 95%) 98% (97% to 99%) 5 6 19
15 17 17
30 33 14
Target condition (reference standard): non-falciparum malaria (PCR)
Type 3
HRP-2 (P. falciparum
specific) and pLDH (pan-
specific)
5 (300/1639) 81% (72% to 88%) 99% (97% to 99%) 5 10 10
15 29 9
30 57 7
Target condition (reference standard): P.vivax with or without other malaria species (microscopy)
HRP-2 (P. falciparum
specific) and pLDH (P. vi-
vax-specific)
8 (580/3682) 95% (86% to 99%) 99% (99% to 100%) 5 3 10
15 8 9
30 15 7
Conclusions: The majority of studies evaluated RDTs which are designed to differentiate falciparum malaria from non-falciparum malaria, but cannot differentiate between different non-
falciparum species or identify non-falciparum malaria species within a mixed infection. In these types of tests, specificity for non-falciparum malaria in the absence ofP. falciparum infection
was high, but sensitivity was low, tests missing between 11% and 22% of non-falciparum cases. RDTs which are designed to detect P. vivax specifically, whether alone or part of a mixed
infection, were more accurate with tests missing less than 5% of P. vivax cases. This review can help decision-making about which RDT to use, in combination with other published
information about in vitro test performance and stability in the field
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D I S C U S S I O N
Summary of main results
Test Types 2, 3 and 4, and other tests that identified non-falci-
parum malaria through deduction of a positive result for pan-
malarial antigens along with a negative result for P. falciparum
specific antigens, had sensitivities that ranged in pooled analyses
from 78% (Type 2) to 89% (Type 4). Further analysis of the false
negative results showed that the majority of non-falciparum only
cases that were missed by the RDTs were indicated as ’no malaria’
although some were indicated as P. falciparum or mixed infection.
Type 4 tests were significantly more sensitive than Type 2 tests.
Specificities were consistently high, ranging from 98% (Type 4)
to 99% (Type 2 and Type 3). There were no apparent differences
between microscopy and PCR as the reference standard.
In studies that verified RDTs with microscopy, tests that used a
P. vivax specific antibody line to identify P. vivax had a pooled
sensitivity of 95% (95% CI 86% to 99%) and a pooled specificity
of 99% (95% CI 99% to 100%). In contrast, the two studies that
verified these types of RDTs with PCR demonstrated much lower
sensitivity of 59% (47% to 70%) and 77% (56% to 91%).
In Summary of findings, assuming prevalences of 5%, 15% and
30%, the number of missed non-falciparum or P. vivax malaria
cases and the number of false positives in a hypothetical cohort
of 1000 patients are presented by test type. In the case of tests for
non-falciparum only, the performance may in reality be affected
by the prevalence of P. falciparum parasitaemia; this effect is not
possible to estimate with any accuracy, however it is likely to be
small, and has therefore been ignored.
Strengths and weaknesses of the review
Completeness of evidence
It is probable that some studies eligible for inclusion in the review
were missed by our search strategy. DTA studies are known to be
poorly indexed, and hence liable to be missed, even when searches
are designed to be very sensitive (Whiting 2009). However, our
search was comprehensive.
Accuracy of the reference standards used
Microscopy is an imperfect diagnostic test in itself, raising the
possibility that in some cases of discordant results between mi-
croscopy and RDT, the RDT result may in fact have been correct,
and the microscopy results incorrect. However, with the excep-
tion of P. vivax specific tests, where only two studies verified by
PCR were available, results for studies which verified RDT results
against PCR gave similar results to those which used microscopy
as a reference standard.
In studies reporting on sensitivity by parasitaemia level, RDTs
tended to reach high levels of sensitivity (above 90%) at levels of
parasitaemia above 500 to 1000 asexual parasites for P. vivax, but
were less reliable at lower levels. This finding corresponds closely
with a similar analysis within a DTA review of RDTs for travellers
with fever returning from malaria endemic to non-endemic areas(
Marx 2005).
Quality of reporting of the included studies
The quality of reporting of the included studies, as assessed by
the number of ’unclear’ evaluations of study quality was variable.
Nineteen study cohorts (40%) did not provide enough informa-
tion for us to adequately assess the adequacy of the reference stan-
dard, which we judged to be the most important quality indicator
for this review.
Quality of the included studies
Where sufficient information was provided to assess the quality
of included studies, the quality was variable. Twenty (43%) study
cohorts reported an adequate reference standard, while 37 (79%)
reported that readers of the reference standard were blinded to the
results of theRDTs. ForType 3 tests, wewere able to investigate the
effect of adequacy of the reference standard on test performance.
There was no evidence of a difference in test performance between
studieswith an adequate, inadequate or unclear reference standard.
Completeness and relevance of the review
This review focused specifically on the use of RDTs for diagnosing
non-falciparum malaria in people living in malaria endemic areas
and attending ambulatory health care setting with symptoms of
malaria; therefore evaluating the tests in the context in which they
are intended to be most often used. Previously published reviews
have evaluated the accuracy of RDTs under laboratory conditions
(WHO 2012) and for use by travellers returning from malaria en-
demic to non-endemic areas (Marx 2005). By classifying asexual
parasitaemia as positive and gametocytes only as negative we fo-
cused on malarial illness requiring curative treatment, in line with
current treatment recommendations (WHO 2010). In the future,
as malaria comes closer to elimination, it may become important
to cure gametocytaemia to prevent transmission, and diagnostic
priorities may change.
Applicability of findings to the review question
Qualities of RDTs
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RDT types 2, 3 and 4, which aim to identify ’non-falciparum
malaria only’ as a proxy for P. vivaxmay miss between 11% (Type
4) and 22% (Type 2 and Type 3) of cases, with the majority of
missed cases being incorrectly identified as free of malaria. In ad-
dition, the design of these tests does not allow the identification
of non-falciparum malaria as part of a mixed infection, or the dif-
ferentiation of P. vivax from P. ovale and P. malariae. These tests
therefore do not appear adequately sensitive for the identification
of P. vivax, although they may play a role in areas where both P. vi-
vax and P. falciparum occur and are initially treated with the same
drugs. In contrast, RDT types using pLDH designed to detect P.
vivax specifically, whether alone or part of a mixed infection ap-
pear to be both highly sensitive (missing 5% of cases) and highly
specific for P. vivax.However, two studies included in this review,
which verified the test with PCR, found much lower sensitivities.
Consideration also needs to be made for variation in sensitivity by
brand (WHO 2012).
Application to clinical decision-making in practice
The evaluations presented in this review were conducted in pa-
tients with symptoms of clinical malaria and inferences about the
results relate to this context, and not to mass surveys of well pop-
ulations. The evaluations should also be read in conjunction with
other published information regarding the in vitro performance,
stability and costs of the tests, including the WHO FIND report
(WHO 2012). Results between this review and the FIND anal-
ysis for some RDTs differ slightly. The FIND report tested in-
dividual products under laboratory conditions using standardised
blood samples at low and high parasite densities (200 and 2000
parasites per µL) and reported the ’panel detection score’; which
is defined as the percentage of times that two tests within a batch
detected parasites at low density, and percentage of times that one
test detected parasites at high density. This measure is slightly dif-
ferent to sensitivity, as it includes an aspect of consistency, whereas
the studies in this review were conducted in field conditions with
patients, and this is likely to account for variations between the
datasets. The results in our review more closely mimic the condi-
tions in which the tests would be used in practice; where parasite
density is generally unknown, and may be affected by storage of
the test, quality of a specific batch, local parasite densities, local
parasite antigen patterns, quality of local microscopy and accuracy
of reading the tests. Equally, these factors bring in more variation
than tests from a laboratory using standardised samples.
RDTs can only influence clinical practice if the results are be-
lieved and acted upon. There may be reluctance on the part of
both health providers and patients to believe negative RDT re-
sults, leading to unnecessary repeat testing and prescription of an-
timalarials for negative cases (Tavrow 2000). Various studies have
shown that patients with fever and negative malaria test results,
whether by microscopy or RDT, often still receive antimalarials
(Hamer 2007), thus reducing their potential usefulness and cost-
effectiveness. However, some educational interventions have been
shown to be effective in reducing prescriptions for antimalarials
in negative cases (Ngasala 2008).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
RDT types 2, 3 and 4, which aim to identify ’non-falciparum
malaria only’ as a proxy for P. vivax are limited by their design as
they are unable to identify P. vivax specifically or to identify any
species of non-falciparum malaria as part of mixed infection. In
addition, they have a relatively low sensitivity for ’non-falciparum
malaria only’. They may be useful in areas where the majority of
malaria is caused by P. falciparum or mixed infection and where
good quality microscopy is not available; our related review (Abba
2011) has shown that these test types are sensitive for the detection
of P. falciparum. RDT types which are designed to detect P. vivax
specifically, whether alone or part of amixed infection appear to be
both more directly applicable to practice in P. vivax endemic areas
and in the majority of published studies have been shown to be
more accurate. Data were insufficient to determine test accuracy
by parasite density, which will affect the sensitivity and specificity
thresholds that decide whether a test is useful in practice.
Implications for research
More studies are needed to assess the accuracy of the newer RDT
types designed to detect P. vivax specifically, particularly in areas
with low prevalence.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Alam 2011
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatments for malaria: No explicit exclusions based on previous treatment
and no information presented on previous treatment
Clinical setting: Matiranga Upazila Health Complex (UHC)
Country: Bangladesh
Malaria endemicity: Perennial transmission of malaria with 2 peaks in pre-monsoon
(MarchMay) and post-monsoon (September to November) periods
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 338
Age: Median age was 14 years and the range was 18 months to 82 years
Sex: Both males and females eligible. 50.3% of participants were female
Co-morbidities or pregnancy: Not mentioned, either as an inclusion criteria or char-
acteristic of included participants
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 4 RDTs: Paracheck test was performed at concurrently with
the microscopy. The remaining 3 RDTs were performed using stored samples. Samples
from each individual were tested by all tests
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum andP. vivax
Reference standard test(s) used:Microscopy, thick and thin smear slides and PCR
Whoperformed the reference standard tests, andwhere? 2 independentmicroscopists:
1 employed by the study and the other at Matiranga UHC; not reported for PCR
If microscopy was used, how many high power fields were looked at? 200 fields in
the Giemsa-stained thick film
How many observers or repeats were used? 2 observers
How were discrepancies between observers resolved? By a third microscopist posted
at the Khagrachari Civil Surgeon’s office situated 20 km away from Matiranga UHC
Index and comparator tests Commercial name of the test: Paracheck (Orchid Biomedical System, India), FalciVax
Pf (Zephyr Biomedicals, India), Onsite Pf (CTK Biotech Inc, USA) and Onsite Pf/Pv
(CTK Biotech Inc, USA)
Parasite species the test is designed to detect:
• Paracheck: P. falciparum
• Onsite Pf: P. falciparum
• FalciVax: P. vivax and P. falciparum
• Onsite Pf/Pv: P. vivax and P. falciparum
Designated type:
• Paracheck: Type 1
• Onsite Pf: Type 1
• FalciVax: Type Other (HRP-2 antigen for P. falciparum and pLDH antigen for P.
vivax)
• Onsite Pf/Pv: Type Other (HRP-2 antigen for P. falciparum and pLDH antigen
56Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries (Review)
Copyright © 2015 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Alam 2011 (Continued)
for P. vivax)
Batch numbers: Not provided
Transport and storage conditions: Not provided
Who performed the index test, and where? Not reported. All the RDTs were used
following the manufacturer’s instructions
Follow-up
Notes Source of funding: funded by icddr,b and its donors. Paracheck provided by NMCP;
Onsite Pf and Onsite Pf/Pv provided by CTK Biotech Inc, USA as a donation
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Febrile patients referred to microscopy for
malaria diagnosis. Other characteristics, in-
clusion and exclusion criteria not described
Acceptable reference standard?
All tests
Yes Microscopy: 2 experienced, independent
microscopists assessed each slide. Therewas
provision for a third microscopist to re-
solve any disagreement between them. 200
fields were viewed, another 200 fields were
viewed if malaria was identified, to identify
mixed infections
PCR is also a reference standard.
Partial verification avoided?
All tests
Yes All participants receiving index tests had
their diagnosis verified by reference test
Differential verification avoided?
All tests
Yes The same reference tests were used regard-
less of the index test results
Incorporation avoided?
All tests
Yes The reference standardwasmicroscopy and
PCR.
Reference standard results blinded?
All tests
Unclear Blinding not described.
Index test results blinded?
All tests
Unclear Blinding not described.
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
57Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries (Review)
Copyright © 2015 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Alam 2011 (Continued)
Withdrawals explained?
All tests
Yes The number recruited into the study was
clearly stated and corresponded with the
number included in the analysis, therefore
there were no withdrawals
Andrade 2010
Clinical features and settings Presenting signs and symptoms: Malaria-related symptoms
Previous treatments for malaria: Not mentioned, either as an inclusion criteria or
characteristic of included participants
Clinical setting: Diagnostic centres of the Brazilian National Foundation of Health
(FUNASA)
Country: Brazil
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 311
Age: Median age was 33.5 years and the range was 4 to 65 years
Sex: Both males and females eligible. 60.5% of participants were male
Co-morbidities or pregnancy: Not mentioned, either as an inclusion criteria or char-
acteristic of included participants
Study design Participants were recruited consecutively. The sampling method was not described. 1
RDT was evaluated
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax malaria
Reference standard test(s) used: Microscopy thick and thin blood films and nested
PCR
Who performed the reference standard tests, and where? Experienced malaria field
microscopists from the FUNASA performed microscopy; not stated who performed the
nested PCR. All tests were repeated and confirmed at the main laboratory at the Centro
de Pesquisas Goncalo Moniz, Bahia, Brazil
If microscopy was used, how many high power fields were looked at? Not stated
How many observers or repeats were used? 2 repeats with 2 different observers
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: Optimal-IT RDT (DiaMed China Ltd, Hong Kong,
China)
Parasite species the test is designed to detect: P. falciparum and P. vivax malaria
Designated type: Antigens test detects stated
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? Not stated
Follow-up Not applicable
Notes Source of funding: FINEP (010409605)/FNDCT-CT Amazônia.
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Andrade 2010 (Continued)
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Patients were attending a clinic with symp-
toms of malaria. Study authors excluded
people who had lived in the area for less
than 6 months or had received antimalari-
als in the last 2 weeks
Acceptable reference standard?
All tests
Unclear 2 independent microscopists performed
microscopy, 1 in the field and 1 in the cen-
tral laboratory. The number of fields viewed
is not stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference tests
Differential verification avoided?
All tests
Yes The same reference tests were used regard-
less of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Unclear Not reported whether the tests were read
blindly.
Index test results blinded?
All tests
Unclear Not reported whether the tests were read
blindly.
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals
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Ashton 2010
Clinical features and settings Presenting signs and symptoms: Symptoms of uncomplicated malaria (axillary tem-
perature > 37.5°C or report of fever in the previous 48 hours)
Previous treatments for malaria: Not mentioned, either as an inclusion criteria or
characteristic of included participants
Clinical setting: 1 health centre and 3 health posts per woreda
Country: Ethiopia
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 2400
Age: All ages over 6 months eligible. Actual age profile of participant population not
presented
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated
Co-morbidities or pregnancy:Patients with any life-threatening diseases were excluded.
No exclusion criteria based on pregnancy. No details about the frequency of pregnancy
in the patient population are presented
Study design Enrolment was consecutive and prospective. 3 RDTs were evaluated (CareStart®,
ParaScreen® and ICT Combo®). Each individual received all the tests
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax malaria
Reference standard test(s) used:Microscopy thick and thin blood films
Who performed the reference standard tests, and where? Staff at the health centre and
experienced microscopists at a regional malaria reference laboratory who was blinded to
the initial results. And a third, blinded, reading was conducted to address discrepancies
If microscopy was used, how many high power fields were looked at? 200 fields at
1000× magnification
How many observers or repeats were used? 2
How were discrepancies between observers resolved? They were corrected according
to a third, blinded, readings: presence or absence of asexual parasites, difference in species,
or > 50% difference in parasite count. Microscopy results and parasite counts were
corrected according to the third reading
Index and comparator tests Commercial name of the test:
• CareStart® pf-HRP2/pan-pLDH (AccessBio, USA, catalogue number G0131SK)
• ParaScreen® pf-HRP2/pan-pLDH (Zephyr Biomedicals, India, catalogue
number 50310025)
• ICT Combo® pf-HRP2/pan-aldolase (ICT Diagnostics, South Africa, catalogue
number ML02)
Parasite species the test is designed to detect: Multi-species
Designated type:
• CareStart and ParaScreen - Type 3
• ICT Combo - Type 2
Batch numbers: Not stated
Transport and storage conditions:
“RDTs were transported unrefrigerated by air to Addis Ababa, where they were stored
at ambient conditions until transfer to field sites. Temperature was monitored (Tinytag,
Gemini Data Loggers, UK) but not controlled while RDTs were transported by road to
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Ashton 2010 (Continued)
health centres and during storage at the health centres. Temperatures during transport
reached a maximum 36°C, but at health facilities temperatures did not exceed 30°C.”
Who performed the index test, and where? Health extension workers or nurses at the
health centres
Follow-up Not applicable
Notes Source of funding: “United States Agency for International Development (Cooperative
Agreement 663-A-00-09-00404-00). BC is funded by the ACT Consortium which is
supported by a grant from the Bill & Melinda Gates Foundation to the London School
of Hygiene and Tropical Medicine. Manufacturers supplied CareStart and ParaScreen
RDTs free of charge for this evaluation, and ICT Combo was provided at a reduced
price.”
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were visiting an outpatient de-
partment of a health centre with symptoms
suggestive of malaria
Acceptable reference standard?
All tests
Yes 2 independent microscopists viewed the
slides, a third viewed any discrepancies; 200
fields were looked at
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference tests were used regard-
less of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standards
Reference standard results blinded?
All tests
Yes “RDT and microscopy results were read
by different staff at the health centre, each
blinded to the results of the other diagnos-
tic technique”
Index test results blinded?
All tests
Yes “RDT and microscopy results were read
by different staff at the health centre, each
blinded to the results of the other diagnos-
tic technique”
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
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Ashton 2010 (Continued)
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals
Bell 2001a
Clinical features and settings Presenting signs and symptoms: History of fever, headache, chills or rigors occurring
within the preceding 3 days; or more distant history of fever or non-specific signs sug-
gestive of malaria
Previous treatment for malaria: Participants who had recently taken antimalarials were
not excluded; 5% of participants reported prior antimalarial use
Clinical setting: Village health workers in 5 barangaya (districts)
Country: Philippines (Agusan del Sur Province in the northeast of the island of Main-
dano)
Malaria endemicity: Generally low perennial transmission, with pockets of high trans-
mission
Malaria endemic species: P. falciparum andP. vivax
Participants Sample size: 350
Age: Eligible age range not stated. Mean age of the participants was 19.5 years
Sex: Both males and females eligible. There were 171 male and 179 female participants
Co-morbidities and pregnancy: Not mentioned, either an exclusion criteria or charac-
teristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was prospective. The sampling method was not described. 1 RDT was eval-
uated
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy of thick and thin blood smears
Who performed the reference standard tests, and where? An experienced local mi-
croscopist for all slides; selected slides were also read by an experienced parasitologist.
Microscopy was performed in a local laboratory and hospital laboratory in Australia
If microscopy was used, how many high power fields were looked at? 100
How many observers or repeats were used? 1, except in discordant cases where RDT
and microscopy results differed, all cases RDT-positive for P. vivax and 20% of cases
negative by slide and RDT, in which case a second reader was used
How were discrepancies between observers resolved? The second, off-site reading was
taken as the correct 1
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv (Amrad-ICT, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum ormixed infection, non-falciparummalaria
species only
Designated type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Refrigerated until 2 weeks before use
Person(s) performing RDT: Researchers
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Bell 2001a (Continued)
RDT setting: Study villages
Follow-up Not applicable
Notes Source of funding: The Australian National Health and Medical Research Council
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants had approached village
health workers with symptoms suggestive
of malaria, but the sampling method was
not described
Acceptable reference standard?
All tests
Yes An experiencedmicroscopist viewed at least
100 high powered fields and discordant re-
sults were re-examined
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes “slides were read by a local microscopist
who was not aware of the results of the ICT
tests”
Index test results blinded?
All tests
Yes RDTs were performed 2 to 4 weeks before
microscopy.
Uninterpretable results reported?
All tests
Yes The paper reported that there was 1 unin-
terpretable microscopy result
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not stated; therefore
it is unclear whether there were any with-
drawals
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Bell 2001b
Clinical features and settings Presenting signs and symptoms: History of fever, headache, child or rigors occurring
within the preceding 3 days; or more distant history of fever or non-specific signs sug-
gestive of malaria
Previous treatment for malaria: Patients treated with antimalarials during the 4 weeks
preceding the test were excluded from the analysis
Clinical setting: Health centre in Visaya
Country: Philippines (Agusan del Sur Province in the northeast of the island of Main-
dano)
Malaria endemicity: Generally low perennial transmission, with pockets of high trans-
mission
Malaria endemic species: P. falciparum andP. vivax
Participants Sample size: 113
Age: Eligible age range not stated. Mean age of the participants was 19.8 years
Sex: Both males and females eligible. There were 73 male and 40 female participants
Co-morbidities and pregnancy:Not mentioned, either as an exclusion criteria or char-
acteristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was prospective. The sampling method was not described. 1 RDT was eval-
uated
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy of thick and thin blood smears
Who performed the reference standard tests, and where? Not stated.
Setting: Regional Health Units
If microscopy was used, how many high power fields were looked at? Not stated,
but probably 100 as in the other trial reported together in the same paper
How many observers or repeats were used? Not stated
How were discrepancies between observers resolved? Not applicable
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv (Amrad-ICT, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum ormixed infection, non-falciparummalaria
species only
Designated type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Stored by barangay health workers at room temper-
ature, averaging about 25°C for up to 6 months
Person(s) performing RDT: Barangay health workers
RDT setting: Health centre
Follow-up Not applicable
Notes Source of funding: The Australian National Health and Medical Research Council
Table of Methodological Quality
Item Authors’ judgement Description
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Bell 2001b (Continued)
Representative spectrum?
All tests
Unclear All participants were attending a health
centre with history of fever, headache, child
or rigors within the preceding 3 days; more
distant history of fever or non-specific signs
suggestive of malaria; but the sampling
method was not described
Acceptable reference standard?
All tests
Unclear No details given of the microscopy process.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes Clear that blinding had taken place, as it
was not possible to match up all the RDT
and microscopy results by name and date
Index test results blinded?
All tests
Yes Clear that blinding had taken place, as it
was not possible to match up all the RDT
and microscopy results by name and date
Uninterpretable results reported?
All tests
Yes 25 of 393 tests done were considered in-
valid because of an indistinct control band.
Invalid results were excluded from the anal-
ysis
Withdrawals explained?
All tests
Yes Only 113 microscopy results could be
matched with RDT results by name and
date; the others were lost from the analysis
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Bendezu 2010
Clinical features and settings Presenting signs and symptoms: History of fever with or without chills, sweating and
headache
Previous treatments for malaria: No history of anti-malarial treatment during the last
2 weeks
Clinical setting: Health facilities
Country: Peru
Malaria endemicity: “Despite a reduction of the incidence by up to 40% during the last
4 years in Peru, malaria due to P. falciparum and P. vivax remains an important public
health problem, especially in the Amazon region where more than 70% of the cases of
the country are reported.”
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 332
Age: Eligible age range not stated. Mean age was 32 ± 16 years
Sex: Not mentioned either as an inclusion criteria or a characteristic of participants
Co-morbidities or pregnancy: Not mentioned either as an inclusion criteria or a char-
acteristic of participants
Study design Enrolment was prospective. The sampling method was not described. 1 RDT was eval-
uated
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax malaria
Reference standard test(s) used:Microscopy thick and thin blood films and PCR
Who performed the reference standard tests, and where? Reference standards were
carried out by different staff blinded to each other result. Expert microscopy was carried
out by experts in the 6 health centres; not described for PCR
If microscopy was used, how many high power fields were looked at? Not stated
How many observers or repeats were used? 10% of the slides were examined by a
second expert microscopist at the reference laboratory
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: ParaScreen (Zephyr Biomedical Systems)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum species only
Designated type: ParaScreen - Type 3
Batch numbers: Lot 101051
Transport and storage conditions: Not described
Who performed the index test, and where? Not stated
Follow-up
Notes Source of funding: by The Global Fund to fight AIDS, Tuberculosis and Malaria
through the - Organismo Andino de Salud - Convenio Hipolito Unanue’ (Principal
Recipient of the Multi-Country Malaria Project “Malaria control on the cross border
areas of the Andean Region: A community based approach”-PAMAFRO), Grant Num-
ber MAA-305-G01-M; and by the Directorate General for Development Cooperation
(DGCD) of the Belgian Government (framework agreement 02, 2003-2007), project
95501
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Bendezu 2010 (Continued)
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were attending health centres
with fever and no history of malaria treat-
ment within the last 2 weeks
Acceptable reference standard?
All tests
No Only 10% of slides were viewed twice. The
number of high power fields viewed before
declaring a sample negative was not stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference tests were used regard-
less of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes Reported that the tests were read blindly.
Index test results blinded?
All tests
Yes Reported that the tests were read blindly.
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals
Bharti 2008
Clinical features and settings Presenting signs and symptoms: Fever or history of fever, and suspicion of malaria
Previous treatment for malaria: No exclusions based on previous treatment; it was
undertaken in a remote area with no medical facilities
Clinical setting: Mobile field clinics in ten villages
Country: India (remote forested region of Jabalpur during the peak monsoon season)
Malaria endemicity: Low endemic areas with higher transmission during the monsoon
Malaria endemic species: P. falciparum andP. vivax
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Participants Sample size: 291
Age: All age groups eligible. Actual age range of participants 1 to 60 years
Sex: Both males and females eligible. Male: female ratio 1:1.15
Co-morbidities and pregnancy: No criteria based on co-morbidities or pregnancy. No
details of the frequency of these conditions in the participant population presented
Parasite density of microscopy positive cases: Range 80 to 111,920 parasites per µL,
mean 8011, standard deviation 21,595
Study design Enrolment was consecutive and prospective. 1 RDT was evaluated
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood films
Who performed the reference standard tests, and where? Experienced microscopist
in the laboratory of NIMR
If microscopy was used, how many high power fields were looked at? 100
How many observers or repeats were used? 1 for all samples, 2 independent readers
for samples discordant between microscopy and RDT
How were discrepancies between observers resolved? Where the second reading gave
a different result from the first, the results of the second reading were confirmed by a
third examination by another technician
Index and comparator tests Commerical name of RDT: First Response ComboMalaria Ag card test (Premier Med-
ical Corporation Ltd, Mumbai, India)
Parasite(s) designed to detect: P. falciparum ormixed infection, non-falciparummalaria
species only
Designated type: Type 3
Batch numbers: 61F0107
Transport and storage conditions: RDTs were stored properly, at temperature of 4°C
to 30°C, and used within their shelf life
Person(s) performing RDT: Field laboratory assistants. Independent staff re-read the
saved tests after 2 months and matched them with the originally recorded results
RDT setting: Field laboratory
Follow-up Not applicable
Notes Source of funding: Indian Council of Medical Research, Delhi. Test kits provided by
Premier Medical Corporation Ltd
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
people attending mobile field clinics with
fever or history of fever, and suspicion of
malaria
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Acceptable reference standard?
All tests
Yes An experiencedmicroscopist viewed at least
100 high power fields before declaring a
slide negative, and results discordant with
RDT were independently re-examined by
a second microscopist, and a third if neces-
sary
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes Microscopy was undertaken “without ref-
erence to the RDT”.
Index test results blinded?
All tests
Yes RDTs were undertaken on site, and the re-
sults recorded before themicroscopy results
became available
Uninterpretable results reported?
All tests
Yes The paper reported that there were no in-
valid results.
Withdrawals explained?
All tests
Yes The number of participants enrolled in the
study was clearly stated and corresponded
to the number presented in the analysis;
therefore there were no withdrawals
Chanie 2011
Clinical features and settings Presenting signs and symptoms: Suspectedmalaria: clinical symptoms of malaria, fever
Previous treatments for malaria: 12.5% of the subjects had anti-malaria treatment in
the preceding month
Clinical setting: Outpatient departments of 3 health facilities
Country: Ethiopia
Malaria endemicity: High endemicity
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 1092
Age: Mean 22.3 (SD 12.8); range 3 months to 78 years of age
Sex: 48.57% female, 51.43% male
Co-morbidities or pregnancy: Co-morbidities and pregnancy not stated
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
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Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy thick and thin smears
Who performed the reference standard tests, and where? Experienced malaria tech-
nicians performed the microscopic test. Location not reported (presumably at each of
the participating health centres)
If microscopy was used, how many high power fields were looked at? A minimum
of 100 high power fields examined on a thick smear
How many observers or repeats were used? Not stated
How were discrepancies between observers resolved? 20% of the positive and 10%
of the negative slides and discordant results between RDT and microscopic tests were
examined by another well experienced technician
Index and comparator tests Commercial name of the test: CareStart Malaria Pf/Pv Combo (Access Bio Inc, New
Jersey, USA)
Parasite species the test is designed to detect: P. falciparum and P. vivax
Designated type: Type Other (HRP-2 antigen for P. falciparum and pLDH antigen for
P. vivax)
Batch numbers: Lot No H38 IV and Lot No H28 IV
Transport and storage conditions: Lot No H38 IV and Lot No H28 IV
Who performed the index test, and where? Experiencedmalaria technicians performed
the index test
Follow-up Not applicable
Notes Source of funding: Addis Ababa University, The FederalMinistry of Health of Ethiopia.
RDT kits were donated by Acces Bio Inc
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes All participants were attending primary
health centres with fever and symptoms of
malaria, sampling was consecutive
Acceptable reference standard?
All tests
Yes “...discordant results between RDT and
microscopic tests were examined by an-
other well experienced technician”. Expe-
rienced malaria technicians viewed 200
white blood cells or 100 fields
Partial verification avoided?
All tests
Yes Characteristics of participants are well de-
scribed and the only exclusion criterionwas
refusal to participate in the study
Differential verification avoided?
All tests
Yes The same reference standard was used.
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Incorporation avoided?
All tests
Yes The reference standard was microscopy.
Reference standard results blinded?
All tests
Unclear Blinding procedures not stated. However,
microscopic evaluation and RDT were
performed independently. Results were
recorded in separate sheets
Index test results blinded?
All tests
Unclear Blinding procedures not stated. However,
microscopic evaluation and RDT were
performed independently. Results were
recorded in separate sheets
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes The number recruited into the study was
clearly stated, and corresponded with the
number included in the analysis, therefore
there were no withdrawals
Chayani 2004
Clinical features and settings Presenting signs and symptoms: Specific symptoms: rigor, chills, rise of high temper-
ature and profuse sweating; or irregular fever, joint pain and jaundice
Previous treatment for malaria: No explicit exclusions based on previous treatment
and no information presented on previous treatment
Clinical setting: Diagnostic and research centre (takes referrals from physicians for the
diagnosis of malaria)
Country: Orissa, India
Malaria endemicity: Not stated
Malaria endemic species: In sample, 78.6% P. falciparum, 21.4% P. vivax
Participants Sample size: 232
Age: Not mentioned, either as inclusion criteria or characteristic of participants
Sex: Not mentioned, either as inclusion criteria or characteristic of participants
Co-morbidities and pregnancy: Not mentioned, either as inclusion criteria or charac-
teristic of participants
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was prospective. The sampling method was unclear. 1 RDT was evaluated
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and think blood smear
Who performed the reference standard tests, and where?Microscopists in a diagnostic
and research centre
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If microscopy was used, how many high power fields were looked at? 200
How many observers or repeats were used? 2 independent observers
How were discrepancies between observers resolved? A third microscopist’s opinion
was taken into account
Index and comparator tests Commerical name of RDT: OptiMAL (DiaMed, AG, Cressier, Switzerland)
Parasite(s) designed to detect: P. falciparum ormixed infection, non-falciparummalaria
species only
Designated type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending an ambu-
latory clinic with rigor, chills, rise of high
temperature and profuse sweating; or irreg-
ular fever, joint pain and jaundice.However
the sampling method was not described
Acceptable reference standard?
All tests
Yes 2 independent microscopists viewed 200
high powered fields before declaring a slide
negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Unclear Blinding not described.
Index test results blinded?
All tests
Unclear Blinding not described.
Uninterpretable results reported?
All tests
No The number of participants originally en-
rolled in the study was not explicitly stated;
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therefore it is not possible to judge whether
any were excluded from the analysis due to
invalid test results
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is not possible to judge whether
there were any withdrawals
Dev 2004
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No information presented on previous treatment; no
suggestion of any exclusions based on previous treatment
Clinical setting: Malaria clinics
Country: India (Assam)
Malaria endemicity: Mesoendemic
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 336; but varied by RDT evaluated (10 to 139)
Age: Infants under 12 months excluded; actual age range 1 to 60 years
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated
Co-morbidities and pregnancy:No exclusions criteria based on co-morbidities or preg-
nancy were stated, and no details of the frequency of these conditions in the participant
population is presented
Parasite density of microscopy positive cases: Range 300 to 350,000 parasites per µL,
mean 59,842, standard deviation (SD) 78,780
Study design Enrolment was prospective. The sampling method was not described. 7 RDTs were
evaluated; it is unclear how each RDT was allocated, as no participant received all the
tests
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Who performed the reference standard tests, and where?Technician; all positive slides
and 20% of negative slides were also examined by the senior technician for confirmation
of result. Setting was the laboratory at the malaria clinics
If microscopy was used, how many high power fields were looked at? 100
Howmany observers or repeats were used? 1 in the case of most smears judged negative
by the technician. 2 in the case of 20% of those initially judged negative, and all those
judged positive
How were discrepancies between observers resolved? The judgement of the senior
technician was used
Index and comparator tests Commerical name of RDT:
• Paracheck Pf (Orchid Biomedical Systems, Goa, India)
• ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ)
• ParaHIT-F (Span diagnostics Ltd, Surat, India)
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Dev 2004 (Continued)
• ICT Malaria Pf (ICT Diagnostics, Sydney, Australia)
• New Pf-1 mini (Monozyme India Ltd, Secundrabad, India)
• SD Malaria Pf/Pv (SD Diagnostics Inc, Korea)
• Diamed OptiMAL (Flow Inc. Portlad, OR)
Parasite(s) designed to detect:
• Paracheck Pf - P. falciparum
• ParaSight-F - P. falciparum
• ParaHIT-F - P. falciparum
• ICT Malaria Pf - P. falciparum
• New Pf-1 mini - P. falciparum
• SD Malaria Pf/Pv - P. falciparum or mixed infection, non-falciparum malaria
species only
• Diamed OptiMAL - P. falciparum or mixed infection, non-falciparum malaria
species only
Designated type:
• Paracheck Pf - Type I
• ParaSight-F - Type I
• ParaHIT-F - Type I
• ICT Malaria Pf - Type I
• New Pf-1 mini - Type I
• SD Malaria Pf/Pv - Type 3
• Diamed OptiMAL - Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: The laboratory attendant performed the test and recorded
his or her interpretation. The test kit result was then re-read for verification by the senior
technician
RDT setting: Malaria clinic laboratory
Follow-up Not applicable
Notes Source of funding: Mian source of funding not stated. Test kits supplied by the Gov-
ernment of Assam
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending malaria
clinics with fever; however, during the
study period, 6663 blood smears were ex-
amined but only 336 were evaluated with
RDT kits, and the sampling method for
RDT evaluation was unclear
Acceptable reference standard?
All tests
Unclear 2 observers were used in the vast majority
of cases; however, it is unclear whether the
observers worked independently
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Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes Microscopy and RDT results were com-
pared by an independent observer
Index test results blinded?
All tests
Yes Microscopy and RDT results were com-
pared by an independent observer
Uninterpretable results reported?
All tests
No No information presented on numbers ini-
tially allocated each RDT, so not possible
to judge this
Withdrawals explained?
All tests
Unclear No information presented on numbers ini-
tially allocated each RDT, so not possible
to judge this
Eibach 2013
Clinical features and settings Presenting signs and symptoms: Suspected malaria with a temperature > 37.5°C
Previous treatments for malaria: More than 90% of the patients reported receiving
traditional or registered drugs, including antipyretics, antimalarials and antibiotics previ-
ously. However, the quality of drugs, the dosage and the duration of treatment remained
unknown
Clinical setting: General health centre
Country:Mali
Malaria endemicity: Hyperendemic in the peripheral villages, mesoendemic in the
periurban area and hypoendemic in the city
Malaria endemic species: 95% P. falciparum
Participants Sample size: 727
Age: Mean 23.5 (SD 14.9) median = 21, range 1 to 60)
Sex: Not reported
Co-morbidities or pregnancy: Not reported
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 2 RDTs
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum, PAN malaria
Reference standard test(s) used:Microscopy thick and thin smears
Who performed the reference standard tests, and where? Local investigators
If microscopy was used, how many high power fields were looked at? 100
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How many observers or repeats were used? Thick and thin smears were assessed by
2 local investigators, and by an expert at the Parasitology Department of the Lyon
University Hospital, as a quality control
How were discrepancies between observers resolved?
Local investigators resolved all discrepancies between themselves by consensus. All dis-
cordant results between microscopy and the 2 RDTs were resolved by PCR and test
characteristics were recalculated according to the PCR-corrected results
Index and comparator tests Commercial name of the test: VIKIA Malaria Ag Pf/Pan (IMAccess, Lyon, France),
CareStart Malaria (AccessBio, USA)
Parasite species the test is designed to detect:
VIKIA Malaria Ag Pf/Pan: P. falciparum or mixed infection, non-falciparum malaria
species only
CareStart Malaria: P. falciparum or mixed infection, non-falciparum malaria species only
Designated type: VIKIA Malaria Ag Pf/Pan: Type 2
CareStart Malaria: Type 3
Batch numbers: VIKIA Malaria Ag Pf/Pan: RD MA2 110527
CareStart Malaria: G21MR
Transport and storage conditions: Not reported
Who performed the index test, and where? Local community health workers trained
to use both tests .
Follow-up Not applicable
Notes Source of funding: The study was supported by IMACCESS.
Data from the Lyon part of the study was not included as it did not match inclusion
criteria
The VIKIA Malaria Ag Pf/Pan™ test was read at different time points (15, 20, 30, 60
minutes), while the CareStart Malaria™ test was read after 20 minutes as recommended
2 drops of blood were spotted onto filter paper, individually stored in a plastic bag and
sent to the Parasitology Department of the Lyon University Hospital for PCR correction
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Consecutive sample of people attending a
clinic with symptoms of malaria
Acceptable reference standard?
All tests
Yes Microscopy was undertaken by 2 trained
local health workers and corrected by PCR
at the Parasitology Department of the Lyon
University Hospital
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference tests
Differential verification avoided?
All tests
Yes The same reference test was used.
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Incorporation avoided?
All tests
Yes Standard microscopy and PCR.
Reference standard results blinded?
All tests
Yes Allmicroscopistswere blinded to the results
of the RDTs.
Index test results blinded?
All tests
Yes RDTs were performed immediately after
sampling.
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes The number of participants enrolled was
clearly stated, and the number included in
the analysis corresponds to this number, in-
dicating no withdrawals
Elahi 2013
Clinical features and settings Presenting signs and symptoms: Febrile patients with clinical symptoms
Previous treatments for malaria: Not described
Clinical setting: Health posts in remote border areas
Country: Bangladesh
Malaria endemicity: Endemic
Malaria endemic species: 74% P. falciparum, 26% P. vivax,P. malariae and P. ovale were
also present in the area, but were not found within the study sample
Participants Sample size: 327
Age: Not reported
Sex: Not reported
Co-morbidities or pregnancy: Not reported
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum, PAN malaria
Reference standard test(s) used:Microscopy thick and thin smears; quantitative PCR
Who performed the reference standard tests, and where? Experienced microscopists
at the field sites
If microscopy was used, how many high power fields were looked at? 100
How many observers or repeats were used? 2 independent microscopists, blinded to
the findings of the other
How were discrepancies between observers resolved? Where there was a discrepancy
between the 2 microscopists, the sample was excluded from the study. The number
excluded for this reason was not stated
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Index and comparator tests Commercial name of the test: Parascreen (Zephyr Biomedical Systems, India)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 3
Batch numbers: 101159
Transport and storage conditions: Not described
Who performed the index test, and where? Laboratory personnel at the Parisitology
Laboratory, icddr,b
Follow-up Not applicable
Notes Source of funding: icddr,b and its donors, which provide unrestricted support to icddr,
b for its operations and support. Parascreen was donated by the manufacturer
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Recruitment was prospective, but the sam-
pling procedure was not stated. Samples
with mixed infections or where the 2 mi-
croscopists’ findings did not agree were ex-
cluded, and the number excluded was not
stated
Acceptable reference standard?
All tests
Unclear Microscopy was undertaken by 2 experi-
enced microscopists, but the number of
fields viewed before declaring a slide nega-
tive was not stated
PCR was also used as a separate, additional
reference standard
Partial verification avoided?
All tests
Yes All participants received both the reference
test and the index test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes Microscopy was used as the reference stan-
dard.
Reference standard results blinded?
All tests
Yes Microscopists were blinded to prior results.
Index test results blinded?
All tests
Unclear Blinding not described, however, index and
reference tests were undertaken at different
locations
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Uninterpretable results reported?
All tests
No Uninterpretable results were not reported
on.
Withdrawals explained?
All tests
No It was stated that samples withmixed infec-
tion or where microscopists disagreed were
excluded; however, the number of samples
excluded and the original number of par-
ticipants enrolled was not presented
Endeshaw 2012a
Clinical features and settings Presenting signs and symptoms: Clinically presumptive malaria: an axillary tempera-
ture greater than or equal to 37.5°C or
history of fever in the previous 48 hours
Previous treatments for malaria: Not stated
Clinical setting: Ten health centres
Country: Ethiopia
Malaria endemicity: The study was conducted in an area with range of transmission
intensities, during the peak transmission period of malaria infection
Malaria endemic species: Not stated
Participants Sample size: 1997. 4 RDTs were not done (reason not reported)
Age: Range: 8 months to 85 years. Mean 20.7 (SD not stated)
Sex: 56.2 male, 43.8 female
Co-morbidities or pregnancy: Patients with other known causes of non malarial febrile
illnesses or serious illness were excluded. Pregnancy status not stated
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy, thick and thin smears
Who performed the reference standard tests, and where?Microscopy assessment was
performed by experienced medical laboratory technicians
If microscopy was used, how many high power fields were looked at? Not stated
Howmany observers or repeats were used? Slides were also sent for expert microscopy
at The Carter Center in Addis Ababa
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: ParaScreen Pan/Pf (Zephyr Biomedical systems, Verna,
Goa, India)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 3
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? The ten experienced laboratory technicians
involved in this study were trained on the RDT sampling and evaluation procedures
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Follow-up Not applicable
Notes Source of funding: Not stated.
“Out of 2000 recruited patients, 1997 febrile cases were examined for malaria parasites
by blood slide microscopy.”
“Of the 1997 persons tested by slide, 1993 samples were also examined by ParaScreen
RDT at the health centers.”
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes In each health centre the first 200 self-
presenting patients of any age and either
sex who qualified as clinically presumptive
malaria were recruited
Acceptable reference standard?
All tests
Unclear Slideswere evaluated by trained technicians
at each site andwere also sent to a central lab
for expert microscopy. However, number
of microscopic field was not stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes Microscopy was used as reference standard.
Reference standard results blinded?
All tests
Yes Although blind procedures for local techni-
cians are not reported, slides were also sent
for expert microscopy at a central lab where
they were examined in blinded fashion
Index test results blinded?
All tests
Yes Microscopy and ParaScreen Pan/PfHRDT
were done immediately by health centre
technicians
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated as 2000, 1993 were presented in
the analysis; therefore there were 7 with-
drawals. These were explained as 3 who de-
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clined to participate and 4 who did not
have RDT because the technicians had too
much work
Endeshaw 2012b
Clinical features and settings Presenting signs and symptoms: Clinically presumptive malaria: an axillary tempera-
ture greater than or equal to 37.5°C or history of fever in the previous 48 hours
Previous treatments for malaria: Not stated
Clinical setting: Ten health centres
Country: Ethiopia
Malaria endemicity: The study was conducted in an area with range of transmission
intensities, during the peak transmission period of malaria infection
Malaria endemic species: Not stated
Participants Sample size: 1997. 4 RDTs were not done (reason not reported)
Age: Range: 8 months to 85 years. Mean 20.7 (SD not stated)
Sex: 56.2 male, 43.8 female
Co-morbidities or pregnancy: Patients with other known causes of non malarial febrile
illnesses or serious illness were excluded. Pregnancy status not stated
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy, thick and thin smears
Who performed the reference standard tests, and where?Microscopy assessment was
performed by experienced medical laboratory technicians
If microscopy was used, how many high power fields were looked at? Not stated
Howmany observers or repeats were used? Slides were also sent for expert microscopy
at The Carter Center in Addis Ababa
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: ParaScreen Pan/Pf (Zephyr Biomedical systems, Verna,
Goa,India)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 3
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? The ten experienced laboratory technicians
involved in this study were trained on the RDT sampling and evaluation procedures
Follow-up Not applicable
Notes Source of funding: Not stated.
“Out of 2000 recruited patients, 1997 febrile cases were examined for malaria parasites
by blood slide microscopy.”
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“Of the 1997 persons tested by slide, 1993 samples were also examined by ParaScreen
RDT at the health centers.”
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes In each health centre the first 200 self-
presenting patients of any age and either
sex who qualified as clinically presumptive
malaria were recruited
Acceptable reference standard?
All tests
Unclear Slideswere evaluated by trained technicians
at each site andwere also sent to a central lab
for expert microscopy. However, number
of microscopic fields was not stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes Microscopy was used as a reference stan-
dard.
Reference standard results blinded?
All tests
Yes Although blind procedures for local techni-
cians are not reported, slides were also sent
for expert microscopy at a central lab where
they were examined in blinded fashion
Index test results blinded?
All tests
Yes Microscopy and ParaScreen Pan/PfHRDT
were done immediately by health centre
technicians
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated as 2000, 1993 were presented in
the analysis; therefore there were 7 with-
drawals. These were explained as 3 who de-
clined to participate and 4 who did not
have RDT because the technicians had too
much work
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Clinical features and settings Presenting signs and symptoms: Clinically presumptive malaria: an axillary tempera-
ture greater than or equal to 37.5°C or
history of fever in the previous 48 hours
Previous treatments for malaria: Not stated
Clinical setting: Ten health centres
Country: Ethiopia
Malaria endemicity: The study was conducted in an area with range of transmission
intensities, during the peak transmission period of malaria infection
Malaria endemic species: Not stated
Participants Sample size: 1997. 4 RDTs were not done (reason not reported)
Age: Range: 8 months to 85 years. Mean 20.7 (SD not stated)
Sex: 56.2 male, 43.8 female
Co-morbidities or pregnancy: patients with other known causes of non malarial febrile
illnesses or serious illness were excluded. Pregnancy status not stated
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy, thick and thin smears
Who performed the reference standard tests, and where?Microscopy assessment was
performed by experienced medical laboratory technicians
If microscopy was used, how many high power fields were looked at? Not stated
Howmany observers or repeats were used? Slides were also sent for expert microscopy
at The Carter Center in Addis Ababa
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: ParaScreen Pan/Pf (Zephyr Biomedical systems, Verna,
Goa, India)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 3
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? The ten experienced laboratory technicians
involved in this study were trained on the RDT sampling and evaluation procedures
Follow-up Not applicable
Notes Source of funding: Not stated.
“Out of 2000 recruited patients, 1997 febrile cases were examined for malaria parasites
by blood slide microscopy.”
“Of the 1997 persons tested by slide, 1993 samples were also examined by ParaScreen
RDT at the health centers.”
Table of Methodological Quality
Item Authors’ judgement Description
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Representative spectrum?
All tests
Yes In each health centre, the first 200 self-
presenting patients of any age and either
sex who qualified as clinically presumptive
malaria were recruited
Acceptable reference standard?
All tests
Unclear Slideswere evaluated by trained technicians
at each site andwere also sent to a central lab
for expert microscopy. However, number
of microscopic field have not been stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes Microscopy was used as reference standard.
Reference standard results blinded?
All tests
Yes Although blind procedures for local techni-
cians are not reported, slides were also sent
for expert microscopy at a central lab where
they were examined in blinded fashion
Index test results blinded?
All tests
Yes Microscopy and ParaScreen Pan/PfHRDT
were done immediately by health centre
technicians
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated as 2000, 1993 were presented in
the analysis; therefore there were 7 with-
drawals. These were explained as 3 who de-
clined to participate and 4 who did not
have RDT because the technicians had too
much work
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Clinical features and settings Presenting signs and symptoms: Clinically presumptive malaria: an axillary tempera-
ture greater than or equal to 37.5°C or history of fever in the previous 48 hours
Previous treatments for malaria: Not stated
Clinical setting: Ten health centres
Country: Ethiopia
Malaria endemicity: The study was conducted in an area with range of transmission
intensities, during the peak transmission period of malaria infection
Malaria endemic species: Not stated
Participants Sample size: 1997. 4 RDTs were not done (reason not reported)
Age: Range: 8 months to 85 years. Mean 20.7 (SD not stated)
Sex: 56.2 male, 43.8 female
Co-morbidities or pregnancy: Patients with other known causes of non malarial febrile
illnesses or serious illness were excluded. Pregnancy status not stated
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy, thick and thin smears
Who performed the reference standard tests, and where?Microscopy assessment was
performed by experienced medical laboratory technicians
If microscopy was used, how many high power fields were looked at? Not stated
Howmany observers or repeats were used? Slides were also sent for expert microscopy
at The Carter Center in Addis Ababa
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: ParaScreen Pan/Pf (Zephyr Biomedical systems, Verna,
Goa, India)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 3
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? The ten experienced laboratory technicians
involved in this study were trained on the RDT sampling and evaluation procedures
Follow-up Not applicable
Notes Source of funding: Not stated.
“Out of 2000 recruited patients, 1997 febrile cases were examined for malaria parasites
by blood slide microscopy.”
“Of the 1997 persons tested by slide, 1993 samples were also examined by ParaScreen
RDT at the health centers.”
Table of Methodological Quality
Item Authors’ judgement Description
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Representative spectrum?
All tests
Yes In each health centre, the first 200 self-
presenting patients of any age and either
sex who qualified as clinically presumptive
malaria were recruited
Acceptable reference standard?
All tests
Unclear Slideswere evaluated by trained technicians
at each site andwere also sent to a central lab
for expert microscopy. However, the num-
ber of microscopic fields was not stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes Microscopy was used as reference standard.
Reference standard results blinded?
All tests
Yes Although blind procedures for local techni-
cians are not reported, slides were also sent
for expert microscopy at a central lab where
they were examined in blinded fashion
Index test results blinded?
All tests
Yes Microscopy and ParaScreen Pan/PfHRDT
were done immediately by health centre
technicians
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated as 2000, 1993 were presented in
the analysis; therefore there were 7 with-
drawals. These were explained as 3 who de-
clined to participate and 4 who did not
have RDT because the technicians had too
much work
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Clinical features and settings Presenting signs and symptoms: Clinically presumptive malaria: an axillary tempera-
ture greater than or equal to 37.5°C or
history of fever in the previous 48 hours
Previous treatments for malaria: Not stated
Clinical setting: Ten health centres
Country: Ethiopia
Malaria endemicity: The study was conducted in an area with range of transmission
intensities, during the peak transmission period of malaria infection
Malaria endemic species: Not stated
Participants Sample size: 1997. 4 RDTs were not done (reason not reported)
Age: Range: 8 months to 85 years. Mean 20.7 (SD not stated)
Sex: 56.2 male, 43.8 female
Co-morbidities or pregnancy: Patients with other known causes of non malarial febrile
illnesses or serious illness were excluded. Pregnancy status not stated
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy, thick and thin smears
Who performed the reference standard tests, and where?Microscopy assessment was
performed by experienced medical laboratory technicians
If microscopy was used, how many high power fields were looked at? Not stated
Howmany observers or repeats were used? Slides were also sent for expert microscopy
at The Carter Center in Addis Ababa
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: ParaScreen Pan/Pf (Zephyr Biomedical systems, Verna,
Goa,India)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 3
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? The ten experienced laboratory technicians
involved in this study were trained on the RDT sampling and evaluation procedures
Follow-up Not applicable
Notes Source of funding: Not stated.
“Out of 2000 recruited patients, 1997 febrile cases were examined for malaria parasites
by blood slide microscopy.”
“Of the 1997 persons tested by slide, 1993 samples were also examined by ParaScreen
RDT at the health centers.”
Table of Methodological Quality
Item Authors’ judgement Description
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Representative spectrum?
All tests
Yes In each health centre the first 200 self-
presenting patients of any age and either
sex who qualified as clinically presumptive
malaria were recruited
Acceptable reference standard?
All tests
Unclear Slideswere evaluated by trained technicians
at each site andwere also sent to a central lab
for expert microscopy. However, number
of microscopic field have not been stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes Microscopy was used as reference standard.
Reference standard results blinded?
All tests
Yes Although blind procedures for local techni-
cians are not reported, slides were also sent
for expert microscopy at a central lab where
they were examined in blinded fashion
Index test results blinded?
All tests
Yes Microscopy and ParaScreen Pan/PfHRDT
were done immediately by health centre
technicians
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated as 2000, 1993 were presented in
the analysis; therefore there were 7 with-
drawals. These were explained as 3 who de-
clined to participate and 4 who did not
have RDT because the technicians had too
much work
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Clinical features and settings Presenting signs and symptoms: Clinically presumptive malaria: an axillary tempera-
ture greater than or equal to 37.5°C or history of fever in the previous 48 hours
Previous treatments for malaria: Not stated
Clinical setting: Ten health centres
Country: Ethiopia
Malaria endemicity: The study was conducted in an area with range of transmission
intensities, during the peak transmission period of malaria infection
Malaria endemic species: Not stated
Participants Sample size: 1997. 4 RDTs were not done (reason not reported)
Age: Range: 8 months to 85 years. Mean 20.7 (SD not stated)
Sex: 56.2 male, 43.8 female
Co-morbidities or pregnancy: patients with other known causes of non malarial febrile
illnesses or serious illness were excluded. Pregnancy status not stated
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy, thick and thin smears
Who performed the reference standard tests, and where?Microscopy assessment was
performed by experienced medical laboratory technicians
If microscopy was used, how many high power fields were looked at? Not stated
Howmany observers or repeats were used? Slides were also sent for expert microscopy
at The Carter Center in Addis Ababa
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: ParaScreen Pan/Pf (Zephyr Biomedical systems, Verna,
Goa,India)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 3
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? The ten experienced laboratory technicians
involved in this study were trained on the RDT sampling and evaluation procedures
Follow-up Not applicable
Notes Source of funding: Not stated.
“Out of 2000 recruited patients, 1997 febrile cases were examined for malaria parasites
by blood slide microscopy.”
“Of the 1997 persons tested by slide, 1993 samples were also examined by ParaScreen
RDT at the health centers.”
Table of Methodological Quality
Item Authors’ judgement Description
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Representative spectrum?
All tests
Yes In each health centre the first 200 self-
presenting patients of any age and either
sex who qualified as clinically presumptive
malaria were recruited
Acceptable reference standard?
All tests
Unclear Slideswere evaluated by trained technicians
at each site andwere also sent to a central lab
for expert microscopy. However, number
of microscopic field have not been stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes Microscopy was used as reference standard.
Reference standard results blinded?
All tests
Yes Although blind procedures for local techni-
cians are not reported, slides were also sent
for expert microscopy at a central lab where
they were examined in blinded fashion
Index test results blinded?
All tests
Yes Microscopy and ParaScreen Pan/PfHRDT
were done immediately by health centre
technicians
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated as 2000, 1993 were presented in
the analysis; therefore there were 7 with-
drawals. These were explained as 3 who de-
clined to participate and 4 who did not
have RDT because the technicians had too
much work
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Clinical features and settings Presenting signs and symptoms: Clinically presumptive malaria: an axillary tempera-
ture greater than or equal to 37.5°C or history of fever in the previous 48 hours
Previous treatments for malaria: Not stated
Clinical setting: Ten health centres
Country: Ethiopia
Malaria endemicity: The study was conducted in an area with range of transmission
intensities, during the peak transmission period of malaria infection
Malaria endemic species: Not stated
Participants Sample size: 1997. 4 RDTs were not done (reason not reported)
Age: Range: 8 months to 85 years. Mean 20.7 (SD not stated)
Sex: 56.2 male, 43.8 female
Co-morbidities or pregnancy: patients with other known causes of non malarial febrile
illnesses or serious illness were excluded. Pregnancy status not stated
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy, thick and thin smears
Who performed the reference standard tests, and where?Microscopy assessment was
performed by experienced medical laboratory technicians
If microscopy was used, how many high power fields were looked at? Not stated
Howmany observers or repeats were used? Slides were also sent for expert microscopy
at The Carter Center in Addis Ababa
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: ParaScreen Pan/Pf (Zephyr Biomedical systems, Verna,
Goa,India)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 3
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? The 10 experienced laboratory technicians
involved in this study were trained on the RDT sampling and evaluation procedures
Follow-up Not applicable
Notes Source of funding: Not stated.
“Out of 2000 recruited patients, 1997 febrile cases were examined for malaria parasites
by blood slide microscopy”
“Of the 1997 persons tested by slide, 1993 samples were also examined by ParaScreen
RDT at the health centers.”
Table of Methodological Quality
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Representative spectrum?
All tests
Yes In each health centre the first 200 self-
presenting patients of any age and either
sex who qualified as clinically presumptive
malaria were recruited
Acceptable reference standard?
All tests
Unclear Slideswere evaluated by trained technicians
at each site andwere also sent to a central lab
for expert microscopy. However, number
of microscopic field have not been stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes Microscopy was used as reference standard.
Reference standard results blinded?
All tests
Yes Although blind procedures for local techni-
cians are not reported, slides were also sent
for expert microscopy at a central lab where
they were examined in blinded fashion
Index test results blinded?
All tests
Yes Microscopy and ParaScreen Pan/PfHRDT
were done immediately by health centre
technicians
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated as 2000, 1993 were presented in
the analysis; therefore there were 7 with-
drawals. These were explained as 3 who de-
clined to participate and 4 who did not
have RDT because the technicians had too
much work
92Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries (Review)
Copyright © 2015 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Endeshaw 2012h
Clinical features and settings Presenting signs and symptoms: Clinically presumptive malaria: an axillary tempera-
ture greater than or equal to 37.5°C or history of fever in the previous 48 hours
Previous treatments for malaria: Not stated
Clinical setting: Ten health centres
Country: Ethiopia
Malaria endemicity: The study was conducted in an area with range of transmission
intensities, during the peak transmission period of malaria infection
Malaria endemic species: Not stated
Participants Sample size: 1997. 4 RDTs were not done (reason not reported)
Age: Range: 8 months to 85 years. Mean 20.7 (SD not stated)
Sex: 56.2 male, 43.8 female
Co-morbidities or pregnancy: patients with other known causes of non malarial febrile
illnesses or serious illness were excluded. Pregnancy status not stated
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy, thick and thin smears
Who performed the reference standard tests, and where?Microscopy assessment was
performed by experienced medical laboratory technicians
If microscopy was used, how many high power fields were looked at? Not stated
Howmany observers or repeats were used? Slides were also sent for expert microscopy
at The Carter Center in Addis Ababa
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: ParaScreen Pan/Pf (Zephyr Biomedical systems, Verna,
Goa,India)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 3
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? The ten experienced laboratory technicians
involved in this study were trained on the RDT sampling and evaluation procedures
Follow-up Not applicable
Notes Source of funding: Not stated.
“Out of 2000 recruited patients, 1997 febrile cases were examined for malaria parasites
by blood slide microscopy.”
“Of the 1997 persons tested by slide, 1993 samples were also examined by ParaScreen
RDT at the health centers.”
Table of Methodological Quality
Item Authors’ judgement Description
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Representative spectrum?
All tests
Yes In each health centre the first 200 self-
presenting patients of any age and either
sex who qualified as clinically presumptive
malaria were recruited
Acceptable reference standard?
All tests
Unclear Slideswere evaluated by trained technicians
at each site andwere also sent to a central lab
for expert microscopy. However, number
of microscopic field have not been stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes Microscopy was used as reference standard.
Reference standard results blinded?
All tests
Yes Although blind procedures for local techni-
cians are not reported, slides were also sent
for expert microscopy at a central lab where
they were examined in blinded fashion
Index test results blinded?
All tests
Yes Microscopy and ParaScreen Pan/PfHRDT
were done immediately by health centre
technicians
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated as 2000, 1993 were presented in
the analysis; therefore there were 7 with-
drawals. These were explained as 3 who de-
clined to participate and 4 who did not
have RDT because the technicians had too
much work
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Clinical features and settings Presenting signs and symptoms: Clinically presumptive malaria: an axillary tempera-
ture greater than or equal to 37.5°C or history of fever in the previous 48 hours
Previous treatments for malaria: Not stated
Clinical setting: Ten health centres
Country: Ethiopia
Malaria endemicity: The study was conducted in an area with range of transmission
intensities, during the peak transmission period of malaria infection
Malaria endemic species: Not stated
Participants Sample size: 1997. 4 RDTs were not done (reason not reported)
Age: Range: 8 months to 85 years. Mean 20.7 (SD not stated)
Sex: 56.2 male, 43.8 female
Co-morbidities or pregnancy: patients with other known causes of non malarial febrile
illnesses or serious illness were excluded. Pregnancy status not stated
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy, thick and thin smears
Who performed the reference standard tests, and where?Microscopy assessment was
performed by experienced medical laboratory technicians
If microscopy was used, how many high power fields were looked at? Not stated
Howmany observers or repeats were used? Slides were also sent for expert microscopy
at The Carter Center in Addis Ababa
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: ParaScreen Pan/Pf (Zephyr Biomedical systems, Verna,
Goa,India)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 3
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? The ten experienced laboratory technicians
involved in this study were trained on the RDT sampling and evaluation procedures
Follow-up Not applicable
Notes Source of funding: Not stated.
“Out of 2000 recruited patients, 1997 febrile cases were examined for malaria parasites
by blood slide microscopy.”
“Of the 1997 persons tested by slide, 1993 samples were also examined by ParaScreen
RDT at the health centers.”
Table of Methodological Quality
Item Authors’ judgement Description
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Representative spectrum?
All tests
Yes In each health centre the first 200 self-
presenting patients of any age and either
sex who qualified as clinically presumptive
malaria were recruited
Acceptable reference standard?
All tests
Unclear Slideswere evaluated by trained technicians
at each site andwere also sent to a central lab
for expert microscopy. However, number
of microscopic field have not been stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes Microscopy was used as reference standard.
Reference standard results blinded?
All tests
Yes Although blind procedures for local techni-
cians are not reported, slides were also sent
for expert microscopy at a central lab where
they were examined in blinded fashion
Index test results blinded?
All tests
Yes Microscopy and ParaScreen Pan/PfHRDT
were done immediately by health centre
technicians
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated as 2000, 1993 were presented in
the analysis; therefore there were 7 with-
drawals. These were explained as 3 who de-
clined to participate and 4 who did not
have RDT because the technicians had too
much work
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Clinical features and settings Presenting signs and symptoms: Clinically presumptive malaria: an axillary tempera-
ture greater than or equal to 37.5°C or
history of fever in the previous 48 hours
Previous treatments for malaria: Not stated
Clinical setting: Ten health centres
Country: Ethiopia
Malaria endemicity: The study was conducted in an area with range of transmission
intensities, during the peak transmission period of malaria infection
Malaria endemic species: Not stated
Participants Sample size: 1997. 4 RDTs were not done (reason not reported)
Age: Range: 8 months to 85 years. Mean 20.7 (SD not stated)
Sex: 56.2 male, 43.8 female
Co-morbidities or pregnancy: patients with other known causes of non malarial febrile
illnesses or serious illness were excluded. Pregnancy status not stated
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy, thick and thin smears
Who performed the reference standard tests, and where?Microscopy assessment was
performed by experienced medical laboratory technicians
If microscopy was used, how many high power fields were looked at? Not stated
Howmany observers or repeats were used? Slides were also sent for expert microscopy
at The Carter Center in Addis Ababa
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: ParaScreen Pan/Pf (Zephyr Biomedical systems, Verna,
Goa, India)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 3
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? The ten experienced laboratory technicians
involved in this study were trained on the RDT sampling and evaluation procedures
Follow-up Not applicable
Notes Source of funding: Not stated.
“Out of 2000 recruited patients, 1997 febrile cases were examined for malaria parasites
by blood slide microscopy.”
“Of the 1997 persons tested by slide, 1993 samples were also examined by ParaScreen
RDT at the health centers.”
Table of Methodological Quality
Item Authors’ judgement Description
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Endeshaw 2012j (Continued)
Representative spectrum?
All tests
Yes In each health centre the first 200 self-
presenting patients of any age and either
sex who qualified as clinically presumptive
malaria were recruited
Acceptable reference standard?
All tests
Unclear Slideswere evaluated by trained technicians
at each site andwere also sent to a central lab
for expert microscopy. However, number
of microscopic field have not been stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes Microscopy was used as reference standard.
Reference standard results blinded?
All tests
Yes Although blind procedures for local techni-
cians are not reported, slides were also sent
for expert microscopy at a central lab where
they were examined in blinded fashion
Index test results blinded?
All tests
Yes Microscopy and ParaScreen Pan/PfHRDT
were done immediately by health centre
technicians
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated as 2000, 1993 were presented in
the analysis; therefore there were 7 with-
drawals. These were explained as 3 who de-
clined to participate and 4 who did not
have RDT because the technicians had too
much work
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Fernando 2004
Clinical features and settings Presenting signs and symptoms: Fever or history of fever
Previous treatment for malaria: No exclusions because of prior antimalarial use, and
no data presented on the frequency of recent antimalarial use in the participants
Clinical setting: A malaria research station and a malaria clinic
Country: Sri Lanka
Malaria endemicity: Not stated
Malaria endemic species: P. vivax (70%) and P. falciparum
Participants Sample size: 328
Age: All ages above 5 years eligible; mean age 28.3 years (range 5 to 72 years)
Sex: Both males and females eligible; 64% of the participants were males
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was consecutive and prospective. 1 RDT was evaluated
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and think blood films
Who performed the reference standard tests, and where? Trained microscopists at the
clinics and in a laboratory
If microscopy was used, how many high power fields were looked at? 400
Howmany observers or repeats were used? 2 independent readers; 1 at the clinics and
another in a laboratory
How were discrepancies between observers resolved? There were no discrepancies
between the 2 microscopists
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv (Amrad-ICT, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum ormixed infection, non-falciparummalaria
species only
Designated type: Type 2
Batch numbers: Not stated
Transport and storage conditions: Stored and used at room temperature which often
exceeds 30°C
Person(s) performing RDT: The researchers
RDT setting: At the clinics
Follow-up Not applicable
Notes Source of funding: National Science Foundation, Sri Lanka
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
people attending clinics with fever or his-
tory of fever
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Fernando 2004 (Continued)
Acceptable reference standard?
All tests
Yes 2 independent trained
microscopists viewed 400 high power fields
before declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Unclear Blinding not described.
Index test results blinded?
All tests
Unclear Blinding not described.
Uninterpretable results reported?
All tests
Unclear The number of participants enrolled was
clearly stated, and the number included in
the analysis corresponds to this number, in-
dicating no withdrawals
Withdrawals explained?
All tests
Yes The number of participants enrolled was
clearly stated, and the number included in
the analysis corresponds to this number, in-
dicating no withdrawals
Harani 2006
Clinical features and settings Presenting signs and symptoms: Clinical symptoms of malaria and history of fever
over 37.5°C. People with known causes of fever other than malaria were excluded
Previous treatment for malaria: Patients who had been treated for malaria in the pre-
vious 4 weeks were excluded from the study
Clinical setting: Outpatient department of a reference hospital
Country: Pakistan
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 560
Age: All age groups eligible; actual age range of included participants 2 to 73 years
Sex: Both males and females eligibles. Participants included 339 males and 221 females
Co-morbidities and pregnancy:Not mentioned, either as an inclusion criteria or char-
acteristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was prospective. The sampling method was not described. 1 RDT was tested
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Harani 2006 (Continued)
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Who performed the reference standard tests, and where? Senior technologist and
principle author in the
Department of Pathology and Microbiology, Aga Khan University
If microscopy was used, how many high power fields were looked at? 200
How many observers or repeats were used? Unclear, 2 microscopists were used but
how they divided the work between them was not described
How were discrepancies between observers resolved? Not applicable
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv (Binax Inc. Portland, Maine, USA)
Parasite(s) designed to detect: P. falciparum ormixed infection, non-falciparummalaria
species only
Designated type: Type 2
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: The second author
RDT setting: Microbiology section of Aga Khan University
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were presenting at an out-
patients department with symptoms of
malaria and history of fever, but the sam-
pling method was not described
Acceptable reference standard?
All tests
Unclear 2 microscopists at a University laboratory
viewed 200 high power fields before declar-
ing a slide negative; however, it is unclear
how the 2 microscopists worked together
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes “The microscopists were unaware of the
microscopy results”.
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Harani 2006 (Continued)
Index test results blinded?
All tests
Yes “These results were read by the second au-
thor who was blind to the microscopy re-
sults”
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated, and
corresponds with the number presented in
the analysis; therefore there were no exclu-
sions due to invalid results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated, and
corresponds with the number presented in
the analysis; therefore there were no with-
drawals due to invalid results
Kolaczinski 2004
Clinical features and settings Presenting signs and symptoms: Suspected malaria or febrile illness
Previous treatment for malaria: No exclusion criteria based on previous use of anti-
malarials, and no data on previous antimalarial use of the participants was presented
Clinical setting: Basic health units within an Afghan refugee camp
Country: Pakistan (North West Frontier Province)
Malaria endemicity: Not stated
Malaria endemic species: 80% P. vivax, 20%P. falciparum
Participants Sample size: 499
Age: All age groups eligible for inclusion; actual age range of the participants not stated
Sex: Both males and females eligible for inclusion; actual age range of the participants
not stated
Co-morbidities and pregnancy: No exclusions based on co morbidities or pregnancy,
and no data presented on the frequency of these conditions in the study population
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was consecutive and prospective. 1 RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and think blood films
Who performed the reference standard tests, and where? Microscopists in the basic
health units within an Afghan refugee camp and HNI’s reference laboratory in Peshawar
If microscopy was used, how many high power fields were looked at? 100
How many observers or repeats were used? 2, 1 at the BHU and 1 at the reference
laboratory
How were discrepancies between observers resolved? Unclear “all of the smears
checked by the microscopist at each BHU were cross checked at HNI’s reference labo-
ratory at Pashawar”
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Kolaczinski 2004 (Continued)
Index and comparator tests Commerical name of RDT: OptiMAL (DiaMed, AG, Cressier, Switzerland)
Parasite(s) designed to detect: P. falciparum ormixed infection, non-falciparummalaria
species only
Designated type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Microscopists
RDT setting: Basic health units
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of pa-
tients attending a basic health units with
suspected malaria
Acceptable reference standard?
All tests
Yes 2 microscopists, 1 working in a central lab-
oratory, viewed at least 100 high power
fields before declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
No The index test and reference test were un-
dertaken by the same person
Index test results blinded?
All tests
No The index test and reference test were un-
dertaken by the same person
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated, and
corresponded to the number presented in
the analysis: therefore there were no exclu-
sions due to invalid test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated, and
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Kolaczinski 2004 (Continued)
corresponded to the number presented in
the analysis: therefore there were no with-
drawals
Kosack 2013
Clinical features and settings Presenting signs and symptoms: Fever or a history of fever in the prior 24 hours
Previous treatments for malaria: Not reported
Clinical setting: 2 primary care clinics
Country:Myanmar
Malaria endemicity: High endemicity
Malaria endemic species: P. falciparum, P. vivax
Participants Sample size: 2585
Age: Mean 10.9 years (SD not reported), range 0.1 to 94 years
Sex: 51.3% male, 48.7% female
Co-morbidities or pregnancy: Pregnant women were not included
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for:Multi-species malaria
Reference standard test(s) used:Microscopy thick and thin smears.
Who performed the reference standard tests, and where? A laboratory technician
performed the reference test. Location not reported, presumably on site
If microscopy was used, how many high power fields were looked at? At least 200
fields
Howmany observers or repeats were used? Slides were sent to a malaria research centre
in Thailand, for external quality control
How were discrepancies between observers resolved? Not reported
Index and comparator tests Commercial name of the test: SD Bioline Malaria Ag P.f/Pan 05FK60 (Standard Di-
agnostics, Kyonggi, Republic of Korea),
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum species
Designated type: Type 3
Batch numbers: Not reported
Transport and storage conditions: Not reported
Who performed the index test, and where? Not reported. As patients with fever or
history of fever in the past 24 hours were immediately tested, presumable the RDTs were
performed at the clinics
Follow-up Not applicable
Notes Source of funding: Source of funding not reported
Table of Methodological Quality
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Kosack 2013 (Continued)
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes All non-pregnant patients visiting primary
care clinics with fever or a history of fever
in the prior 24 hours were included
Acceptable reference standard?
All tests
No It is reported that the program follows the
WHOMalaria Microscopy Quality Assur-
ance recommendation (reference provided)
. 1 technician read the slide on site. 900
(450 negative and 450 positive) of 2585
slides were sent to a malaria research unit
in Thailand for external control
Partial verification avoided?
All tests
Yes All participants had their RDT results ver-
ified by microscopic reference test
Differential verification avoided?
All tests
Yes Microscopy was used for all samples.
Incorporation avoided?
All tests
Yes Microscopy was used for all samples.
Reference standard results blinded?
All tests
Yes The laboratory technician was not aware of
the RDT result when examining the smear
Index test results blinded?
All tests
Yes RDT was performed immediately. The
slide for microscopic evaluation was pre-
pared after the RDT was performed
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals
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Mekonnen 2010
Clinical features and settings Presenting signs and symptoms: Febrile, clinically suspected for malaria
Previous treatment for malaria: No exclusions based on previous treatment, and no
relevant data presented
Clinical setting: Outpatient department of a health centre
Country: Ethiopia (Jimma, South-West) - 300 km south-west of Addis Ababa, 1760 m
above sea level
Malaria endemicity: Not stated: transmission takes place throughout the year
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 240
Age: Eligible age range not stated. Actual age range of participants was 1 to 60 years,
with a mean age of 25 years
Sex: Both males and females eligible. 57.5% of the study participants were male, 42.5%
female
Co-morbidities and pregnancy:Not mentioned, either as an exclusion criteria or char-
acteristic of the included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was prospective. The sampling method was not described. 1 RDT was eval-
uated
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced malaria technicians
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 300
Number of observer or repeats: Discordant results between RDTs and slides were
repeated.
Resolution of discrepancies between observers: Not described.
Index and comparator tests Commerical name of RDT: CareStart Malaria Pf/Pv Combo (Access Bio Inc, Mon-
mouth Junction, New Jersey, USA)
Parasite(s) designed to detect: P. falciparum and P. vivax
Designated type: Type 5
Batch numbers: Not stated
Transport and storage conditions: Stored according to the guidelines of the manufac-
turer and quality of package desiccant was checked before use
Person(s) performing RDT: Experienced malaria technicians
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Recieved financial support from the School of Laboratory Studies
of the Jimma Univeristy and the VLIR-IUC program between Flanders and Jimma
Univeristy. Access Bio Ltd donated the CareStart Malaria Pf/Pv Combo test kit
Table of Methodological Quality
Item Authors’ judgement Description
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Mekonnen 2010 (Continued)
Representative spectrum?
All tests
Unclear All participants were attending a clinic with
fever and suspected malaria, but the sam-
pling method was not described
Acceptable reference standard?
All tests
Yes Experienced technicians independently
viewed 300 high power fields before declar-
ing a slide negative. Discordant results was
repeated independently
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes Blinding not described.
Index test results blinded?
All tests
Yes “Results of the CareStart tests were deter-
mined prior to microscopic results with
strict blinding to themicroscopic examina-
tion of the blood film”
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated, and
corresponded to the number presented in
the analysis: therefore there were no exclu-
sions due to invalid test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated, and
corresponded to the number presented in
the analysis: therefore there were no with-
drawals
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Metzger 2011
Clinical features and settings Presenting signs and symptoms: Not stated
Previous treatments for malaria: Not mentioned, either as an exclusion criteria or
characteristic of included participants
Clinical setting: Health posts
Country: Venezuela
Malaria endemicity: “In 2007, the annual parasite index (API) was 68.4 cases/1000
inhabitants, but hot spots of higher malaria risk were seen in some indigenous ethnic
groups.”
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 550
Age: Not mentioned either as an inclusion criteria or a characteristic of participants
Sex: Not mentioned either as an inclusion criteria or a characteristic of participants
Co-morbidities or pregnancy: Not mentioned either as an inclusion criteria or a char-
acteristic of participants
Study design No details of the enrolment and sampling method were reported. 1 RDT was evaluated
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used: microscopy
Who performed the reference standard tests, and where? Slides were examined by
microscopists in health posts, then all positive and 10% of negative slides were re-
examined by microscopists at the Regional Central Laboratory. Slides were then sent to
the National Amazon Centre for Research and Control of Tropical Diseases in Puerto
Ayacucho for re-examination by expert microscopists
If microscopy was used, how many high power fields were looked at? In the health
posts and Regional Central Laboratory 200 fields of thick blood smears, and in the
National Amazon Centre for Research and Control of Tropical Diseases the complete
blood smear was read before being declared negative
How many observers or repeats were used? 3
How were discrepancies between observers resolved? Not reported
Index and comparator tests Commercial name of the test:OptiMAL-IT (Diamed AG, Cressier sur Morat, Switzer-
land)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum malaria species only
Designated type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Samples were transported by messengers using boat,
aeroplane, motorbike, bicycle and foot transportation, sometimes taking up to 4 weeks.
Due to lack of refrigerators or due to electrical power cuts, or both, samples were often
exposed to local ambient conditions (study average temperature of 26.9C, with frequent
peaks up to 40°C)
Who performed the index test, and where? Microscopists at health posts and expert
microscopists at the Amazon Centre for Research and Control of Tropical Diseases in
Puerto Ayacucho
Follow-up Not applicable
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Metzger 2011 (Continued)
Notes Source of funding: UNICEF
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear No details of the characteristics of the par-
ticipants were reported
Acceptable reference standard?
All tests
Yes 3microscopists read the slides at either 200
fields or the complete smear before declar-
ing a test as negative
Partial verification avoided?
All tests
Yes “550 RDTs (OptiMAL-IT) ans concomi-
tant slides originating from the HPs of
Aturesmunicipalitywere received in the or-
der of their arrival at the RCL in Puerto
Ayacucho”
Differential verification avoided?
All tests
Yes The same reference tests were used regard-
less of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes Reported blinding.
Index test results blinded?
All tests
Yes Reported blinding.
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore no
withdrawals due to invalid results
Withdrawals explained?
All tests
Yes “36 tests had to be excluded because coding
was lost during transport and/or because
they could not be clearly allocated”
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Moges 2012
Clinical features and settings Presenting signs and symptoms: Suspected malaria: fever, headache, fatigue, sweating/
chills/rigors, vomiting, splenomegaly, myalgia and arthralgia, anaemia, hypoglycaemia
Previous treatments for malaria: Patients who had received anti-malarial drugs during
the past 4 weeks were excluded
Clinical setting: Medical and paediatric out-patient departments of a health centre
Country: Ethiopia
Malaria endemicity: High endemicity
Malaria endemic species: P. vivax and P. falciparum
Participants Sample size: 254
Age: Mean 21.4 (SD14.76), range 0.4 to 75 years
Sex: 61% male, 39% female
Co-morbidities or pregnancy: Co-morbities are not reported. However, critically ill
patients who were unable to give blood were excluded from the study
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy thick and thin smears
Who performed the reference standard tests, and where? The tests were performed by
an experienced laboratory technician at the health centre and an experiencedmicroscopist
at a university hospital laboratory
If microscopy was used, how many high power fields were looked at? 200 fields
How many observers or repeats were used? 2 observers
How were discrepancies between observers resolved? A third of discordant results, a
third expert reader was used. This third reader’s results were considered final
Index and comparator tests Commercial name of the test: CareStart™ Malaria HRP2/pLDH COMBO (Access
Bio Inc., USA)
Parasite species the test is designed to detect: P. falciparum or mixed infection, non-
falciparum species only
Designated type: Type 3
Batch numbers: Not reported
Transport and storage conditions: Not reported
Who performed the index test, and where? The index test was performed at the health
centre. Information on the person who performed the test is not reported
Follow-up Not applicable
Notes Source of funding: Source of funding not reported. RDT kits were supplied by the
North Gondar Zonal Health Bureau
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Subjects with suspected malaria symptoms
were recruited (all symptoms reported)
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Moges 2012 (Continued)
Acceptable reference standard?
All tests
Yes Microscopy evaluations were performed by
2 independent observers (200 fields). Dis-
cordant results were referred to a third ob-
server
Partial verification avoided?
All tests
Yes All participants receiving the index test had
their diagnosis verified my microscopy
Differential verification avoided?
All tests
Yes Microscopy was used as reference test for
all samples.
Incorporation avoided?
All tests
Yes The reference standard for all samples was
microscopy.
Reference standard results blinded?
All tests
Yes The microscopists were blinded to the
RDT results.
Index test results blinded?
All tests
Unclear The same finger-prick blood sample used
for microscopy was used to perform the in-
dex in parallel
Uninterpretable results reported?
All tests
Unclear The number of participants enrolled in the
study was clearly stated and corresponded
to the number presented in the analysis;
therefore there were no exclusions due to
uninterpretable test results
Withdrawals explained?
All tests
Yes The number of participants enrolled in the
study was clearly stated and corresponded
to the number included in the analysis;
therefore there were no withdrawals
Mohon 2012
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatments for malaria: Not reported
Clinical setting: Upazila Health Complexes
Country: Bangladesh
Malaria endemicity: Hypo-endemicity
Malaria endemic species: 95% P. falciparum
Participants Sample size: 372
Age: Median 19.4, range 1.5 to 82 years
Sex: 52.8 male, 47.2% female
Co-morbidities or pregnancy:
Co-morbidities and pregnancy not reported.
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Mohon 2012 (Continued)
Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum, P. vivax
Reference standard test(s) used:Microscopy thick and thin smears, nested PCR.
Who performed the reference standard tests, and where?Microscopy was performed
by experienced microscopists on site and the icddr,b laboratory
Ifmicroscopywas used, howmany high power fields were looked at?Microscopy was
performed following the standard procedure. Details, not reported(reference provided)
How many observers or repeats were used? 2
How were discrepancies between observers resolved? Not reported
Index and comparator tests Commercial name of the test: OnSite (Pf /Pan) (CTK Biotech Inc, USA)
Parasite species the test is designed to detect: P. falciparum, non-falciparum, P. vivax
Designated type: Type 3
Batch numbers: Not reported
Transport and storage conditions: Not reported
Who performed the index test, and where? The index test was performed at the icddr,
b Parasitology Laboratory
Follow-up Not applicable
Notes Source of funding: International Centre for Diarrheal Research Bangladesh (icddr,b)
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Febrile patients were recruited. However,
patients with mixed infections and those
with discordant microscopy/PCR results
were excluded and the numbers excluded
for these reasons are not stated
Acceptable reference standard?
All tests
Yes Microscopy was verified with PCR.
Partial verification avoided?
All tests
Yes All participants that received the index test
had their diagnosis verified by reference test
Differential verification avoided?
All tests
Yes PCR adjusted microscopy was used as the
reference test.
Incorporation avoided?
All tests
Yes PCR adjusted microscopy was used as the
reference test.
Reference standard results blinded?
All tests
Unclear Blinding not reported.
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Mohon 2012 (Continued)
Index test results blinded?
All tests
Unclear Blinding not reported.
Uninterpretable results reported?
All tests
No The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is unclear whether there were
any exclusions due to uninterpretable test
results
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is unclear whether there were
any withdrawals
Pattanasin 2003
Clinical features and settings Presenting signs and symptoms: Fever or history of fever and suspected diagnosis of
uncomplicated malaria
Previous treatment for malaria: No mention of previous treatment for malaria, either
as an exclusion criteria or a characteristic of included participants
Clinical setting: Not stated
Country: Thailand (Mae Sod)
Malaria endemicity: Not stated, peak transmission season
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 271
Age: Children aged under 2 years were excluded. The study included participants aged
2 to 81 years; 71% were aged under 15 years
Sex: Male: female ratio was 1.7:1
Co-morbidities and pregnancy: Pregnant women were excluded
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was prospective. The sampling method was not described. 2 RDTs were
evaluated, the vast majority of participants received both RDTs
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood film
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT:
• Paracheck-Pf (Orchid Biomedical Systems, Goa, India)
• OptiMAL-IT (DiaMed, AG, Cressier, Switzerland)
Parasite(s) designed to detect:
• Paracheck-Pf - P. falciparum
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Pattanasin 2003 (Continued)
• OptiMAL-IT - P. falciparum or mixed infection, non-falciparum species only
Designated type:
• Paracheck-Pf - Type 1
• OptiMAL-IT - Type 4
Batch numbers: Not stated
Transport and storage conditions: Kept at room temperature and opened just before
performing the test to avoid humidity
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants had a fever and suspected
malaria, but the exact clinical setting and
the sampling method were not described
Acceptable reference standard?
All tests
Unclear No details of the microscopy process were
given.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Unclear Blinding not described.
Index test results blinded?
All tests
Yes Test resultswere recordedwithout reference
to the microscopy results
Uninterpretable results reported?
All tests
Yes Doubtful and invalid results were reported
(5 of 271).
Withdrawals explained?
All tests
Unclear Almost all participants were reported to re-
ceive the same index and reference tests
(271 participants in total, 266 received
OptMAL, 269 received Paracheck-Pf ); the
numbers presented in the analysis corre-
spond
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Rakotonirina 2008
Clinical features and settings Presenting signs and symptoms: Fever over 37.5°C or history of fever in the previous
24 hours
Previous treatment for malaria: Participants with recent antimalarial use were not
excluded from the study; 34% of participants declared antimalarial use
Clinical setting: 2 primary health centres
Country:Madagascar (Tsiroanomandidy on the west foothill areas of the Highlands)
Malaria endemicity: Low and predominantly seasonal
Malaria endemic species: P. falciparum (80%) andP. vivax
Participants Sample size: 313
Age: All age groups were eligible for inclusion; the actual age range of the included
participants was 6 months to 79 years (median age 10 years)
Sex: Male: female ratio was 1.2:1
Co-morbidities and pregnancy: Pregnant women were excluded, as were people with
signs of severe or complicated malaria
Parasite density of microscopy positive cases: Range 32 to 52,750 parasites per µL,
mean 4104, SD 7894
Study design Enrolment was consecutive and prospective. 2 RDTs were evaluated, all participants
received both RDTs
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: PCR
Index and comparator tests Commerical name of RDT:
• OptiMAL-IT (DiaMed, AG, Cressier, Switzerland)
• PALUTOP
Parasite(s) designed to detect:
• OptiMAL-IT - P. falciparum or mixed infection, non-falciparum species only
• PALUTOP - P. falciparum, P. vivax and other malaria types
Designated type:
• OptiMAL-IT - Type 4
• PALUTOP - Type 6
Batch numbers:
• OptiMAL-IT - 46110.85.01
• PALUTOP - 91014
Transport and storage conditions: Transported and maintained at the study sites (pri-
mary health centres) at room temperature and opened just before use to avoid humidity
damage
Person(s) performing RDT: Trained technician
RDT setting: Primary health centres
Follow-up Not applicable
Notes Source of funding: Global Fund Project for Madagascar, Round 3
Table of Methodological Quality
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Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
patients attending primary health centres
with fever or history of fever in the previous
24 hours
Acceptable reference standard?
All tests
Yes Reference standard was PCR.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes Stated that the PCR operator was blind to
the results of the other tests performed
Index test results blinded?
All tests
Yes Stated that the test readers were blind to
the results of the other tests performed
Uninterpretable results reported?
All tests
Yes Therewere no test failureswith eitherRDT.
Withdrawals explained?
All tests
Yes The number of participants enrolled in the
study is clearly stated and corresponds to
the number presented in the analysis
Ratsimbasoa 2007
Clinical features and settings Presenting signs and symptoms: Fever over 37.5°C or history of fever in the previous
24 hours, with typical malaria symptoms. Patients with signs of severe or complicated
malaria were excluded
Previous treatment for malaria: Participants with recent antimalarial use were not
excluded from the study; 17% of participants reported antimalarial use
Clinical setting: Primary health centres
Country:Madagascar. Rural areas of Mahasolo (western foothills areas of the highlands)
and Saharevo (eastern foothills areas of the highlands)
Malaria endemicity: Low and predominantly seasonal in both areas
Malaria endemic species: Predominantly P. falciparum; someP. vivax
Participants Sample size: 194
Age: All groups eligible for inclusion not stated; actual age range of the included partic-
ipants was 1 to 79 years (mean age 15.2 years). 12.9% were under 5 years of age
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Sex: Male: female ratio was 0.98:1
Co-morbidities and pregnancy: Pregnant women were excluded, as were people with
signs of severe or complicated malaria
Parasite density of microscopy positive cases: Range 16 to 233,600 parasites per µL,
mean 6564, SD 26,553
Study design Enrolment was prospective. The sampling method was not described. 2 RDTs were
evaluated, all participants received both RDTs
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: An experienced technician
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: 1
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT:
• CareStart Malaria Pf/Pan (Access Bio Inc., Monmouth Junction, NJ)
• SD Malaria Antigen Bioline Pf/Pan (Standard Diagnostics, Suwon City, South
Korea)
• OptiMAL-IT (DiaMed, AG, Cressier, Switzerland)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated type: Type 4
Batch numbers:
• CareStart Malaria - J25IL, J35IL, J45IL, J55IL
• SD Malaria Antigen Bioline - T5001, T5002, T5003, T5004
• OptiMAL-IT - 46110.73.01, 46110.74.01, 46110.75.01
Transport and storage conditions: Transported and maintained at the study sites (pri-
mary health centres) at room temperature and opened just before use to avoid humidity
damage
Person(s) performing RDT: A technician
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Global Fund Project for Madagascar, Round 3. The manufacturers
supplied the test kits
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending primary
health centres with fever and symptoms of
malaria, but the sampling method was not
described
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Ratsimbasoa 2007 (Continued)
Acceptable reference standard?
All tests
No An expert technician viewed 200 high
power fields before declaring a slide nega-
tive; however their findings were not veri-
fied by a second independent reader
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes “Analyzed without reference to the RDT
results”.
Index test results blinded?
All tests
Yes The RDTs were undertaken before the mi-
croscopy.
Uninterpretable results reported?
All tests
Unclear The number recruited into the study was
clearly stated, and corresponded with the
number included in the analysis
Withdrawals explained?
All tests
Yes The number recruited into the study was
clearly stated, and corresponded with the
number included in the analysis
Ratsimbasoa 2008
Clinical features and settings Presenting signs and symptoms: Fever or fever in the previous 24 hours with typical
malaria symptoms
Previous treatment for malaria: Participants with recent antimalarial use were not
excluded from the study; 13% of participants declared antimalarial use
Clinical setting: Primary Health Centre
Country:Madagascar (Ampasimpotsy, Central Highlands)
Malaria endemicity: Transmission is low and predominantly seasonal. This study was
carried out in the low season
Malaria endemic species: P. falciparum (approximately 75%) andP. vivax
Participants Sample size: 200
Age: Eligible age range not stated; actual age range of the included participants was 6
months to 73 years (40% under 5 years, 26.5% 5 to 15 years)
Sex: Male: female ratio was 1.2:1
Co-morbidities and pregnancy: Pregnant women were excluded, as were people with
signs of severe or complicated malaria
Parasite density of microscopy positive cases: Range 16 to 285,000 parasites per µL,
mean 16,757, SD 42,631
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Study design Enrolment was prospective. The sampling method was not described. 2 RDTs were
evaluated, all participants received both RDTs
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: PCR
Index and comparator tests Commerical name of RDT:
• SD Bioline Malaria Ag Pf (Standard Diagnostics Inc., Suwon City, South Korea)
• SD Bioline Malaria Ag Pf/Pan (Standard Diagnostics Inc., Suwon City, South
Korea)
Parasite(s) designed to detect:
• SD Bioline Malaria Ag Pf - P. falciparum
• SD Bioline Malaria Ag Pf/Pan - P. falciparum or mixed infection, non-falciparum
species only
Designated type:
• SD Bioline Malaria Ag Pf - Type 1
• SD Bioline Malaria Ag Pf/Pan - Type 3
Batch numbers:
• SD Bioline Malaria Ag Pf - 05FK50
• SD Bioline Malaria Ag Pf/Pan - 05FK60
Transport and storage conditions: All tests were kept at room temperature and opened
just before use to avoid humidity damage
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Kozone, representing Standard Diagnostics Inc in Madagascar
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Participants were all attending a health cen-
tre with fever and typical symptoms of
malaria, but the sampling method was not
described
Acceptable reference standard?
All tests
Yes The reference standard was PCR.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
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Reference standard results blinded?
All tests
Yes PCR was carried out by technicians blind
to the results of RDT testing
Index test results blinded?
All tests
Yes RDTs were undertaken before the results
of PCR were known
Uninterpretable results reported?
All tests
Yes Uninterpretable results are reported and ex-
cluded from the analysis. There were 2 in-
valid results for Bioline Pf and 1 for Bioline
Pf/Pan
Withdrawals explained?
All tests
No There was 1 participant missing from the
analysis from Bioline Pf/Pan, with no ex-
planation
Samane 2010
Clinical features and settings Presenting signs and symptoms: Suspected malaria with symptoms including fever or
chills of several days, or both
Previous treatments for malaria: Not mentioned, either as an exclusion criteria or
characteristic of included participants
Clinical setting: Health centres
Country: Iran
Malaria endemicity: Not stated
Malaria endemic species: Not stated
Participants Sample size: 250
Age: Not mentioned either as an inclusion criteria or a characteristic of participants
Sex: Not mentioned either as an inclusion criteria or a characteristic of participants
Co-morbidities or pregnancy: Not mentioned either as an inclusion criteria or a char-
acteristic of participants
Study design Enrolment was prospective. The sampling method was not described. 1 RDT was eval-
uated
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum andP. vivax
Reference standard test(s) used:Microscopy
Who performed the reference standard tests, and where? Experienced microscopists
performed the test, it is not stated where this was done
If microscopy was used, how many high power fields were looked at? Not stated
How many observers or repeats were used? 2
How were discrepancies between observers resolved? Not stated
Index and comparator tests Commercial name of the test: BIOTEC Malaria Pv/Pf Rapid Device
Parasite species the test is designed to detect: P. falciparum andP. vivax
Designated type: Other type. HRP-2 for P. falciparum and pLDH for P. vivax.
Batch numbers: Not stated
Transport and storage conditions: Not reported
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Who performed the index test, and where? Not reported
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Characteristics of participants not ade-
quately described, although all had symp-
toms of malaria
Acceptable reference standard?
All tests
Unclear 2 independent microscopists viewed the
slides, but the number of fields viewed was
not reported
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference tests
Differential verification avoided?
All tests
Yes The same reference tests were used regard-
less of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference test.
Reference standard results blinded?
All tests
Yes Reported that the tests were read blindly.
Index test results blinded?
All tests
Yes Reported that the tests were read blindly.
Uninterpretable results reported?
All tests
No Number enrolled in the study was explic-
itly stated but did not correspond to the
number presented in the analysis - 250 pa-
tients were enrolled but 276 were included
in the analysis
Withdrawals explained?
All tests
Unclear Number enrolled in the study was explic-
itly stated but did not correspond to the
number presented in the analysis - 250 pa-
tients were enrolled but 276 were included
in the analysis
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Selimuzzaman 2010
Clinical features and settings Presenting signs and symptoms: Fever with oral temperature 100 °F or more or with
convincing history of fever
Previous treatments for malaria: “Patients taking anti-malarial drugs for current illness
or providing history of anti-malarial therapy within previous four weeks or taking anti-
malarial prophylaxis were excluded from the study”
Clinical setting: Sick bay of 37 Rifle Battalion Headquarters
Country: Bangladesh
Malaria endemicity: “Malaria endemic zone”
Malaria endemic species: Not stated
Participants Sample size: 271
Age: Ranged from 18 years to 57 years
Sex: Male
Co-morbidities or pregnancy: Not mentioned either as an inclusion criteria or a char-
acteristic of participants
Study design Were participants consecutively enrolled in the study?: Yes
Were they enrolled prospectively?: Yes
If the study evaluated more than one RDT, how were tests allocated to individuals,
or did each individual receive all the tests?
1 RDT was evaluated
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax malaria
Reference standard test(s) used:Microscopy thick and thin blood films
Who performed the reference standard tests, and where? Experienced microscopists
at Armed Forces Medical College in Dhaka examined the slides
If microscopy was used, how many high power fields were looked at? 200
How many observers or repeats were used? 1
How were discrepancies between observers resolved? Only 1 microscopist read each
slide
Index and comparator tests Commercial name of the test: MALARIGEN MALARIA Pf/Pv Antigen Rapid Test
(Biotest Diagnostic Corp., Denville, NJ, USA)
Parasite species the test is designed to detect: P. falciparum, P. vivax malaria
Designated type:Unclear, HRP-2 antigen of P. falciparum and unspecified monoclonal
antibodies for detection of non-falciparum malarial parasites
Batch numbers: Not stated
Transport and storage conditions: Not stated
Who performed the index test, and where? Experiencedmicroscopists at Armed Forces
Medical College in Dhaka examined the RDT kits
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
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Representative spectrum?
All tests
Yes Participants were a consecutive series of pa-
tients with clinical signs and symptoms of
malaria
Acceptable reference standard?
All tests
No One microscopist read each slide.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference tests
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standards
Reference standard results blinded?
All tests
Unclear Described as a single blinded study, but no
further details reported
Index test results blinded?
All tests
Unclear Described as a single blinded study, but no
further details reported
Uninterpretable results reported?
All tests
Yes “Three out of 271 (1.11%) cases did not
demonstrate control band or become pos-
itive only after a long time lag and were
excluded from the study. Thin blood films
of 6 patients (2.21%) were marked by the
microscopist as poor quality and were ex-
cluded from the study.”
Withdrawals explained?
All tests
Yes The number of participants enrolled in the
study is clearly stated and corresponds to
the number presented in the analysis minus
the number reported to have invalid test
results or incomplete data
Sharew 2009
Clinical features and settings Presenting signs and symptoms: Febrile patients, clinically suspected for malaria
Previous treatment for malaria: No exclusions based on previous treatment. Informa-
tion on previous treatment collected, but actual data not provided
Clinical setting: Outpatient departments of 2 health centres
Country: Ethiopia (Southern - Wondo Genet)
Malaria endemicity: Takes place throughout the year
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 668
Age: All age groups eligible. Actual age range 6 months to 75 years
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Sex: 361 (54%) males, 307 (46%) females
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was consecutive and prospective. 2 different RDTs were evaluated, and each
participant received both tests
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Who performed the reference standard tests, and where? Experienced malaria tech-
nicians. The microscopy setting was not stated, but in the Wondo Genet area
If microscopy was used, how many high power fields were looked at? 100
How many observers or repeats were used? 2 independent technicians, also checked
by the team leader
How were discrepancies between observers resolved? All discordant results between
microscopy and RDTs were repeated
Index and comparator tests Commerical name of RDT:
• Paracheck Pf (Orchid Biomedical Systems, Goa, India)
• CareStart Malaria Pf/Pv Combo test (Access Bio INc, New Jersey, USA)
Parasite(s) designed to detect: P. falciparum
• Paracheck Pf - P. falciparum
• CareStart Malaria Pf/Pv Combo test - P. falciparum, P. vivax or mixed infection
Designated type:
• Paracheck Pf - Type 1
• CareStart Malaria Pf/Pv Combo test - Type 5
Batch numbers: Not stated
Transport and storage conditions: As per the instructions of the manufacturer
Person(s) performing RDT: Not stated
RDT setting: 2 health centres
Follow-up Not applicable
Notes Source of funding: School of Graduate Studies of the Addis Adaba University through
the Graduate Programme in Tropical and Infectious Diseases, Aklilu Lemma Institute
of Pathobiology and from the Federal Ministry of Health of Ethiopia. Federal Ministry
of Health of Ethiopia and Access Bio Inc donated the test kits
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
febrile patients attending health centres
with suspected malaria
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Acceptable reference standard?
All tests
Yes 2 experiencedmicroscopists independently
viewed 100 high power fields before declar-
ing a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Unclear Not described.
Index test results blinded?
All tests
Yes Strict blinding with the results available be-
fore microscopy reported
Uninterpretable results reported?
All tests
Yes If a test was un-interpretable then it was
repeated.
Withdrawals explained?
All tests
Yes The number of participants enrolled in the
study was clearly stated and corresponds to
the number included in the analysis; there-
fore there were no withdrawals
Singh 2000a
Clinical features and settings Presenting signs and symptoms: Fever suspected to be malaria
Previous treatment for malaria: There were no exclusions based on previous treatment,
and no information presented; this was an outbreak in a rural area
Clinical setting: Mobile field laboratory
Country: India (forest villages in Chhindwara, central India)
Malaria endemicity: Outbreak situation
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 344
Age: All age groups eligible. Actual age range 6 months to 65 years
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was consecutive and prospective. 1 RDT was evaluated
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Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood film
Whoperformed the reference standard tests, and where?Experiencedmicroscopist for
all slides; expertmicroscopist for re-examined slides. Setting was amobile field laboratory
for all slides; Malaria Research Centre at Jabalur for re-examined slides
If microscopy was used, how many high power fields were looked at? Not stated.
However, 200 white blood cells were counted as an alternative indicator; or 500 WBCs
for slides that were re-examined
How many observers or repeats were used? 1, but negative blood smears were re-
examined if the patient was having severe symptoms, the corresponding RDT result was
positive or if P. vivax was diagnosed
How were discrepancies between observers resolved? Not described, most likely ac-
cepted the findings of second microscopist
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv (AMRAD, Australia)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated type: Type 2
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Field laboratory assistants
RDT setting: Mobile field laboratory
Follow-up Not applicable
Notes Source of funding:BectonDickinson provided financial support and supplied the RDTs
free of charge
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes All participants were attending an ambu-
latory setting with fever suspected to be
malaria, and enrolment was consecutive
Acceptable reference standard?
All tests
No Microscopy was undertaken by 1 micro-
scopist only; and the number of high power
fields viewed was unclear (200 white blood
cells)
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
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Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes “Blood films were examined...without ref-
erence to the results of ICT”
Index test results blinded?
All tests
Yes “All specimens were tested...who were
blinded to the results of the blood smear
tests”
Uninterpretable results reported?
All tests
Unclear The numbers of participants originally en-
rolled in the study was clearly stated and
the numbers presented in the analysis cor-
respond; therefore there were no exclusions
due to uninterpretable test results
Withdrawals explained?
All tests
Yes The numbers of participants originally en-
rolled in the study was clearly stated and
the numbers presented in the analysis corre-
spond; therefore there were no withdrawals
Singh 2003
Clinical features and settings Presenting signs and symptoms: Fever or history of fever
Previous treatment for malaria: No explicit exclusions based on previous treatment,
and no data reported
Clinical setting: Hospital malaria clinic
Country: India, Jabalpur
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax in roughly equal proportions
Participants Sample size: 80
Age: All age groups eligible. Adults and children included; mean age 27.7 (SD 16.42)
for males and 29 (SD 12.8) for females
Sex: Both males and females eligible; included 28 males and 18 females
Co-morbidities and pregnancy: No explicit exclusion criteria based on co-morbidities
or pregnancy.Nodetails of the frequency of these conditions in the participant population
is presented
Parasite density of microscopy positive cases: Range 40 to 370,574 parasites per µL
for P. falciparum and 318 to 9970 for P. vivax
Study design Enrolment was prospective. The sampling method was not described. Only 1 RDT was
evaluated
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood films
Who performed the reference standard tests, and where? Not stated. Setting was a
hospital laboratory
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If microscopy was used, how many high power fields were looked at? Not stated
How many observers or repeats were used? If the results of the OptiMAL conflicted
with that of microscopy for any sample, the blood smear was re-examined by a different
technician
How were discrepancies between observers resolved? If the re-examination of dis-
cordant results gave a different result to the first examination, the second results was
confirmed by yet another technician
Index and comparator tests Commerical name of RDT: OptiMAL
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: A technician
RDT setting: Hospital clinic or laboratory
Follow-up Not applicable
Notes Source of funding: Not stated.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Participants were all attending a clinic with
fever or history of fever, but the sampling
method was not described
Acceptable reference standard?
All tests
Unclear Discordant results between RDT and mi-
croscopy were re-examined; however the
number of high power fields viewed before
declaring a sample negative was not stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Unclear Blinding not described.
Index test results blinded?
All tests
Yes Technican were blinded to the results of the
blood smear examination
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Singh 2003 (Continued)
Uninterpretable results reported?
All tests
Unclear The numbers of participants originally en-
rolled in the study was clearly stated and
the numbers presented in the analysis cor-
respond; therefore there were no exclusions
due to uninterpretable test results
Withdrawals explained?
All tests
Yes The numbers of participants originally en-
rolled in the study was clearly stated and
the numbers presented in the analysis corre-
spond; therefore there were no withdrawals
Singh 2010
Clinical features and settings Presenting signs and symptoms: Clinical suspicion of malaria
Previous treatments for malaria: Patients were excluded due to recent anti-malarial
intake
Clinical setting: Field clinic
Country: India
Malaria endemicity:
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 409
Age: All ages were included. Mean age was 15 (SD 14).
Sex: Both sexes were included, ratio was not reported.
Co-morbidities or pregnancy: Pregnant women were excluded from participating. Co-
morbidities notmentioned either as an inclusion criteria or a characteristic of participants
Study design Enrolment was prospective and consecutive. 5 RDTs were evaluated; each participant
received all the tests
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used:Microscopy and PCR
Who performed the reference standard tests, and where?Microscopy was conducted
by an experienced microscopist in the laboratory. PCR was also performed in the labo-
ratory, by an independent research assistant
If microscopy was used, how many high power fields were looked at? 100
How many observers or repeats were used? 1
How were discrepancies between observers resolved? “All negative slides that test
positive on the RDT/PCR or all positive slides that test negative on the RDT/PCR were
re-examined by another expert technician blinded to the results of microscopy, RDT/
PCR and clinical status of the patients.”
Index and comparator tests Commercial name of the test:
• Parascreen Device (rapid test for malaria Pan/Pf ) (Zephyer Biomedicals Goa)
• Falcivax Device (rapid test for malaria Pv/Pf ) (Zephyer Biomedicals Goa)
• Malascan Device (rapid test for malaria Pf/Pan) (Zephyer Biomedicals Goa),
• ParaHIT Total (rapid test for Pf & Pan Malaria species) (SPAN Diagnostics Ltd,
Surat)
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• First Response Malaria Antigen Combo Card test (pLDH/HRP2) (Premier
medical corporation Mumbai)
Parasite species the test is designed to detect:
• Parascreen - malaria Pan/Pf
• Falcivax - malaria Pv/Pf
• Malascan - malaria Pf/Pan
• ParaHIT Total - Pf & Pan Malaria species
• First Response Malaria Antigen Combo Card test - pLDH/HRP2
Designated type:
• Parascreen - Type 3
• Falcivax - Type 5
• Malascan - Type 2
• ParaHIT Total - Type 2
• First Response Malaria Antigen Combo Card test - Type 3
Batch numbers: Not stated
Transport and storage conditions: “RDTs were stored at 25°C on receipt in the study
sites, then allocated to separate groups for storage at 35°C & 45°C for 90 days, at 60°C
for 48 hours, and at -10°C for 60 minutes before testing. At the start of the study, the
incubators were stabilized at the required temperature for three days before the RDTs to
be testedwere placed inside. RDTswere removed from storage to reach room temperature
for 2 hours before testing and comparisons were made with control RDTs kept at 25°C
until use and with microscopy.”
Who performed the index test, and where? 2 research assistants tested in the RCTs in
field in 10 villages of Satanwada Primary Health Centre
Follow-up Not applicable
Notes Source of funding: WHO Country Office, New Delhi, India
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of pa-
tients attending clinics with clinical signs
and symptoms of malaria
Acceptable reference standard?
All tests
No Only 1 microscopist used, except in cases
of discordant results between microscopy
and RDT
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference tests were used regard-
less of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standards
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Reference standard results blinded?
All tests
Yes Reported that the tests were read blindly.
Index test results blinded?
All tests
Yes Reported that the tests were read blindly.
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore no
withdrawals due to invalid results
Withdrawals explained?
All tests
Yes 37 patients (9%) were excluded as not ful-
filling the study enrolment criteria due to
recent anti-malarial intake
Tjitra 1999
Clinical features and settings Presenting signs and symptoms: Symptomatic with a presumptive clinical diagnosis of
malaria: fever or history of fever in the last 24 hours and no other obvious cause of fever
Previous treatment for malaria: Prior use of antimalarials was not an exclusion criteria.
Approximately half of the participants reported use of antimalarials within the previous
4 weeks
Clinical setting: Primary health centre
Country: Indonesia (Laratama sub district, West Sumba, East Nusa Tenggara Province,
Eastern Indonesia)
Malaria endemicity: Infection rate in children 0 to 9 years of 5.1%
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 560
Age: All ages eligible. Actual age range of the participants 0 to 80 years
Sex: Males and females eligible; 289 males and 271 females included
Co-morbidities: Not mentioned either as an exclusion criteria or a characteristic of the
included participants
Parasite density of microscopy positive cases: P. vivax mean 7157 parasites per µL
Study design Enrolment was prospective. The sampling method was not described. 1 RDT was tested
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Who performed the reference standard tests, and where? Expert microscopists with
over 20 years experience each. The setting was
one local (exact setting not stated); cross-checking was done in Darwin, Australia
If microscopy was used, how many high power fields were looked at? at least 100
for all slides, at least 200 for those cross-checked
How many observers or repeats were used? 1 observer for the majority of slides;
discordant results between microscopy and RDT and 20% of slides with concordant
results were cross-checked by a 2nd microscopist, blind to the results of 1st microscopy
and RDT
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Tjitra 1999 (Continued)
How were discrepancies between observers resolved? Not described
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated type: Type 2
Batch numbers: 100088 for the first 393 tests, and 041388 for the remaining 167 tests
Transport and storage conditions: Not described
Person(s) performing RDT: Performed by trained health workers and read by a study
physician blinded to the microscopy results
RDT setting: Primary health centre
Follow-up Not applicable
Notes Source of funding: Financial assistance received from the Northern Territory Govern-
ment 50th Anniversary of Indonesian Independence Malaria-Tuberculosis Research Fel-
lowships. ICT Pf/Pv kits and some logistical costs were supported by AMRAD-ICT
Sydney, New South Wales, Australia
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Participants were all attending a primary
health care centre with fever and symptoms
of malaria, but the sampling method was
not described
Acceptable reference standard?
All tests
Yes All slides were read by an experienced mi-
croscopist viewing at least 100 high power
fields, and results discordant with RDT
were re-examined by another, independent
microscopist
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes “The microscopist was unaware of the im-
munochromatographic test result”
Index test results blinded?
All tests
Yes “The results were read by a study physician
who was blinded to themicroscopy results”
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Tjitra 1999 (Continued)
Uninterpretable results reported?
All tests
Unclear The number of participants enrolled in the
study was clearly stated and correspond to
the number presented in the analysis; there-
fore there were no exclusions due to unin-
terpretable test results
Withdrawals explained?
All tests
Yes The number of participants enrolled in the
study was clearly stated and corresponded
to the number included in the analysis;
therefore there were no withdrawals
Trouvay 2013
Clinical features and settings Presenting signs and symptoms: Febrile patients who consulted for suspected malaria
Previous treatment for malaria: Not reported on, but there were no exclusion criteria
based on antimalarial use
Clinical setting: Not clear
Country: French Guiana
Malaria endemicity: At a low number of focal points on the coast, associated with gold
mining
Malaria endemic species: 31% P. falciparum and 68.5% P. vivax. P. malariae cases are
occasional.
Participants Sample size: 960
Age: All ages eligible. Actual age range of the participants 1 to 92 years (median age 25.
8 years)
Sex: Males and females eligible; ratio of male to female was 1.2:1
Co-morbidities: Not mentioned either as an exclusion criteria or a characteristic of the
included participants
Parasite density of microscopy positive cases: P. vivax mean 0.11%
Study design Enrolment was prospective, with all eligible participants were included. 1 RDT was
tested
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Who performed the reference standard tests, and where? An expert microscopist at
Cayenne Hospital laboratory
If microscopy was used, how many high power fields were looked at? 200 fields in
the thin film
How many observers or repeats were used? 1 observer.
How were discrepancies between observers resolved? Not applicable. However, PCR
was conducted on samples where microscopy and RDT gave different results
Index and comparator tests Commerical name of RDT: SD malaria Ag Pf/Pan
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated type: Type 3
133Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries (Review)
Copyright © 2015 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
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Batch numbers: not stated
Transport and storage conditions: Tests were guaranteed to have been stored at the
correct temperature (24 to 28C) and were used within their recommended shelf life
Person(s) performing RDT: Technician
RDT setting: Cayenne Hospital
Follow-up Not applicable
Notes Source of funding: French Ministry of Health
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes All febrile patients who consulted with sus-
pected malaria during a prospective study
were initially included. P. malariae cases
were subsequently excluded, however, only
3 of 960 enrolled participants were ex-
cluded for this reason
Acceptable reference standard?
All tests
No Only 1 microscopist was used. In case of
discordant results between RDT and mi-
croscopy, PCR was used to determine in-
fections and species. However, the PCR re-
sultswere not used to adjust themicroscopy
results
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes The microscopic examination was carried
out simultaneously.
Index test results blinded?
All tests
Yes Interpretation of the test was carried out in-
dependently of the microscopic examina-
tion
Uninterpretable results reported?
All tests
Yes No invalid RDTs were observed.
Withdrawals explained?
All tests
Yes There were 3 exclusions post-enrolment,
due to P. malariae infection.
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Clinical features and settings Presenting signs and symptoms: Fever or history of fever
Previous treatment for malaria: Not mentioned, either as an exclusion criteria or a
characteristic of included participants
Clinical setting: Malaria clinics and village health workers
Country: India (Delhi, Nadiad, Jabalpur and Sonapur)
Malaria endemicity: 4 sites of different endemicities
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 699
Age: All ages eligible; age range of included participants 1 to 75 years (mean 22.8)
Sex: Included 395 males and 304 females
Co-morbidities: Not mentioned, either as an exclusion criteria or a characteristic of
included participants
Parasite density of microscopy positive cases: P. vivax range 40 to 44,000 parasites/
µL, median 1020, P. falciparum range 120 to 68,480 parasites/µL, median 2000
Study design Enrolment was prospective. The sampling method was not described. 1 RDT was tested
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy
Who performed the reference standard tests, and where? Microscopist. Setting was
not stated
If microscopy was used, how many high power fields were looked at? 100
How many observers or repeats were used? 1 for most slides. All results discordant
with RDT results and 20% of concordant results were cross-checked. Negative slides
which tested positive by kit were re-examined by counting up to 2000 WBCs
How were discrepancies between observers resolved? In the case of initially negative
slides looked at in more detail because of discordant results, the second reading was taken
as true
Index and comparator tests Commerical name of RDT: OptiMAL (DiaMed, AG, Cressier, Switzerland)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated type: Type 4
Batch numbers: 46050.24.05
Transport and storage conditions: Stored below 30°C
Person(s) performing RDT: Not stated
RDT setting: At the study sites (clinic and villages)
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
135Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries (Review)
Copyright © 2015 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Valecha 2003 (Continued)
Representative spectrum?
All tests
Unclear All participants were all attending clinics
or approaching village health workers with
fever or history of fever, but the sampling
method was not described
Acceptable reference standard?
All tests
Unclear Microscopists viewed100high power fields
before declaring a slide negative, and results
discordant with RDTs were cross-checked.
However, it is not clear whether the per-
son doing the cross-checking was a differ-
ent microscopist working independently
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes “Microscopists were blinded to the rapid
test results”.
Index test results blinded?
All tests
Yes The RDT was done before the microscopy.
Uninterpretable results reported?
All tests
No The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is unclear whether there were
any exclusions due to uninterpretable test
results
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is unclear whether there were
any withdrawals
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van den Broek 2006
Clinical features and settings Presenting signs and symptoms:Newepisode of suspectedmalaria, which could include
fever, history or other complaints indicating possible malaria infection
Previous treatment for malaria: Excluded if malaria confirmed (treated or untreated)
within the previous 4 weeks
Clinical setting: Malaria outpatient centre
Country: Colombia
Malaria endemicity: Hypoendemic, annual parasite rate 2 to 5%
Malaria endemic species: P. vivax (54%) P. falciparum (46%)
Participants Sample size: 896
Age: All ages eligible. Actual numbers of children and adults not stated, although the
report mentions that many workers were included,
Sex: Both males and females eligible. Most of the participants were male (646, 79%)
Co-morbidities and pregnancy: No exclusions criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented
Parasite density of microscopy positive cases: Geometric mean approximately 2300
parasites per µL for both P. falciparum and P. vivax
Study design Enrolment was prospective. The sampling method was not described. 3 RDTs were
tested. All individuals received all 3 tests
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy:Well trained, experienced microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: At least 200
Number of observer or repeats: 1, except for about one third of the slides (especially low
density parasitaemias and mixed infections). In this case, another microscopist viewed
the slide and discordant results between microscopists or between slides and RDTs were
sent to the University of Antioquia for external cross-checking
Resolution of discrepancies between observers: Disagreements between the internal
and external results were sent to a third laboratory, of the National Health Institute in
Bogota. In cases where both external laboratories disagreed with the internal laboratory,
results were corrected accordingly
Index and comparator tests Commerical name of RDT:
• Paracheck Pf (Orchid Biomedical Systems, Goa, India)
• OptiMAL-IT (Diamed AG, Switzerland)
• NOWMalaria ICT (Binax, Portland, USA)
Parasite(s) designed to detect:
• Paracheck Pf - P. falciparum
• OptiMAL-IT - P. falciparum or mixed infection, non-falciparum species only
• NOWMalaria ICT - P. falciparum or mixed infection, non-falciparum species
only
Designated type:
• Paracheck Pf - Type 1
• Parascreen - Type 3
• OptiMAL - Type 4
Batch numbers: Not stated
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Transport and storage conditions: Not described
Person(s) performing RDT: A bacteriologist. Where the result was ambiguous, 2 bac-
teriologists read the test results
RDT setting: At the malaria centre
Follow-up Not applicable
Notes Source of funding: Medicins Sans Frontières, Holland, and its donors. The American
Society of Tropical Medicine and Hygiene assisted with publication expenses
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were patients presenting
with suspected malaria, but the sampling
method was not described
Acceptable reference standard?
All tests
No Microscopists viewed at least 200 high
power fields before declaring a slide nega-
tive; however the findings were only veri-
fied by a second independent reader for a
third of slides
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes Report states that microscopists were
blinded to the results of RDTs
Index test results blinded?
All tests
Yes Report states that RDTs were blinded to
the results of microscopy
Uninterpretable results reported?
All tests
Yes There were no uninterpretable results; and
weak lines were scored as positive
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it was not possible to assess
whether there were any withdrawals
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Wongsrichanalai 2003
Clinical features and settings Presenting signs and symptoms:Oral temperature over 38°C, headache or a history of
fever in the previous 72 hours
Previous treatment for malaria:No exclusions based on previous episodes or treatment
for malaria; no data presented on recent antimalarial use in the children
Clinical setting: Malaria clinics
Country: Thailand (Maesod)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum andP. vivax.
Participants Sample size: 246
Age: Inclusion criteria stipulated over 20 years old
Sex: Both males and females were eligible
Co-morbidities and pregnancy:Not mentioned, either as an exclusion criteria or char-
acteristic of the included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was prospective. The sampling method was not described. 1 RDT was tested
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Who performed the reference standard tests, and where? Experienced microscopists
at the
Armed Forces Research Institute of Medical Sciences
If microscopy was used, how many high power fields were looked at? 200
How many observers or repeats were used? 2 independent observers, blinded to each
others findings
How were discrepancies between observers resolved? Resolved by a third expert mi-
croscopist, whose reading was accepted as final. Where there was species discrepancy
between microscopy and NOW ICT, PCR was done
Index and comparator tests Commerical name of RDT: NOW ICT Malaria Pf/Pv
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated type: Type 2
Batch numbers: 030611
Transport and storage conditions: Not described
Person(s) performing RDT: Technician
RDT setting: Armed Forces Research Institute of Medical Sciences
Follow-up Not applicable
Notes Source of funding: US Army Medical Material Development Activity
Table of Methodological Quality
Item Authors’ judgement Description
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Representative spectrum?
All tests
Unclear All participants were attending malaria
clinics with temperature over 38°C,
headache or a history of fever in the pre-
vious 72 hours, but the sampling method
was not adequately described
Acceptable reference standard?
All tests
Yes 2 independent microscopists at a research
laboratory viewed at least 200 high power
fields before declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard.
Reference standard results blinded?
All tests
Yes “read by two microscopists blinded to...the
NOW ICT results”
Index test results blinded?
All tests
Yes The RDT was carried out before mi-
croscopy.
Uninterpretable results reported?
All tests
Yes The RDTs had to be repeated in 39 of 285
assays. A successful testwas eventually com-
pleted for each sample
Withdrawals explained?
All tests
Yes The number of participants enrolled in the
study was clearly stated and corresponded
with the number included in the analysis,
indicating no withdrawals
Xiaodong 2013
Clinical features and settings Presenting signs and symptoms: Suspected malaria
Previous treatments for malaria: Not reported.
Clinical setting: TengChong CDC, China and Health Unlimited clinic in Myanmar
(China-Myanmar border)
Country: China, Myanmar
Malaria endemicity: Endemic
Malaria endemic species: P. falciparum,P. vivax
Participants Sample size: 241
Age: Mean 29.62 (11.21), range 3 to 58 years
Sex: 78.01% male, 21.99% female
Co-morbidities or pregnancy: Not reported
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Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. The study evaluated 1 RDT
Target condition and reference standard(s) Type(s) of malaria parasite tested for: P. falciparum and P. vivax
Reference standard test(s) used: Microscopy (thick and thin blood smears) corrected
by PCR assays
Who performed the reference standard tests, and where? The microscopic evaluation
was done by experienced microscopists. Place not reported. Not reported for PCR
If microscopy was used, how many high power fields were looked at? 100 fields
How many observers or repeats were used? 2 independent microscopists. Also, a
double-blind cross reading of a random 50 blood slides was performed by a senior
microscopist
How were discrepancies between observers resolved?
In the case of discordant results between microscopy and PCR, the results of PCR were
used as the standard method
Index and comparator tests Commercial name of the test: CareStart malaria HRP2/pLDH (Pf/pan) combo test
Parasite species the test is designed to detect: Multi species
Designated type: Type 3
Batch numbers: C201R
Transport and storage conditions: Not reported.
Who performed the index test, and where? 3 health worker-observers. Place not re-
ported.
Follow-up Not applicable
Notes Source of funding: Source of funding not reported. CDC (Chinese Center for Disease
Control and Prevention). It is stated that individual biodata and malaria history in the
previous 1 year were documented from each suspected case. However, co-morbidities
and treatment history have not been reported. Index test was performed by 3 health
worker-observers: the first observer performed readings at 20 minutes (recommended by
the manufacturer) and the other 2 observers, within the next 10 minutes
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Consecutive patients with
suspected malaria were enrolled. Then all
patients who were positive for malaria by
microscopy and a random sample of nega-
tive samples were included in the analysis
Acceptable reference standard?
All tests
Yes Microscopy was undertaken by 2 inde-
pendent experienced microscopists (100
fields) and species identifications was con-
formed PCR assays
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Partial verification avoided?
All tests
Yes All participants receiving the index tests
had their diagnosis verified by reference
standard
Differential verification avoided?
All tests
Yes Microscopy was used as a reference stan-
dard for all samples, regardless of index test
Incorporation avoided?
All tests
Yes Microscopy and PCR was used.
Reference standard results blinded?
All tests
Unclear Blinding of microscopists not reported.
Index test results blinded?
All tests
Yes The 3observerswere blinded to each other’s
readings and to the results of microscopy
and PCR assay
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results.
In case the index test result was considered
invalid, the test was repeated
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals
Yan 2013
Clinical features and settings Presenting signs and symptoms: Suspected uncomplicated malaria, fever with axillary
temperature above 37.5°C at the time of examination
Previous treatments for malaria: Not reported
Clinical setting: Local malaria clinics and hospitals at the Laiza township.
Country:Myanmar (China-Myanmar border)
Malaria endemicity: Endemic. Seasonal; mostly in the rainy season from April to
November
Malaria endemic species:
Predominantly P. falciparum and P. vivax
Participants Sample size: 606
Age: Median 20.3 years, range 6 months to 88 years.
Sex: ~ 50% male 50% female
Co-morbidities or pregnancy: Not reported
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Study design Participants prospectively enrolled, not reported whether participants consecutively en-
rolled. All 606 samples were evaluated microscopically and by One Step Malaria Pf/Pan
test. A subset of 350 were also evaluated by Malaria Pv/Pf test device
Target condition and reference standard(s) Type(s) ofmalaria parasite tested for:Multiple species; falciparumandnon-falciparum.
Reference standard test(s) used:Microscopy thick and thin blood smears and PCR
Who performed the reference standard tests, and where? The reference standard was
performed by experienced microscopists. Location not reported. Not reported for PCR
If microscopy was used, how many high power fields were looked at? 100 fields
How many observers or repeats were used? 2 independent microscopists
How were discrepancies between observers resolved? The results were combined
Index and comparator tests Commercial name of the test:
• One Step Malaria Pf/Pan test (Wondfo, China)
• Malaria Pv/Pf test device (Tycolpharm Co., Limited, UK)
Parasite species the test is designed to detect:
• One Step Malaria Pf/Pan test: P. falciparum and all human Plasmodium species
• Malaria Pv/Pf test device: P. falciparum and P. vivax
Designated type:
• One Step Malaria Pf/Pan test: Type 3
• Malaria Pv/Pf test device: HRP-2 antigen for P. falciparum and pLDH antigen for
P. vivax
Batch numbers: Not reported
Transport and storage conditions: Not reported
Who performed the index test and where? Not reported.
Follow-up Not applicable
Notes Source of funding: The National Institute of Allergy and Infectious Diseases, National
Institutes of Health (U19 AI089672)
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Patients with suspected malaria, having
fever with axillary temperature above 37.
5°C were included in the study. Sampling
methodwas not reported, only a subsample
received Pf/Pv test and sampling method
for this not described
Acceptable reference standard?
All tests
Yes Microscopy was performed by 2 indepen-
dent microscopists. 100 fields. PCR was
also done
Partial verification avoided?
All tests
Yes All participants receiving the index tests
had their diagnosis verified by the reference
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test
Differential verification avoided?
All tests
Yes The same reference test was used.
Incorporation avoided?
All tests
Yes The reference test was microscopy and
PCR.
Reference standard results blinded?
All tests
Yes The microscopists were blinded to the re-
sults of additional diagnostic tests
Index test results blinded?
All tests
Yes The readers of RDTs were blinded to the
results of microscopy and PCR
Uninterpretable results reported?
All tests
Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore there
were no withdrawals
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
A-Elgayoum 2009 Not a study of RDTs (compared usual with expert microscopy).
Abeku 2008 No data presented on non-falciparum malaria.
Abul Faiz 2000 Participants had cerebral malaria.
Ademowo 2012 P. falciparum malaria only.
Adesanmi 2011 P. falciparum malaria only.
Afzaal 2001 Review or narrative.
Ahmad 2003 Report does not contain enough information to assess eligibility
Ahmed 2010 Case-control study.
Albertini 2012 Not a DTA study.
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Allen 2011 P. falciparum malaria only.
Anonymous 2005 Review or narrative.
Ansah 2008 Report does not contain enough information to assess eligibility
Ansah 2010 P. falciparum malaria only.
Araz 2000 Some participants did not have symptoms of malaria.
Arcanjo 2007 Non-English language.
Ardic 2012 Non-English language.
Arora 2003 Participants have severe or complicated malaria.
Arróspide 2004a Most participants had no symptoms of malaria.
Arróspide 2004b Non-English language.
Arróspide 2006
Ashley 2009 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Aslan 2001 Participants were hospital inpatients.
Assal 1999 Not immunochromatographic RDTs.
Avila 2002 Participants were travellers returning from an endemic to a non-endemic region
Ayeh-Kumi 2011 P. falciparum malaria only.
Azazy 2004 Only participants with malaria positive blood films by microscopy received the RDT
Azikiwe 2012 P. falciparum malaria only.
Babacar 2008 Not a DTA study.
Baiden 2012 P. falciparum malaria only.
Baltzell 2013 Not a DTA study.
Banchongaksorn 1996 No data presented on non-falciparum malaria.
Banchongaksorn 1997 No data presented on non-falciparum malaria.
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Barber 2013 Only participants with malaria positive blood films by microscopy were included
Bartoloni 1998 Single case study.
Bassene 2009 Not a DTA study.
Bassett 1991 Not a DTA study.
Batwala 2011 P. falciparum malaria only.
Beadle 1994 Most participants did not have symptoms of malaria.
Bechem 1999 Did not present sufficient data to enable extraction of the numbers of true positives, false positive, true
negatives and false positives
Beg 2005 All participants were positive for malaria by microscopy.
Belizario 2005 Participants were recruited by active case finding.
Bell 2005 Not a consecutive sample: excluded a random sample of participants who were negative for malaria by
microscopy
Bell 2006 Review or narrative.
Bellagra 1998 Participants were travellers returning from an endemic to a non-endemic area
Bendezu 2008 Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Berens-Riha 2009 Subjects were dead.
Bhandari 2008 All participants were positive for malaria by microscopy.
Bhat 2012 Recruited from a tertiary care hospital.
Bhatt 1994 Review or narrative.
Birku 1999 Participants had severe or complicated malaria.
Bisoffi 2009a Not a DTA study.
Bisoffi 2009b Review or narrative.
Bisoffi 2011 Not a DTA study.
Biswas 2004 Not a DTA study.
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Biswas 2006 Not an immunochromatographic test.
Bjorkman 2011 Report does not contain enough information to assess eligibility
Bojang 1999 No data presented on non-falciparum malaria.
Bouchaud 2000 Participants were travellers returning from endemic to non-endemic areas
Bouyou Akotet 2013 Unable to extract raw data.
Brenier-Pinchart 2000 Participants were travellers returning from endemic to non-endemic areas
Bruxvoort 2008 Participants were recruited by active case finding.
Bualombai 2003 No data presented on non-falciparum malaria.
Bualombai 2008 Report does not contain enough information to assess eligibility
Buchachart 2004 Participants are hospital in-patients.
Buhalata 2011 P. falciparum malaria only.
Bujanover 2002 Not a DTA study.
Cabezas 2004 Not a DTA study (comparing ’field’ and laboratory RDT results)
Caraballo 1996 No data presented on non-falciparum malaria.
Carmona Fonseca 2010 Non-English language.
Cavallo 1997 Participants were travellers returning from endemic to non-endemic countries
Chaijaroenkul 2011 Included participants without symptoms of malaria.
Chatterjee 2008 Report did not contain enough information to assess eligibility
Cheng 2006 Review or narrative.
Chilton 2006 Not a DTA study.
Chinkhumba 2010 P. falciparum malaria only.
Chinkhumba 2012 P. falciparum malaria only.
Chiodini 1998 Review or narrative.
147Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries (Review)
Copyright © 2015 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
(Continued)
Chiodini 2005 Not a DTA study.
Chitkara 2004 No data presented on non-falciparum malaria.
Cho 2001 Not undertaken in a malaria endemic area.
Cho 2011 Case-control study in travellers returning from an endemic to a non-endemic area
Cnops 2011 Samples not collected in a malaria endemic area.
Coleman 2002a Most participants did not have symptoms of malaria.
Coleman 2002b Most participants did not have symptoms of malaria.
Cong le 2002 Non-English language.
Cooke 1999 No data presented on non-falciparum malaria.
Craig 1997 Tested blood films with artificially cultured and diluted malaria parasites
Craig 2002 The participants were positive for malaria by microscopy.
Cropley 2000 Participants were travellers returning from endemic to non-endemic areas
Cuadros 2007 Participants were travellers returning from endemic to non-endemic areas
Davoodian 2011 Not enough information presented to judge eligibility.
Dawoud 2008 No data presented on non-falciparum malaria.
de Carsalade 2009 Non-English language.
de Dominguez 1996 Not a DTA study.
De Monbrison 2004 Participants were travellers returning from endemic to non-endemic areas
de Oliveira 2007 No data presented on non-falciparum malaria.
Delaunay 2008 Review or narrative.
Deletoille 1987 Not commercially available RDTs.
Devi 2002 No data presented on non-falciparum malaria.
Di Perry 1997 All participants were positive for malaria by microscopy.
Di Santi 2011 Positive and negative blood samples selected for the study.
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Diarra 2012 Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives for individual malaria species
Dietze 1995 Some participants did not have symptoms of malaria.
Drakeley 2009 Review or narrative.
Dubarry 1990 Not evaluating an immunochromatographic RDT.
Durand 2005 Review or narrative.
Durand 2007 Participants were travellers returning from endemic to non-endemic areas
Durrheim 1998 No data presented on non-falciparum malaria.
Dyer 2000 All participants were positive for malaria by microscopy.
Dzakah 2013 Positive and negative blood samples selected for the study.
Eisen 2000 Not undertaken in a malaria endemic area.
El-Moamly 2007 Participants were travellers returning from a malaria endemic to a non endemic area
Elmardi 2009 Not a DTA study.
Endeshaw 2008 Most participants did not have symptoms of malaria.
Endeshaw 2010 Unable to extract raw data for 2 x 2 table.
Existe 2010 Not enough information presented to judge eligibility.
Falade 2013 P. falciparum malaria only.
Fan 2000 Non-English language.
Fancony 2013 Included assymptomatic individuals (population survey).
Farcas 2003 Participants were travellers returning from endemic to non-endemic areas
Farcas 2004 Not an immunochromatographic test.
Ferro 2002 Participants were travellers returning from an endemic area to an non-endemic area
Figueiredo Filho 2003 All participants were positive for malaria by microscopy.
Fogg 2008 No data presented on non-falciparum malaria.
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Forney 2001 No data presented on non-falciparum malaria.
Forney 2003 No data presented on non-falciparum malaria.
Fryauff 1997 Report did not contain enough information to assess eligibility
Fryauff 2000 Participants did not have symptoms of malaria.
Funk 1999 Participants were travellers returning from endemic to non-endemic areas
Garavelli 2002 Participants were travellers returning from endemic to non-endemic areas
Garcia 1996 Report did not contain enough information to assess eligibility
Gatti 2002 Participants were travellers returning from endemic to non-endemic areas
Gatti 2007 Participants were travellers returning from endemic to non-endemic areas
Gaye 1998 No data presented on non-falciparum malaria.
Gaye 1999 No data presented on non-falciparum malaria.
Gelaglie 2010 Not enough information presented to judge eligibility.
Gerstl 2009 No data presented on non-falciparum malaria.
Ghanchi 2009 Not a DTA study.
Ghosh 2000 No data presented on non-falciparum malaria.
Ghouth 2012 P. falciparum malaria only.
Gillet 2009a Participants were travellers returning from endemic to non-endemic areas
Gillet 2009b Not a DTA study.
Gillet 2009c Participants were travellers returning from an endemic to a non-endemic area
Gillet 2011 Not a DTA study: patients negative by reference standard standard were excluded
Gogtay 1999 Participants had severe or complicated malaria.
Gogtay 2003 Participants were all positive for malaria by blood smear.
Goh 2013 Does not evaluate an RDT.
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Gomes 2013 Selected positve and negative samples by reference test.
Gonzáles-Cerón 2005 Non-English language.
Grobusch 1999 Not undertaken in a malaria endemic area.
Grobusch 2002 Not undertaken in a malaria endemic area.
Grobusch 2003a Participants were travellers returning from endemic to non-endemic areas
Grobusch 2003b Participants were travellers returning from endemic to non-endemic areas
Gupta 2001 Some participants had severe or complicated malaria.
Guthmann 2002 No data presented on non-falciparum malaria.
Gutierrez 2005 Not a DTA study.
Hada 2011 Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives for individual malaria species
Haditsch 2004 Review or narrative.
Hance 2005 Review or narrative.
Happi 2004 All participants were positive for malaria by microscopy.
Harchut 2013 P. falciparum malaria only.
Hashizume 2006 Participants were displaced people from mainly very low endemicity areas
Hawkes 2009 Not a DTA study.
Hernandes 2001 Participants were travellers returning from endemic to non-endemic areas
Holmberg 1992 Not a DTA study.
Hopkins 2007 No data presented on non-falciparum malaria.
Hopkins 2008 No data presented on non-falciparum malaria.
Hossain 2008 Participants had severe or complicated malaria.
Houmsou 2011 Report does not contain enough information to assess eligibility
Houzé 2009 All participants were positive for malaria by microscopy.
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Houzé 2011 Participants were travellers returning from endemic to non-endemic areas
Humar 1997 Participants were travellers returning from endemic to non-endemic areas
Huong 2002 Not based on a consecutive sample; included a group malaria positive bymicroscopy and an asymptomatic
malaria negative control group
Hänscheid 1999 Review or narrative.
Iqbal 2000 Not a consecutive sample: participants were selected to have a high risk of rheumatoid factor
Iqbal 2001 Participants were travellers returning from endemic to non-endemic areas
Iqbal 2002 Participants were travellers returning from endemic to non-endemic areas
Iqbal 2003 No data presented on non-falciparum malaria.
Iqbal 2004 All participants were positive for malaria by microscopy.
Ishengoma 2011 P. falciparum malaria only.
Jang 2013 Participants were travellers returning from endemic to non-endemic areas
Jelinek 1996 Does not evaluate an immunochromatographic RDT for malaria.
Jelinek 1999 Participants were travellers returning from endemic to non-endemic areas
Jelinek 2000 Participants were travellers returning from endemic to non-endemic areas
Jelinek 2001 Participants were travellers returning from endemic to non-endemic areas
Jeurissen 1999 Review or narrative.
John 1998 All participants were positive for malaria by microscopy.
Joshi 2004 Not evaluating an immunochromatographic RDT.
Kaewsonthi 1996 Not a DTA study.
Kahama-Maro 2008 Report does not contain enough information to assess eligibility
Kahama-Maro 2011 No data presented on non-falciparum malaria.
Kakkilaya 2003 Review or narrative.
Kamugisha 2008 Most participants did not have symptoms of malaria.
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Kar 1998 No data presented on non-falciparum malaria.
Karbwang 1996 All participants were positive for malaria by microscopy.
Karimov 2011 Non-English language.
Kashif 2013 P. falciparum malaria only.
Katakai 2011 Positive and negative blood samples selected for the study.
Kattenberg 2011 Not enough information presented to judge eligibility.
Kaur 2000 All participants had cerebral malaria.
Kaushal 1995 Tested for P. knowlesi infection in monkeys.
Kaushal 1997 Review or narrative.
Kawai 2009 Tested for P. knowlesi infection in monkeys.
Keating 2009 Most participants did not have symptoms of malaria.
Khairnar 2009 Participants were travellers returning from an endemic to a non-endemic area
Khan 2004 Participants were hospital inpatients.
Kilian 1997 Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Kilian 1999 No data presented on non-falciparum malaria.
Kim 2008 Includes a symptomatic group with malaria infection identified by microscopy, and an asymptomatic
group with no malaria infection by microscopy
Kim 2011 Only participants with malaria positive blood films by microscopy received the RDT
Kim 2013 Includes a symptomatic group with malaria infection identified by microscopy, and an asymptomatic
group with no malaria infection by microscopy
Knappik 2002 Participants were travellers returning from endemic to non-endemic areas
Kodisinghe 1997 Some participants did not have symptoms of malaria.
Koita 2012 P. falciparum malaria only.
Kumar 1996 No data presented on non-falciparum malaria.
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Kumar 2000 Participants were migrants from a very low endemicity area.
Kumar 2004 No data presented on non-falciparum malaria.
Kumar 2012 Not a DTA study.
Kumar 2013 Not a diganostic test accuracy study.
Kweka 2011 P. falciparum malaria only.
Kyabayinze 2008 No data presented on non-falciparum malaria.
Labbé 2001 No data presented on non-falciparum malaria.
Lee 1999 Some participants did not have symptoms of malaria.
Lee 2008 Participants were soldiers usually residing in non-endemic areas
Lee 2011 Positive and negative blood samples selected for the study.
Lema 1999 Some participants were attending for follow-up of a previously diagnosed and treated case of malaria
Lepère 2004 Not a DTA study.
Lim 2001 Half the participants had malaria confirmed by microscopy before enrolment
Llanos Zavalaga 2000 Not a DTA study.
Llanos-Zavalaga 2002 Non-English language.
Mahajan 2000 Participants were hospital inpatients.
Makler 1998 Review or narrative.
Makler 2009 Review or narrative.
Malik 2004 Study was based at a tertiary referral centre with a high percentage of patients with complicated malaria
Mankhambo 2002 Most participants did not have symptoms of malaria.
Mason 2002 Some participants did not have symptoms of malaria.
Mawili-Mboumba 2010 P. falciparum malaria only.
Mayxay 2004 Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
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Mboera 2006a No data presented on non-falciparum malaria.
McCutchan 2008 Review or narrative.
McMorrow 2010 P. falciparum malaria only.
Meena 2009 Participants were all hospital inpatients.
Menan 1996 Not a study of malaria RDTs.
Mendiratta 2006 No data presented on non-falciparum malaria.
Mendoza 2007 Report does not contain enough information to assess eligibility
Mendoza 2013 Report does not contain enough information to assess eligibility
Mengesha 1999 Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Mens 2007 No data presented on non-falciparum malaria.
Mens 2010 RDT evaluated is not an immunochromatographic test.
Metzger 2008 Participants were recruited by active case finding.
Metzger 2009 Not a DTA study.
Mharakurwa 1997a Participants had all been recently treated for malaria.
Mharakurwa 1997b No data presented on non-falciparum malaria.
Miantuasila 2012 P. falciparum malaria only.
Mikhail 2011 Positive and negative blood samples selected for the study.
Miller 2001 Letter.
Miller 2008 Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Mills 1999 Participants were travellers returning from endemic to non-endemic areas
Mills 2007 Report does not contain enough information to assess eligibility
Mills 2010 P. falciparum malaria only.
Mills 2010a P. falciparum malaria only.
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Minja 2012 Not all participants had symptoms of malaria: prospective cohort of pregnant women
Minodier 2005 Review or narrative.
Mishra 1999 Not a consecutive sample; comprised a malaria positive group by microscopy and negative control groups
Mishra 2007 Report did not contain enough information to assess eligibility
Mohanty 1999 Report did not contain enough information to assess eligibility
Mohapatra 1996 No data presented on non-falciparum malaria.
Montoya 2008 Non-English language.
Moody 2000 Participants were travellers returning from endemic to non-endemic areas
Moody 2002a Review or narrative.
Moody 2002b RDTs tested on artificially cultured blood samples.
Moonasar 2007 Not a DTA study.
Moonasar 2009 No data presented on non-falciparum malaria.
Morankar 2011 P. falciparum malaria only.
Moulin 2009 Review or narrative.
Msellem 2009 No data presented on non-falciparum malaria.
Mtove 2011 P. falciparum malaria only.
Mueller 2007 Participants not representative of people presenting to ambulatory care setting with symptoms of malaria
Muhindo 2012 No data presented on non-falciparum malaria.
Munier 2009 Report does not contain enough information to assess eligibility
Murahwa 1999 No data presented on non-falciparum malaria.
Murray 2003 Review or narrative.
Murray 2008 Review or narrative.
Mwanza 2005 No data presented on non-falciparum malaria.
Myjak 2004 Participants were travellers returning from endemic to non-endemic areas
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Naing 2002a No data presented on non-falciparum malaria.
Nema 2005 All participants were positive for malaria by microscopy.
Neumann 2008 Most participants did not have symptoms of malaria.
Nicastri 2009a No data presented on non-falciparum malaria.
Nigussie 2008 No data presented on non-falciparum malaria.
Nkrumah 2010 RDT evaluated is not an immunochromatographic test.
Nkrumah 2011 P. falciparum malaria only: Only 2 cases of non-falciparum malaria (263 study participants)
Nour 2011 Not enough information presented to extract numbers of true postives, false positives, true negatives and
false negatives
Nwuba 2001 No data presented on non-falciparum malaria.
Nyunt 2013 Not a DTA study: all participants had positive blood slide for P. falciparum
Ochola 2006 Review or narrative.
Omar 1999 No data presented on non-falciparum malaria.
OMS 1999 Not a DTA study.
Onile 2005 Review or narrative.
Osman 2010 Less than one percent of the malaria detected was P. vivax.
Ouattara 2011 Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives for individual malaria species (mainly P. falciparum but numbers not provided).
Ozbilge 2006 Not an immunochromatographic test.
Pabon 2007 Non-English language.
Pakalapati 2013 Unable to extract data on numbers of true positives, false positive, true negatives and false negatives
Palmer 1998 Report did not contain enough information to assess eligibility
Palmer 1999 All participants were positive for malaria by microscopy.
Palmer 2003 Participants were travellers returning from endemic to non-endemic areas
Pammenter 1988 Review or narrative.
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Pandey 1995 Review or narrative.
Pandya 2001 No data presented on non-falciparum malaria.
Park 2003 Not a consecutive sample; included a known malaria group and negative control group by microscopy
Park 2006 Written in Korean only.
Parra 1991 Not a DTA study.
Peng 2012 P. falciparum malaria only.
Penhalbel 2005 Not a consecutive sample; included a known malaria group and negative control group by microscopy
Peyron 1999 Review or narrative.
Phommanivong 2010 Not a DTA study.
Pica 2005 Review or narrative.
Pieroni 1998 Participants were travellers returning from endemic to non-endemic areas
Pinto 1999 All participants had previous tested negative for malaria and had symptoms that meant complicated
malaria could not be ruled out
Piper 1999 Half the participants lived in non-endemic areas.
Pividal 1994 Not a DTA study.
Planche 2001 Review or narrative.
Playford 2002 Participants were travellers returning from endemic to non-endemic areas
Popov 2000 Non-English language.
Popov 2004 Non-English language.
Premji 1994 Participants did not have symptoms of malaria.
Prou 1988 Not an immunochromatographic test.
Proux 2001 Majority of participants did not have symptoms of malaria.
Pérez 2007 Review or narrative.
Quintana 1998 Report did not contain enough information to assess eligibility
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Rabinovich 2006 Non-English language.
Radrianasolo 2007 Non-English language.
Rahim 2002 All participants were positive for malaria by microscopy.
Rajendran 2006 Report does not contain enough information to assess eligibility
Ramutton 2012 Participants had severe malaria.
Ratnawati 2008 Many participants were recruited by active case finding.
Ratsimbasoa 2012 P. falciparum malaria only.
Rehlis 2004 Non-English language.
Reyburn 2007 Not a DTA study.
Ricci 2000 Participants were travellers returning from endemic to non-endemic areas
Richardson 2002 Participants were travellers returning from endemic to non-endemic areas
Richter 2004a Review or narrative.
Richter 2004b Participants were travellers returning from endemic to non-endemic areas
Rimón 2003 No data presented on non-falciparum malaria.
Roche 1995 Not an immunochromatographic test.
Rodríguez-Iglesias 2005 Review or narrative.
Rodulfo 2007 Some of the participants did not have symptoms of malaria.
Rolland 2006 Not a DTA study.
Rosenthal 2012 Not a DTA study: editorial.
Rubio 2001 Participants were travellers returning from endemic to non-endemic areas
Runsewe-Abiodun 2012 Not enough information presented to absolute numbers of true positives, true negatives, false positives
and false negatives
Ryan 2002 Not a DTA study.
Samal 1998 Not an immunochromatographic test.
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Saranya 2003 Review or narrative.
Sayang 2009 No data presented on non-falciparum malaria.
Schachterle 2011 P. falciparum only.
Schmidt 2003 Review or narrative.
Schmidt 2011 Only participants with positive P. falciparum malaria slides were included.
Seidahmed 2008 Not a DTA study.
Senn 2012 Not a diagnostic test accuracy study: blood slide was performed to assess treatment outcome
Sezibera 2009 Not a DTA study.
Shah 2004 All participants were positive for malaria by microscopy.
Shaikh 2013 Does not differentiate malaria parasitiaemia by species.
Shakya 2012 Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Shamsi 1999 Report did not contain enough information to assess eligibility
Sharma 1999 No data presented on non-falciparum malaria.
Sharma 2008 Some participants did not have symptoms of malaria.
She 2007 Not undertaken in a malaria endemic area.
Shenoi 1996 Report did not contain enough information to assess eligibility
Shiff 1993 Some participants did not have symptoms of malaria.
Shillcutt 2008 Not a DTA study.
Shirayama 2008 Not a DTA study.
Shujatullah 2006 Participants had severe or complicated malaria.
Shujatullah 2009 Participants were hospital inpatients.
Singer 2004 Most participants did not have symptoms of malaria.
Singh 1997a No data presented on non-falciparum malaria.
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Singh 1997b No data presented on non-falciparum malaria.
Singh 2000b Some participants did not have symptoms of malaria.
Singh 2000c No data presented on non-falciparum malaria.
Singh 2001 Participants were recruited by active case finding.
Singh 2002a Most participants did not have symptoms of malaria.
Singh 2002b All participants were positive for malaria by microscopy.
Singh 2004a Participants had severe or complicated malaria.
Singh 2005a Most participants did not have symptoms of malaria.
Singh 2005b Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Singh 2005c Some participants did not have symptoms of malaria.
Singh 2007 Most participants did not have symptoms of malaria.
Singh 2013 Participants selected through active case detection.
Skarbinski 2009 Not a DTA study.
Smego 2000 Review or narrative.
Sotimehin 2007 Most participants did not have symptoms of malaria.
Soto Tarazona 2004 Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Srinivasan 2000 Participants were travellers returning from endemic to non-endemic areas
Stauffer 2005 Participants were refugees from an endemic to a non-endemic country
Stauffer 2006 Participants were travellers returning from endemic to non-endemic areas
Stauffer 2009 Participants were all travellers returning from an endemic to a non-endemic area
Stephens 1999 No data presented on non-falciparum malaria.
Stow 1999 No data presented on non-falciparum malaria.
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Strøm 2013 No cases of non-falciparum malaria.
Stürenburg 2009 Review or narrative.
Surpur 2010 Data not presented for P. falciparum and P. vivax separately.
Susi 2005 Participants were all travellers returning from an endemic to a non-endemic area
Swarthout 2007 All participants were positive for malaria by microscopy.
Tagbo 2007 No data presented on non-falciparum malaria.
Tagbor 2008 Most participants did not have symptoms of malaria.
Tahar 2013 P. falciparum malaria only: only 4 cases of non-falciparum malaria (179 participants)
Tarimo 2001 Unable to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Taylor 2002 All participants were positive for malaria by microscopy.
Tekeste 2012 P. falciparum malaria only.
Tham 1999 Participants were all travellers returning from an endemic to a non-endemic area
Thepsamarn 1997 All participants were positive for malaria by microscopy.
Tietche 1996 Not a DTA study.
Tjitra 2001a All participants were positive for malaria by microscopy.
Tjitra 2001b All participants were positive for malaria by microscopy.
Trachsler 1999 Not a DTA study.
Uguen 1995 Participants were travellers returning from endemic to non-endemic areas
Uneke 2008a Review or narrative.
Uneke 2008b Not a DTA study.
Uzochukwu 2009 No data presented on non-falciparum malaria.
Valecha 1998 Report does not contain enough information to assess eligibility
Valecha 2002 Participants were recruited by active case finding.
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Valéa 2009 No data presented on non-falciparum malaria.
Van den Ende 1998 Participants were travellers returning from endemic to non-endemic areas
Van der Palen 2009 Participants were travellers returning from endemic to non-endemic areas
Van Dijk 2009 Participants were travellers returning from an endemic to a non-endemic area
van Hellemond 2009 Not a DTA study.
VanderJagt 2005 Most participants had no symptoms of malaria.
Venkatesh 2007 Participants had severe or complicated malaria.
Verlé 1996 No data presented on non-falciparum malaria.
Voller 1993 Review or narrative.
Waltz 2007 Review or narrative.
Wang J-Y 2007 Not a commercial test kit.
Wanji 2008 Participants did not have symptoms of malaria.
WHO 1996 Review or narrative.
Wiese 2006 Participants were travellers returning from endemic to non-endemic areas
Willcox 2009 No data presented on non-falciparum malaria.
Williams 2008 Not a DTA study.
Wilson 2013 Review or narrative.
Win 2001 Review or narrative.
Wolday 2001 No data presented on non-falciparum malaria.
Wongsrichanalai 1999 No data presented on non-falciparum malaria.
Wongsrichanalai 2001 Review or narrative.
Wongsrichanalai 2007 Review or narrative.
Woyessa 2013 Participants recruited through active case detection (population survey)
Wu 2005 Not an immunochromatographic RDT kit.
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(Continued)
Yadav 1997 No data presented on non-falciparum malaria.
Yadav 2012 Not enough information presented to assess eligibility (not clear where participants presented with symp-
toms)
Yavo 2002 No data presented on non-falciparum malaria.
Zakai 2003 Review or narrative.
Zerpa 2007 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Zheng 1999 Non-English language.
Zhu 1998 Non-English language.
Zikusooka 2008 Not a DTA study.
Zurovac 2008 Not a DTA study.
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 Non-falciparum species only,
microscopy, Type 2, ICT
Combo Cassette
1 2383
2 Non-falciparum species only,
microscopy, Type 2, ICT
Malaria Pf/Pv
7 3151
3 Non-falciparum species only,
microscopy, Type 2, NOW
Malaria ICT
1 246
4 Non-falciparum species only,
microscopy, Type 2, Malascan
1 372
5 Non-falciparum species only,
microscopy, Type 2, VIKIA Ag
Pf/Pan
1 727
6 Non-falciparum species only,
microscopy, Type 2 (All)
11 6879
7 Non-falciparum species only,
microscopy, Type 3, Parascreen
14 5407
8 Non-falciparum species only,
microscopy, Type 3, CareStart
Pf/Pan
4 3544
9 Non-falciparum species only,
microscopy, Type 3, SD
Malaria Antigen Bioline
4 3769
10 Non-falciparum species only,
microscopy, Type 3, First
Response Malaria Combo
2 663
11 Non-falciparum species only,
microscopy, Type 3, One Step
Malaria Pf/Pan
1 606
12 Non-falciparum species only,
microscopy, Type 3 (All)
23 11234
13 Non-falciparum species only,
microscopy, Type 4, OptiMAL
6 1843
14 Non-falciparum species
only, microscopy, Type 4,
OptiMAL-IT
4 1987
15 Non-falciparum species only,
microscopy, Type 4, Carestart
1 195
16 Non-falciparum species only,
microscopy, Type 4 (All)
10 3831
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17 Non-falciparum species only,
microscopy, Other Type,
Malariagen Malaria
1 262
18 Non-falciparum species only,
PCR, Type 3, CareStart Pf/Pan
1 178
19 Non-falciparum species only,
PCR, Type 3, Parascreen
2 659
20 Non-falciparum species only,
PCR, Type 3, One StepMalaria
Pf/Pan
1 606
21 Non-falciparum species only,
PCR, Type 3, SD Malaria
Antigen Bioline
1 196
22 Non-falciparum species only,
PCR, Type 3 (All)
5 1639
23 Non-falciparum species only,
PCR, Type 4, OptiMAL (All)
1 313
24 P. vivax, microscopy, Pf HRP-2
and Pv pLDH, Carestart Pf/Pv
(All)
3 2000
25 P. vivax, microscopy, Pf HRP-2
and Pv pLDH, Biotech Malaria
Pf/Pv
1 250
26 P. vivax, microscopy, Pf HRP-2
and Pv pLDH, Falcivax
2 710
27 P. vivax, microscopy, Pf HRp-2
and Pv pLDH, Onsite Pf/Pv
2 710
28 P. vivax, microscopy, Pf HRP-2
and Pv pLDH, Pf/Pv Malaria
Device
1 350
29 P. vivax, microscopy, Pf HRP-2
and Pv pLDH (All)
8 3682
30 P. vivax, PCR, Pf HRP-2 and
Pv pLDH, Falcivax
1 338
31 P. vivax, PCR, Pf HRP-2 and
Pv pLDH, OnSite Pf/Pv
1 338
32 P. vivax, PCR, Pf HRP-2 and
Pv pLDH, Pf/Pv Malaria
Device
1 350
33 P. vivax, PCR, Pf HRP-2 and
Pv pLDH (All)
2 688
34 P. vivax, PCR, Type 6,
PALUTOP (All)
1 313
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Test 1. Non-falciparum species only, microscopy, Type 2, ICT Combo Cassette.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 1 Non-falciparum species only, microscopy, Type 2, ICT Combo Cassette
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ashton 2010 209 85 37 2052 0.85 [ 0.80, 0.89 ] 0.96 [ 0.95, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 2. Non-falciparum species only, microscopy, Type 2, ICT Malaria Pf/Pv.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 2 Non-falciparum species only, microscopy, Type 2, ICT Malaria Pf/Pv
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bell 2001a 32 2 16 300 0.67 [ 0.52, 0.80 ] 0.99 [ 0.98, 1.00 ]
Bell 2001b 25 9 6 73 0.81 [ 0.63, 0.93 ] 0.89 [ 0.80, 0.95 ]
Fernando 2004 70 2 29 227 0.71 [ 0.61, 0.79 ] 0.99 [ 0.97, 1.00 ]
Harani 2006 27 10 3 520 0.90 [ 0.73, 0.98 ] 0.98 [ 0.97, 0.99 ]
Singh 2000a 34 3 13 294 0.72 [ 0.57, 0.84 ] 0.99 [ 0.97, 1.00 ]
Tjitra 1999 27 27 9 497 0.75 [ 0.58, 0.88 ] 0.95 [ 0.93, 0.97 ]
van den Broek 2006 217 1 74 604 0.75 [ 0.69, 0.79 ] 1.00 [ 0.99, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 3. Non-falciparum species only, microscopy, Type 2, NOWMalaria ICT.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 3 Non-falciparum species only, microscopy, Type 2, NOW Malaria ICT
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Wongsrichanalai 2003 59 0 9 178 0.87 [ 0.76, 0.94 ] 1.00 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 4. Non-falciparum species only, microscopy, Type 2, Malascan.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 4 Non-falciparum species only, microscopy, Type 2, Malascan
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Singh 2010 39 7 18 308 0.68 [ 0.55, 0.80 ] 0.98 [ 0.95, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 5. Non-falciparum species only, microscopy, Type 2, VIKIA Ag Pf/Pan.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 5 Non-falciparum species only, microscopy, Type 2, VIKIA Ag Pf/Pan
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Eibach 2013 4 6 1 716 0.80 [ 0.28, 0.99 ] 0.99 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 6. Non-falciparum species only, microscopy, Type 2 (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 6 Non-falciparum species only, microscopy, Type 2 (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ashton 2010 209 85 37 2052 0.85 [ 0.80, 0.89 ] 0.96 [ 0.95, 0.97 ]
Bell 2001a 32 2 16 300 0.67 [ 0.52, 0.80 ] 0.99 [ 0.98, 1.00 ]
Bell 2001b 25 9 6 73 0.81 [ 0.63, 0.93 ] 0.89 [ 0.80, 0.95 ]
Eibach 2013 4 6 1 716 0.80 [ 0.28, 0.99 ] 0.99 [ 0.98, 1.00 ]
Fernando 2004 70 2 29 227 0.71 [ 0.61, 0.79 ] 0.99 [ 0.97, 1.00 ]
Harani 2006 27 10 3 520 0.90 [ 0.73, 0.98 ] 0.98 [ 0.97, 0.99 ]
Singh 2000a 34 3 13 294 0.72 [ 0.57, 0.84 ] 0.99 [ 0.97, 1.00 ]
Singh 2010 39 7 18 308 0.68 [ 0.55, 0.80 ] 0.98 [ 0.95, 0.99 ]
Tjitra 1999 27 27 9 497 0.75 [ 0.58, 0.88 ] 0.95 [ 0.93, 0.97 ]
van den Broek 2006 217 1 74 604 0.75 [ 0.69, 0.79 ] 1.00 [ 0.99, 1.00 ]
Wongsrichanalai 2003 59 0 9 178 0.87 [ 0.76, 0.94 ] 1.00 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 7. Non-falciparum species only, microscopy, Type 3, Parascreen.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 7 Non-falciparum species only, microscopy, Type 3, Parascreen
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ashton 2010 203 96 43 2041 0.83 [ 0.77, 0.87 ] 0.96 [ 0.95, 0.96 ]
Bendezu 2010 64 6 19 243 0.77 [ 0.67, 0.86 ] 0.98 [ 0.95, 0.99 ]
Elahi 2013 49 3 5 270 0.91 [ 0.80, 0.97 ] 0.99 [ 0.97, 1.00 ]
Endeshaw 2012a 3 4 3 190 0.50 [ 0.12, 0.88 ] 0.98 [ 0.95, 0.99 ]
Endeshaw 2012b 32 4 4 160 0.89 [ 0.74, 0.97 ] 0.98 [ 0.94, 0.99 ]
Endeshaw 2012c 6 3 5 184 0.55 [ 0.23, 0.83 ] 0.98 [ 0.95, 1.00 ]
Endeshaw 2012d 2 1 2 195 0.50 [ 0.07, 0.93 ] 0.99 [ 0.97, 1.00 ]
Endeshaw 2012e 5 7 0 185 1.00 [ 0.48, 1.00 ] 0.96 [ 0.93, 0.99 ]
Endeshaw 2012f 8 0 0 192 1.00 [ 0.63, 1.00 ] 1.00 [ 0.98, 1.00 ]
Endeshaw 2012g 3 1 2 192 0.60 [ 0.15, 0.95 ] 0.99 [ 0.97, 1.00 ]
Endeshaw 2012h 14 0 2 184 0.88 [ 0.62, 0.98 ] 1.00 [ 0.98, 1.00 ]
Endeshaw 2012i 10 4 0 186 1.00 [ 0.69, 1.00 ] 0.98 [ 0.95, 0.99 ]
Endeshaw 2012j 4 3 12 181 0.25 [ 0.07, 0.52 ] 0.98 [ 0.95, 1.00 ]
Singh 2010 44 6 13 309 0.77 [ 0.64, 0.87 ] 0.98 [ 0.96, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 8. Non-falciparum species only, microscopy, Type 3, CareStart Pf/Pan.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 8 Non-falciparum species only, microscopy, Type 3, CareStart Pf/Pan
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ashton 2010 209 77 37 2060 0.85 [ 0.80, 0.89 ] 0.96 [ 0.96, 0.97 ]
Eibach 2013 3 4 2 718 0.60 [ 0.15, 0.95 ] 0.99 [ 0.99, 1.00 ]
Moges 2012 20 4 38 192 0.34 [ 0.22, 0.48 ] 0.98 [ 0.95, 0.99 ]
Xiaodong 2013 59 0 6 115 0.91 [ 0.81, 0.97 ] 1.00 [ 0.97, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 9. Non-falciparum species only, microscopy, Type 3, SD Malaria Antigen Bioline.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 9 Non-falciparum species only, microscopy, Type 3, SD Malaria Antigen Bioline
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Dev 2004 5 0 2 23 0.71 [ 0.29, 0.96 ] 1.00 [ 0.85, 1.00 ]
Kosack 2013 454 26 133 1972 0.77 [ 0.74, 0.81 ] 0.99 [ 0.98, 0.99 ]
Ratsimbasoa 2007 11 4 4 175 0.73 [ 0.45, 0.92 ] 0.98 [ 0.94, 0.99 ]
Trouvay 2013 111 3 18 828 0.86 [ 0.79, 0.92 ] 1.00 [ 0.99, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 10. Non-falciparum species only, microscopy, Type 3, First Response Malaria Combo.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 10 Non-falciparum species only, microscopy, Type 3, First Response Malaria Combo
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bharti 2008 34 15 7 235 0.83 [ 0.68, 0.93 ] 0.94 [ 0.90, 0.97 ]
Singh 2010 48 11 9 304 0.84 [ 0.72, 0.93 ] 0.97 [ 0.94, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 11. Non-falciparum species only, microscopy, Type 3, One Step Malaria Pf/Pan.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 11 Non-falciparum species only, microscopy, Type 3, One Step Malaria Pf/Pan
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Yan 2013 51 5 22 528 0.70 [ 0.58, 0.80 ] 0.99 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
172Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries (Review)
Copyright © 2015 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Test 12. Non-falciparum species only, microscopy, Type 3 (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 12 Non-falciparum species only, microscopy, Type 3 (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ashton 2010 209 77 37 2060 0.85 [ 0.80, 0.89 ] 0.96 [ 0.96, 0.97 ]
Bendezu 2010 64 6 19 243 0.77 [ 0.67, 0.86 ] 0.98 [ 0.95, 0.99 ]
Bharti 2008 34 15 7 235 0.83 [ 0.68, 0.93 ] 0.94 [ 0.90, 0.97 ]
Dev 2004 5 0 2 23 0.71 [ 0.29, 0.96 ] 1.00 [ 0.85, 1.00 ]
Eibach 2013 3 4 2 718 0.60 [ 0.15, 0.95 ] 0.99 [ 0.99, 1.00 ]
Elahi 2013 49 3 5 270 0.91 [ 0.80, 0.97 ] 0.99 [ 0.97, 1.00 ]
Endeshaw 2012a 3 4 3 190 0.50 [ 0.12, 0.88 ] 0.98 [ 0.95, 0.99 ]
Endeshaw 2012b 32 4 4 160 0.89 [ 0.74, 0.97 ] 0.98 [ 0.94, 0.99 ]
Endeshaw 2012c 6 3 5 184 0.55 [ 0.23, 0.83 ] 0.98 [ 0.95, 1.00 ]
Endeshaw 2012d 2 1 2 195 0.50 [ 0.07, 0.93 ] 0.99 [ 0.97, 1.00 ]
Endeshaw 2012e 5 7 0 185 1.00 [ 0.48, 1.00 ] 0.96 [ 0.93, 0.99 ]
Endeshaw 2012f 8 0 0 192 1.00 [ 0.63, 1.00 ] 1.00 [ 0.98, 1.00 ]
Endeshaw 2012g 3 1 2 192 0.60 [ 0.15, 0.95 ] 0.99 [ 0.97, 1.00 ]
Endeshaw 2012h 14 0 2 184 0.88 [ 0.62, 0.98 ] 1.00 [ 0.98, 1.00 ]
Endeshaw 2012i 10 4 0 186 1.00 [ 0.69, 1.00 ] 0.98 [ 0.95, 0.99 ]
Endeshaw 2012j 4 3 12 181 0.25 [ 0.07, 0.52 ] 0.98 [ 0.95, 1.00 ]
Kosack 2013 454 26 133 1972 0.77 [ 0.74, 0.81 ] 0.99 [ 0.98, 0.99 ]
Moges 2012 20 4 38 192 0.34 [ 0.22, 0.48 ] 0.98 [ 0.95, 0.99 ]
Ratsimbasoa 2007 11 4 4 175 0.73 [ 0.45, 0.92 ] 0.98 [ 0.94, 0.99 ]
Singh 2010 44 6 13 309 0.77 [ 0.64, 0.87 ] 0.98 [ 0.96, 0.99 ]
Trouvay 2013 111 3 18 828 0.86 [ 0.79, 0.92 ] 1.00 [ 0.99, 1.00 ]
Xiaodong 2013 59 0 6 115 0.91 [ 0.81, 0.97 ] 1.00 [ 0.97, 1.00 ]
Yan 2013 51 5 22 528 0.70 [ 0.58, 0.80 ] 0.99 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 13. Non-falciparum species only, microscopy, Type 4, OptiMAL.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 13 Non-falciparum species only, microscopy, Type 4, OptiMAL
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Chayani 2004 23 2 3 204 0.88 [ 0.70, 0.98 ] 0.99 [ 0.97, 1.00 ]
Dev 2004 26 0 3 111 0.90 [ 0.73, 0.98 ] 1.00 [ 0.97, 1.00 ]
Kolaczinski 2004 142 5 23 328 0.86 [ 0.80, 0.91 ] 0.98 [ 0.97, 1.00 ]
Ratsimbasoa 2007 15 2 2 175 0.88 [ 0.64, 0.99 ] 0.99 [ 0.96, 1.00 ]
Singh 2003 22 1 0 57 1.00 [ 0.85, 1.00 ] 0.98 [ 0.91, 1.00 ]
Valecha 2003 173 16 13 497 0.93 [ 0.88, 0.96 ] 0.97 [ 0.95, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 14. Non-falciparum species only, microscopy, Type 4, OptiMAL-IT.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 14 Non-falciparum species only, microscopy, Type 4, OptiMAL-IT
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Andrade 2010 84 14 0 213 1.00 [ 0.96, 1.00 ] 0.94 [ 0.90, 0.97 ]
Metzger 2011 52 6 30 426 0.63 [ 0.52, 0.74 ] 0.99 [ 0.97, 0.99 ]
Pattanasin 2003 56 2 29 179 0.66 [ 0.55, 0.76 ] 0.99 [ 0.96, 1.00 ]
van den Broek 2006 256 6 36 598 0.88 [ 0.83, 0.91 ] 0.99 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 15. Non-falciparum species only, microscopy, Type 4, Carestart.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 15 Non-falciparum species only, microscopy, Type 4, Carestart
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ratsimbasoa 2007 12 5 3 175 0.80 [ 0.52, 0.96 ] 0.97 [ 0.94, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 16. Non-falciparum species only, microscopy, Type 4 (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 16 Non-falciparum species only, microscopy, Type 4 (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Andrade 2010 84 14 0 213 1.00 [ 0.96, 1.00 ] 0.94 [ 0.90, 0.97 ]
Chayani 2004 23 2 3 204 0.88 [ 0.70, 0.98 ] 0.99 [ 0.97, 1.00 ]
Dev 2004 26 0 3 111 0.90 [ 0.73, 0.98 ] 1.00 [ 0.97, 1.00 ]
Kolaczinski 2004 142 5 23 328 0.86 [ 0.80, 0.91 ] 0.98 [ 0.97, 1.00 ]
Metzger 2011 52 6 30 426 0.63 [ 0.52, 0.74 ] 0.99 [ 0.97, 0.99 ]
Pattanasin 2003 56 2 29 179 0.66 [ 0.55, 0.76 ] 0.99 [ 0.96, 1.00 ]
Ratsimbasoa 2007 12 5 3 175 0.80 [ 0.52, 0.96 ] 0.97 [ 0.94, 0.99 ]
Singh 2003 22 1 0 57 1.00 [ 0.85, 1.00 ] 0.98 [ 0.91, 1.00 ]
Valecha 2003 173 16 13 497 0.93 [ 0.88, 0.96 ] 0.97 [ 0.95, 0.98 ]
van den Broek 2006 256 6 36 598 0.88 [ 0.83, 0.91 ] 0.99 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 17. Non-falciparum species only, microscopy, Other Type, Malariagen Malaria.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 17 Non-falciparum species only, microscopy, Other Type, Malariagen Malaria
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Selimuzzaman 2010 11 12 1 238 0.92 [ 0.62, 1.00 ] 0.95 [ 0.92, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 18. Non-falciparum species only, PCR, Type 3, CareStart Pf/Pan.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 18 Non-falciparum species only, PCR, Type 3, CareStart Pf/Pan
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Xiaodong 2013 59 0 6 113 0.91 [ 0.81, 0.97 ] 1.00 [ 0.97, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 19. Non-falciparum species only, PCR, Type 3, Parascreen.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 19 Non-falciparum species only, PCR, Type 3, Parascreen
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bendezu 2010 67 3 21 241 0.76 [ 0.66, 0.85 ] 0.99 [ 0.96, 1.00 ]
Elahi 2013 49 3 5 270 0.91 [ 0.80, 0.97 ] 0.99 [ 0.97, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 20. Non-falciparum species only, PCR, Type 3, One Step Malaria Pf/Pan.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 20 Non-falciparum species only, PCR, Type 3, One Step Malaria Pf/Pan
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Yan 2013 51 15 20 520 0.72 [ 0.60, 0.82 ] 0.97 [ 0.95, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 21. Non-falciparum species only, PCR, Type 3, SD Malaria Antigen Bioline.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 21 Non-falciparum species only, PCR, Type 3, SD Malaria Antigen Bioline
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ratsimbasoa 2008 14 1 8 173 0.64 [ 0.41, 0.83 ] 0.99 [ 0.97, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 22. Non-falciparum species only, PCR, Type 3 (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 22 Non-falciparum species only, PCR, Type 3 (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bendezu 2010 67 3 21 241 0.76 [ 0.66, 0.85 ] 0.99 [ 0.96, 1.00 ]
Elahi 2013 49 3 5 270 0.91 [ 0.80, 0.97 ] 0.99 [ 0.97, 1.00 ]
Ratsimbasoa 2008 14 1 8 173 0.64 [ 0.41, 0.83 ] 0.99 [ 0.97, 1.00 ]
Xiaodong 2013 59 0 6 113 0.91 [ 0.81, 0.97 ] 1.00 [ 0.97, 1.00 ]
Yan 2013 51 15 20 520 0.72 [ 0.60, 0.82 ] 0.97 [ 0.95, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 23. Non-falciparum species only, PCR, Type 4, OptiMAL (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 23 Non-falciparum species only, PCR, Type 4, OptiMAL (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Rakotonirina 2008 15 6 2 290 0.88 [ 0.64, 0.99 ] 0.98 [ 0.96, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
178Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries (Review)
Copyright © 2015 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Test 24. P. vivax, microscopy, Pf HRP-2 and Pv pLDH, Carestart Pf/Pv (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 24 P. vivax, microscopy, Pf HRP-2 and Pv pLDH, Carestart Pf/Pv (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Chanie 2011 25 4 0 1063 1.00 [ 0.86, 1.00 ] 1.00 [ 0.99, 1.00 ]
Mekonnen 2010 61 0 3 176 0.95 [ 0.87, 0.99 ] 1.00 [ 0.98, 1.00 ]
Sharew 2009 155 9 1 503 0.99 [ 0.96, 1.00 ] 0.98 [ 0.97, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 25. P. vivax, microscopy, Pf HRP-2 and Pv pLDH, Biotech Malaria Pf/Pv.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 25 P. vivax, microscopy, Pf HRP-2 and Pv pLDH, Biotech Malaria Pf/Pv
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Samane 2010 110 0 2 138 0.98 [ 0.94, 1.00 ] 1.00 [ 0.97, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 26. P. vivax, microscopy, Pf HRP-2 and Pv pLDH, Falcivax.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 26 P. vivax, microscopy, Pf HRP-2 and Pv pLDH, Falcivax
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Alam 2011 19 1 2 316 0.90 [ 0.70, 0.99 ] 1.00 [ 0.98, 1.00 ]
Singh 2010 45 3 23 301 0.66 [ 0.54, 0.77 ] 0.99 [ 0.97, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 27. P. vivax, microscopy, Pf HRp-2 and Pv pLDH, Onsite Pf/Pv.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 27 P. vivax, microscopy, Pf HRp-2 and Pv pLDH, Onsite Pf/Pv
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Alam 2011 19 4 2 313 0.90 [ 0.70, 0.99 ] 0.99 [ 0.97, 1.00 ]
Mohon 2012 71 4 2 295 0.97 [ 0.90, 1.00 ] 0.99 [ 0.97, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 28. P. vivax, microscopy, Pf HRP-2 and Pv pLDH, Pf/Pv Malaria Device.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 28 P. vivax, microscopy, Pf HRP-2 and Pv pLDH, Pf/Pv Malaria Device
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Yan 2013 45 5 16 284 0.74 [ 0.61, 0.84 ] 0.98 [ 0.96, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 29. P. vivax, microscopy, Pf HRP-2 and Pv pLDH (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 29 P. vivax, microscopy, Pf HRP-2 and Pv pLDH (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Alam 2011 19 1 2 316 0.90 [ 0.70, 0.99 ] 1.00 [ 0.98, 1.00 ]
Chanie 2011 25 4 0 1063 1.00 [ 0.86, 1.00 ] 1.00 [ 0.99, 1.00 ]
Mekonnen 2010 61 0 3 176 0.95 [ 0.87, 0.99 ] 1.00 [ 0.98, 1.00 ]
Mohon 2012 71 4 2 295 0.97 [ 0.90, 1.00 ] 0.99 [ 0.97, 1.00 ]
Samane 2010 110 0 2 138 0.98 [ 0.94, 1.00 ] 1.00 [ 0.97, 1.00 ]
Sharew 2009 155 9 1 503 0.99 [ 0.96, 1.00 ] 0.98 [ 0.97, 0.99 ]
Singh 2010 45 3 23 301 0.66 [ 0.54, 0.77 ] 0.99 [ 0.97, 1.00 ]
Yan 2013 45 5 16 284 0.74 [ 0.61, 0.84 ] 0.98 [ 0.96, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 30. P. vivax, PCR, Pf HRP-2 and Pv pLDH, Falcivax.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 30 P. vivax, PCR, Pf HRP-2 and Pv pLDH, Falcivax
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Alam 2011 20 0 6 312 0.77 [ 0.56, 0.91 ] 1.00 [ 0.99, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 31. P. vivax, PCR, Pf HRP-2 and Pv pLDH, OnSite Pf/Pv.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 31 P. vivax, PCR, Pf HRP-2 and Pv pLDH, OnSite Pf/Pv
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Alam 2011 20 3 6 309 0.77 [ 0.56, 0.91 ] 0.99 [ 0.97, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 32. P. vivax, PCR, Pf HRP-2 and Pv pLDH, Pf/Pv Malaria Device.
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 32 P. vivax, PCR, Pf HRP-2 and Pv pLDH, Pf/Pv Malaria Device
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Yan 2013 43 7 30 270 0.59 [ 0.47, 0.70 ] 0.97 [ 0.95, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 33. P. vivax, PCR, Pf HRP-2 and Pv pLDH (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 33 P. vivax, PCR, Pf HRP-2 and Pv pLDH (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Alam 2011 20 3 6 309 0.77 [ 0.56, 0.91 ] 0.99 [ 0.97, 1.00 ]
Yan 2013 43 7 30 270 0.59 [ 0.47, 0.70 ] 0.97 [ 0.95, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 34. P. vivax, PCR, Type 6, PALUTOP (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries
Test: 34 P. vivax, PCR, Type 6, PALUTOP (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Rakotonirina 2008 19 0 2 292 0.90 [ 0.70, 0.99 ] 1.00 [ 0.99, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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A D D I T I O N A L T A B L E S
Table 1. Types of malaria RDTs by antigen combination and parasite species detected
Type of test Antigen combinations Possible results
Type 1 HRP-2 (P. falciparum specific) No Pf; Pf; invalid
Type 2 HRP-2 (P. falciparum specific) and aldolase (pan-specific) No malaria; Pf or mixed; Pv, Pf, or Pm; invalid
Type 3 HRP-2 (P. falciparum specific) and pLDH (pan-specific) No malaria; Pf or mixed; Pv, Pf, or Pm; invalid
Type 4 pLDH (P. falciparum specific) and pLHD (pan-specific) No malaria; Pf or mixed; Pv, Pf, or Pm; invalid
Type 5 pLDH (P. falciparum specific) and pLHD (P. vivax-spe-
cific)
No malaria; Pf; Pv; Pf and Pv; invalid
Type 6 HRP-2 (P. falciparum specific), pLHD (pan-specific) and
pLDH (P. vivax specific)
No malaria; Pf and Pv ± Po and/or Pm; Pf ± Po and/or
Pm; Pv ± Po or Pm; Po or Pm; invalid
Type 7 Aldolase (pan-specific) No malaria; Pf, Pv, Po,or Pm; invalid
Other HRP-2 (P. falciparum specific) and pLDH (P. vivax spe-
cific)
No malaria; Pf; Pv; Pf and Pv; invalid
Table 2. Malaria ’zones’ by endemic parasite species and type of test appropriate for each
Zone Endemic malaria parasites Geographic area Appropriate test type
1 P. falciparum only or other species almost
always as a mixed infection
Most of sub-Saharan Africa; lowland
Papua New Guinea
Tests using HRP-2 to detect P. falci-
parum only
(Type 1)
2 Both P. falciparum and P. vivax, most
commonly as a single species
Asia and the Americas; Ethiopian high-
lands
Combination RDTs which detect all
species and distinguish between P. falci-
parum and P. vivax
(Types 2 to 6)
3 Non-falciparum only Vivax-only areas of East Asia and Cen-
tral Asia; some highland areas elsewhere
Pan-specific or vivax-specific RDTs
(Type 7; Pan-pLDH only; vivax-pLDH
only)
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Table 3. Number of studies by RDT type and reference standard
Type of RDT Number of study cohorts (test evaluations) by reference standard
Microscopy PCR
Non-falciparum species in the absence of P. falciparum
Type 2 11 (11) 0 (0)
Type 3 23 (25) 5 (5)
Type 4 10 (11) 1 (1)
Other type 1 (1) 0 (0)
P. vivax
Pf HRP2 and Pv pLDH 8 (9) 2 (3)
Type 6 0 (0) 1 (1)
Table 4. False negatives for non-falciparum and P. vivax by RDT type
Study Test Number of false nega-
tives
% false negatives indi-
cating ’no malaria’
% false negatives indi-
cating ’P. falciparum’
Type 2 tests
Ashton 2010 ICT Combo 37 22 78
Bell 2001a ICT Malaria trial 1 16 13 88
Bell 2001b ICT Malaria trial 2 6 67 33
Fernando 2004 ICT Malaria Pf/Pv 29 100 0
Harani 2006 ICT Malaria Pf/Pv 3 67 33
Singh 2000a ICT Malaria Pf/Pv 13 62 38
Singh 2010 Malascan 18 67 33
Tjitra 1999 ICT Malaria Pf/Pv 8 75 25
van den Broek 2006 NOW malaria ICT 72 67 33
Wongsrichanalai 2003 ICT Malaria Pf/Pv 9 67 33
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Table 4. False negatives for non-falciparum and P. vivax by RDT type (Continued)
van den Broek 2006 OptiMAL-IT 34 74 26
Median (range) 67 (13 to 100) 33 (0 to 88)
Pooled estimate (95% CI)* 65 (43 to 81) 35 (19 to 57)
Type 3 tests
Ashton 2010 Carestart 37 22 78
Ashton 2010 Parascreen 43 14 86
Bendezu 2010 Parascreen 19 84 16
Bharti 2008 First response 7 100 0
Dev 2004 Diamed OptiMAL 3 100 0
Eibach 2013 CareStart 3 100 0
Elahi 2013 Parascreen 5 60 40
Kosack 2013 SD Bioline 133 89 11
Moges 2012 Carestart 38 89 11
Ratsimbasoa 2007 SDMalaria Antigen Bio-
line
4 100 0
Singh 2010 Parascreen 13 54 46
Singh 2010 First response 9 33 67
Singh 2010 ParaHIT Total 48 92 8
Trouvay 2013 SD Malaria Ag Pf/Pan 18 78 22
Yan 2013 Pf/Pan Device 24 25 75
Median (range) 84 (14 to 100) 16 (0 to 86)
Pooled estimate (95% CI) 74 (52 to 88) 26 (12 to 48)
Type 4 tests
Andrade 2010 OptiMAL-IT 0 0 0
Chayani 2004 OptiMAL 3 100 0
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Table 4. False negatives for non-falciparum and P. vivax by RDT type (Continued)
Dev 2004 SD Malaria 2 100 0
Kolaczinski 2004 OptiMAL 23 100 0
Metzger 2011 OptiMAL-IT 30 100 0
Pattanasin 2003 OptiMAL-IT 26 65 35
Ratsimbasoa 2007 OptiMAL-IT 2 100 0
Ratsimbasoa 2007 Carestart Malaria 3 33 67
Singh 2003 OptiMAL (field) 0 0 0
Soto Tarazona 2004 OptiMAL 3 100 0
Valecha 2003 OptiMAL 13 77 23
Median (range) 100 (0 to 100) 0 (0 to 67)
Pooled estimate (95% CI) 87 (79 to 92) 13 (8 to 21)
*The pooled estimates of the percentage of false negatives indicating ’no malaria’ and the percentage of false negatives indicating
’P. falciparum’ were computed by using a random effects logistic regression model for Type 2 and Type 3. A fixed effects logistic
regression model was used for Type 4.
This table shows participants with non-falciparum malaria monoinfection identified by microscopy who were negative by non-fal-
ciparum monoinfection by RDT, by whether the RDT incorrectly identified the participant as not having malaria, or as having P.
falciparum malaria.
Table 5. Non-falciparum infections by RDT types verified by microscopy
RDT Type Study cohort Participants Malaria cases Pooled sensitivity
(95% CI) (%)
Pooled specificity
(95% CI) (%)
Test1
Type 2 11 6879 958 78 (73 to 82) 99 (97 to 99) P = 0.008
Type 3 23 11,234 1537 78 (69 to 85) 99 (98 to 99)
Type 4 10 3831 986 90 (79 to 95) 98 (97 to 99)
Other type 1 262 12 92 (62 to 100) 95 (92 to 98)
1Likelihood ratio test for evidence of a difference in sensitivity or specificity, or both, between Types 2, 3, and 4.
*Only one test brand (randomly selected) from each cohort is included in the analysis of each type.
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Table 6. Comparisons of RDT types for non-falciparum infections verified by microscopy
Ratio of sensitivity
(95% CI),
P value for comparison
Ratio of specificity
(95% CI),
P value for comparison
Type 2 Type 3
Studies (participants) 11 (6879) 23 (11,234)
Studies (participants) Sensitivity (95% CI)
Specificity (95% CI)
78 (73 to 82)
99 (97 to 99)
78 (69 to 84)
99 (98 to 99)
Type 2 11 (6879) 78 (73 to 82)
99 (97 to 99)
- -
Type 3 23 (11,234) 78 (69 to 84)
99 (98 to 99)
1.00 (0.89 to 1.12), P =
1.00
1.00 (0.99 to 1.01), P =
0.87
-
Type 4 10 (3831) 90 (79 to 95)
98 (97 to 99)
0.87 (0.78 to 0.96), P =
0.01
1.00 (0.99 to 1.02), P =
0.52
0.87 (0.76 to 0.99), P =
0.03
1.01 (1.00 to 1.02), P =
0.29
We computed the ratio of sensitivities and specificities by division of the sensitivity and specificity for the column by the sensitivity
and specificity for the row. If the ratio of sensitivities is greater than one, the sensitivity of the test for the column is higher than
that for the row; if less than one, the sensitivity of the test in the row is higher than in the column. The same applies to the ratio of
specificities.
A P P E N D I C E S
Appendix 1. Search strategy
Search set MEDLINE EMBASE
1 Exp Malaria[MeSH] Exp Malaria [Emtree]
2 Exp Plasmodium [MeSH] Exp Plasmodium [Emtree]
3 Malaria ti, ab Malaria ti, ab
4 1 or 2 or 3 1 or 2 or 3
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(Continued)
5 Exp Reagent kits, diagnostics [MeSH] Exp Diagnostic procedures [Emtree]
6 rapid diagnos* test* ti, ab rapid diagnos$ test$ ti, ab
7 RDT ti, ab RDT ti, ab
8 Dipstick* ti, ab Dipstick$ ti, ab
9 Rapid diagnos* device* ti, ab Rapid diagnos$ device$ ti, ab
10 MRDD ti, ab MRDD ti, ab
11 OptiMal ti, ab OptiMal ti, ab
12 Binax NOW ti, ab Binax NOW ti, ab
13 ParaSight ti, ab ParaSight ti, ab
14 Immunochromatograph* ti, ab Immunochromatography [Emtree]
15 Antigen detection method* Antigen detection method$
16 Rapid malaria antigen test* Rapid malaria antigen test$
17 Combo card test* ti, ab Combo card test$ ti, ab
18 Immunoassay [MeSH] Immunoassay [Emtree]
19 Chromatography [MeSH] Chromatography [Emtree]
20 Enzyme-linked immunosorbent assay [MeSH] Enzyme-linked immunosorbent assay [Emtree]
21 Rapid test* ti, ab Rapid test$ ti, ab
22 Card test* ti, ab Card test$ ti, ab
23 Rapid AND (detection* or diagnos*) ti, ab Rapid AND (detection$ or diagnos$) ti, ab
24 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or
16 or 17 or 18 or 19 or 20 or 21 or 22 or 23
5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or
16 or 17 or 18 or 19 or 20 or 21 or 22 or 23
25 4 and 19 4 and 19
26 Limit 20 to Humans Limit 20 to Human
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Appendix 2. Data extraction: characteristics of included studies
Study ID First author, year of publication.
Clinical features and settings Presenting signs and symptoms, previous treatments for malaria, clinical setting
Participants Sample size, age, sex, comorbidities or pregnancy, country and locality, P. falciparum malaria en-
demicity, endemic malaria species, average parasite density in microscopy positive cases
Study design Were consecutive patients enrolled retrospectively or prospectively?
Whether the samplingmethodwas consecutive or random, or whether themethodwas not described
but consecutive sampling was most probable
If the study evaluated more than one RDT, how were tests allocated to individuals, or did each
individual receive all the tests?
Target condition Malaria parasitaemia.
Reference standard The reference standard test(s) used.
If microscopy was used, who performed it, and where?
If microscopy was used, how many high power fields were looked at?
If microscopy was used, how many observers or repeats were used?
If microscopy was used, how were discrepancies between observers resolved?
Index tests The parasite species the test was designed to detect, the commercial name, and the type of test. Batch
numbers if provided. Transport and storage conditions. Details of the test operators, including any
special training provided
Notes Source of funding.
Appendix 3. Data extraction and criteria for judgement: methodological quality
Quality indicator Notes
Was the spectrum of patients representative of the spectrum of
patients who will receive the test in practice?
• ’Yes’ if the inclusion criteria clearly stipulated people
attending an ambulatory healthcare setting with symptoms of
malaria, and the sampling method was consecutive or random.
• ’No’ if the sample was unrepresentative of people with
uncomplicated malaria in general (for example, if the majority of
participants also had some other presenting health problem,
such as pneumonia). Where a proportion of potential
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(Continued)
participants were excluded due to recent antimalarial use, well
defined comorbidities or pregnancy, the sample could be classed
as representative because these groups may also be excluded from
testing as normal clinical practice, depending on local policy and
practice.
• ’Unclear’ if the source or characteristics of participants was
not adequately described; or if the sampling method was not
described.
Is the reference standard likely to correctly identify the target con-
dition?
• ’Yes’ if microscopy was undertaken by experienced
microscopists with adequate laboratory facilities. Laboratory
facilities were assumed to be adequate unless the study report
indicated otherwise. Slides were viewed by at least two
independent observers, either for all slides or for those where
there are discordant results between the index and the reference
test. At least 100 microscopic fields were viewed before declaring
a slide negative.
• ’Yes’ if reference standard was PCR.
• ’No’ if microscopy was undertaken by insufficiently trained
individuals, by one individual only, or in a situation with
inadequate equipment, or if they viewed less than 100
microscopic fields before declaring negative.
• ’Unclear’ if insufficient information was provided.
Is partial verification avoided? • ’Yes’ if all participants who received the index test also
received the reference test.
• ’No’ if not all the participants who received the index test
also received the reference test.
• ’Unclear’ if insufficient information was provided to assess
this.
If not all participants received the reference test, we reported how
many did not
Is differential verification avoided? • ’Yes’ if the same reference test was used regardless of the
index test results.
• ’No’ if different reference tests were used depending on the
results of the index test.
• ’Unclear’ if insufficient information was provided.
If any participants received a different reference test, we reported
the reasons stated for this, and how many participants were in-
volved
Is incorporation avoided? (the index test does not form part of the
reference standard)
This should be ’Yes’ for all studies, as the reference standard is
defined in the inclusion criteria as microscopy or PCR
Are the reference standard test results blinded? • ’Yes’ if the person undertaking the reference test did not
know the results of the index tests, if the two tests were carried
out in different places, or it was clear that the reference test was
undertaken and the results recorded before the index test.
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(Continued)
• ’No’ if the same person performed both tests, or the results
of the index tests were known to the person undertaking the
reference tests.
• ’Unclear’ if insufficient information was provided.
Are the index test results blinded? • ’Yes’ if the person undertaking the index test did not know
the results of the reference tests, or if the two tests were carried
out in different places, or it was clear that the index test was
undertaken and the results recorded before the reference test.
• ’No’ if the same person performed both tests, or the results
of the index tests were known to the person undertaking the
reference tests.
• ’Unclear’ if insufficient information was provided.
Were uninterpretable results reported? • ’Yes’ if the paper stated whether there were any
uninterpretable or invalid results, and how those were handled;
for example whether they were repeated until a valid result was
obtained, or excluded from the analysis.
• ’No’ if the number of participants presented in the analysis
did not match the number of participants originally enrolled in
the study, and insufficient explanation was provided for any
discrepancy.
• ’Unclear’ if uninterpretable or invalid test results were not
mentioned, but the number of participants presented in the
analysis corresponded to the number of participants reported to
be originally recruited into the study, or if insufficient
information was given to permit this judgement; for example if
the original number of participants recruited into the study was
unclear.
We reported how many results were uninterpretable (of the total)
and how these were handled in the analysis
Were any withdrawals explained? • ’Yes’ if it was clear that no participants were excluded from
the analysis (the number participants originally enrolled was
clearly stated, and corresponded to the number presented in the
analysis) or if exclusions were adequately described.
• ’No’ if there were participants missing or excluded from the
analysis and there was no explanation given; usually where the
number of participants reported to have been enrolled and the
number presented in the analysis did not correspond.
• ’Unclear’ if not enough information was given to assess
whether any participants were excluded from the analysis; for
example if the original number of participants recruited into the
study was unclear.
We reported how many participants were excluded from the anal-
ysis
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Appendix 4. Direct comparisons between test types
Study Sensitivity (true positives/
malaria cases) (%)
Differ-
ence (95%
CI) (%)
P value Specificity (true negatives/
non-cases) (%)
Difference
(95% CI)
(%)
P value
Type 2 versus Type 3
Type 2 Type 3 Type 2 Type 3
Ashton
2010
85 (209/
246)
85 (209/
246)
0 (-6.3 to 6.
3)
P = 1.00 96 (2052/
2137)
96 (2060/
2137)
0 (-1.5 to 0.8
)
P = 0.58
Eibach 2013 80 (4/5) 60 (3/5) 20.0 (-35.4
to 75.4)
P = 1.00 99 (716/
722)
99 (718/
722)
0 (-1.1 to 0.
6)
P = 0.75
Singh 2010 68 (39/57) 77 (44/57) -8.8 (-25.0
to 7.5)
P = 0.40 98 (308/
315)
98 (309/
315)
0 (-2.5 to 1.
9)
P = 1.00
Type 2 versus Type 4
Type 2 Type 4 Type 2 Type 4
van den
Broek 2006
75 (217/
291)
88 (256/
292)
-13.1 (-19.4
to -6.8)
P < 0.001 100 (604/
605)
99 (598/
604)
0.8 (0 to 1.7) P = 0.07
Type 3 versus Type 4
Type 3 Type 4 Type 3 Type 4
Dev 2004 71 (5/7) 90 26/29 -18.2 (-53.5
to 17.0)
P = 0.24 100 (23/23) 100 (111/
111)
0 (Not es-
timable)
Not
estimable
Ratsimbasoa
2007
73 (11/15) 80 (12/15) -6.7 (-36.8
to 23.5)
P = 1.0 98 (175/
179)
97 (175/
180)
0.50 (-2.7 to
3.8)
P = 1.0
We presented the difference in sensitivities and specificities between test types compared within each study as percentages. If a study
evaluatedmore than one commercial brand of a test type on the same patients against the same reference standard, we randomly selected
one brand for the comparison of test types.
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Appendix 5. Comparison of microscopy and PCR reference standards for non-falciparum infections
Test type,
RDT brand
Microscopy PCR
Number of
studies
Num-
ber of par-
ticipants
Sensi-
tivity (95%
CI) (%)
Speci-
ficity (95%
CI) (%)
Number of
studies
Num-
ber of par-
ticipants
Sensi-
tivity (95%
CI) (%)
Speci-
ficity (95%
CI) (%)
Type
3, CareStart
Pf/Pan
4 3544 74 (45 to
91)
99 (96 to
100)
1 179 91 (81 to
97)
100 (97 to
100)
Type 3,
Parascreen
14 5407 79 (67 to
88)
98 (98 to
99)
2 659 84 (70 to
92)
99 (97 to
100)
Type
3, One Step
Malaria Pf/
Pan
1 606 70 (58 to
81)
99 (98 to
100)
1 606 72 (60 to
82)
97 (95 to
98)
Type 3,
SD Malaria
Antigen Bi-
oline
4 3769 80 (73 to
85)
99 (98 to
100)
1 196 64 (41 to
83)
99 (97 to
100)
Type 4, Op-
tiMAL
6 1843 90 (85 to
93)
98 (97 to
99)
1 313 88 (64 to
99)
98 (96 to
99)
WH A T ’ S N E W
Last assessed as up-to-date: 31 December 2013.
Date Event Description
16 April 2015 Amended Errors in the number of malaria cases were corrected in the Summary of Findings table
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
In the protocol, we considered RDTs for the detection of P. falciparum and non-falciparum malaria within one Cochrane Review.
However, it became apparent during production of the review that such a publication would be very large. For this reason we decided
to split results for the different target conditions into two separate Cochrane Reviews.
In the protocol, we stated that in the search for eligible studies we would contact test manufacturers to identify any unpublished studies,
handsearch conference proceedings and contact study authors and other experts for information on ongoing and unpublished studies.
However, due to the number of citations returned by our search (over 4000) and the large size of the reviews, we did not have the
resources to undertake any of these additional search methods, and the methods stated in the review reflect this.
Since the publication of the protocol, we added three additional exclusion criteria relating to study eligibility. We excluded studies if
the study authors used active case detection to recruit participants, as we felt the threshold of symptoms leading to testing may be lower
than for a self-selecting sample attending healthcare facilities and that this may influence the findings. We also excluded studies if they
did not present sufficient data to allow us to extract or calculate absolute numbers of true positives, false positives, false negatives and
true negatives, as we considered it would be distracting to the reader to present data on studies that did not contribute to the analyses.
Due to resource constraints, we excluded studies if they were written in non-English languages, or if they did not provide enough
information to enable a full assessment of their eligibility for the review.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
Antigens, Protozoan [∗analysis]; Cohort Studies; Malaria [∗diagnosis; immunology; parasitology]; Malaria, Vivax [∗diagnosis; im-
munology]; Microscopy; Parasitemia [diagnosis]; Plasmodium [∗immunology]; Plasmodium vivax [immunology]; Polymerase Chain
Reaction; Reagent Kits, Diagnostic [∗parasitology]; Sensitivity and Specificity; Species Specificity
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Humans
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